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Abstract 
 
Modern medicine continuously develops new artificial short-term or permanent devices to 
assist in the performance of physiological functions. Implantation of medical devices 
represents one of the most important risk factors of all nosocomial infections, when implant 
materials become infected due to bacterial adhesion and subsequent formation of bio films. 
The latter are impossible to treat with antibiotics and represent a dramatic complication for 
the patient, leading to implant replacement, in the worst case to death. Therefore, prevention 
of bacterial adhesion and bio film formation is important.  
We have developed new coordination compounds with silver ions and specially designed 
ligands. This way, one can tune the structure, the light stability and, most importantly for the 
biological application, the solubility. With an appropriate chemical linker, one is able to 
connect such compounds to metallic surfaces forming a nano-structured coating. We analyzed 
the coated surfaces and present the nano-structured surface topography. The chemical 
composition of the coating on Au(111) as a model surface, the antimicrobial properties of the 
coated implants, and, on a molecular level, the interaction of silver ions with peptide 
sequences and subsequent silver nanoparticle formation are presented in this thesis.  
We have investigated this coating using several methods, namely powder X-ray, XPS, AFM, 
SEM, micro- and nano-calorimetry and antimicrobial studies with different bacteria. XPS and 
powder x-ray analyses have shown that the deposited compound is [Ag(L)NO3], described 
previously. The AFM revealed peak-like nano-structures and the SEM measurements the 
bigger sized crystalline structures 0.5-1000 µm. AAS method have been used to determine the 
silver loading on the surface in function the crystallisation time and the concentration. The 
results show that we are able to control the silver loading on the surface choosing the 
appropriate treating conditions. Our silver coordination compound was shown to form regular 
material coatings on different metal substrates. 
Several anti-microbial tests were carried out. Flow-chamber experiments with S. sanguinis 
have been done to test the coating on dental implant material. The vitality of adhered bacteria 
was evaluated by applying a dual fluorescent staining, with the result that 99% of bacteria 
were killed. Plating of coated samples (Au(111) and titanium and steel restorative implant 
materials) in agar in presence of S. epidermis or S. aureus for 24h showed the formation of 
large inhibition zones of the order of >2 cm. In vivo microbiological assays show a high 
efficiency of the silver coating against S. epidermis. The antimicrobial properties were 
confirmed by microcalorimetry, measuring the bacterial cell multiplication heat. Furthermore 
the antimicrobial properties are proven for dental as well as general implant materials. 
To study the working mechanism of the silver inside of the bacteria and determining the silver 
affinity of some amino acids and short amino acid sequences, on-bead screening of split-and-
mix libraries have been used. It is a powerful tool for the identification of peptides that attach 
the silver and induce the formation of silver nanoparticles (AgNPs) when using either light or 
a chemical reducing agent. It allowed identifying simple tripeptides that would have been 
difficult to predict rationally. In addition, the study revealed peptide motives that generate 
AgNPs with distinctly different sizes. Some microbiological assays have been done using 
isothermal microcalorimetry method to test the antimicrobial effect of the generated AgNPs. 
We have thus developed a new coating which is able to stop bacterial adhesion and 
multiplication, while being biocompatible with fibroblasts. 
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1 Introduction 
 
The title of the thesis: “Novel silver containing antimicrobial coatings for implant 
materials: new applications of Ag(I) coordination networks” suggests a complex 
interdisciplinary work based on chemistry using knowledge of materials and surface sciences, 
the analytical methods and the understanding of microbiology to finally give a useful solution 
to medicine. Prior to the report of our results, some main topics should be discussed.   
 
At the beginning of the 20th century, coordination chemistry became an individual discipline 
of the chemistry thanks to Werner’s theory. In a complex molecule, the central metal atom 
binds, via coordination bonds, ligand molecules in a determined geometry. The crystal field 
theory completed Werner’s model. Since 1950, the scientists use these theories to explain the 
coordination bond. The molecular orbitals of the central metal atom determine the geometry 
e.g. as octahedral, tetrahedral and square planar of the complex. Since these coordination 
compounds have in general a determined geometry, this facilitates the special arrangements in 
the solid state, and thus the crystallisation. Hence, the principal analytical method for solid 
state coordination compounds is X-ray crystallography. The huge variety of the possible 
coordinating ligands, which can be mono-, bi-, tri-, tetra-, polydentate (depending on how 
many coordination sites are present in the molecule) or open chain or cyclic ligands results in 
a large number of a possible compounds. If the metal atom is coordinating to more than one 
ligand and the ligand is able to bond to at least two different metal atoms, the possibility to 
build an infinite network via coordination bonds exists. Compounds formed in such a way are 
called coordination networks or coordination polymers referring to the organic polymers. The 
number of structures of coordination networks can be infinite due to the large variety of the 
ligand molecules and metal ions. 
The motif of the ligand-metal 
network can vary from linear one 
dimensional (1D) chains to 
complicated 3D motifs.  
Coordination chemistry and polymer networks 
 
Figure 1-1: 1D linear chain motif 
of {[Ag(L1)PF6]}n coordination polymer. [207] 
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Figure 1-2, Polycatenane 3D 
motif of {[Ag(L1)SO3CF3]}n 
coordination polymer [207] 
 
 
 
 
 
Transition metal ions are generally used to build up coordination compounds. For these 
special coordination compounds (coordination networks), the d10 metals (Ag, Cu) are widely 
used because their flexible coordination sphere allows building up various structures with N, 
O and/or S donor atom containing ligands. Silver may have the oxidation states Ag(I), Ag(II), 
and Ag(III) [208].  Ag(II) complexes are less stable than those of Ag(I) and Ag(III), which 
not very stable either [209]. The most stable and used one is Ag(I). Ag(I) has a very flexible 
coordination sphere: it can adopt coordination number from 2 to 6 (from linear geometry 
[210,211] to octahedral [203] respectively), and it prefers to form simple linear chain motifs. 
Ag(I) being a soft Lewis acid, it has a coordination preference with donor atoms in the order 
S>N>O. Silver ions bind to ligands and organic molecules not only in glassware in the 
chemistry laboratory, but it binds readily to proteins in the human body (including albumins 
and metallothioneins) and interacts with trace metals in metabolic pathways [197]. 
 
For thousands of years, silver was used as a noble metal: as money or as tableware. In parallel 
to the common wear of the metal, the silver chemistry also developed fast. Hippocrates, who 
described the virtues of silver in healing, mentions the biological effect. The Phoenicians also 
used to store water, wine, and vinegar in silver bottles to prevent spoiling. In the early 1800s, 
doctors used silver sutures in surgical wounds with very successful results. Silver compounds 
were applied successfully to prevent infections in World War I. Prior to the discovery of 
Silver in the past 
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antibiotics silver leaf was used to combat infection in wounds sustained by troops during the 
war. By 1940, there were approximately four dozen different silver compounds on the market. 
They were used to treat every known infectious disease. The widespread use of silver went 
out of fashion with the development of modern antibiotics. Recently, however, there has been 
renewed interest in silver as a broad-spectrum antibiotic. These are designed to prevent 
infections as part of wound management procedures, in particular applicable to burn victims 
[79].   
In the 18th century, another important invention drew attention to the silver compounds. 
Johann Heinrich Schulze made the first «pictures» of an image using light, in 1727. Schulze 
found that silver nitrate solution would darken in response to light, forming a transient image, 
but these images darkened with the time. In 1839, however, Louis J. M Daguerre patented a 
new procedure based on silver halide photochemistry and included a process for making the 
image permanent. At the end of the nineteenth century, William Henry Fox Talbot improved 
the process for coating silver halides directly on paper in combination with a hyposulfite 
fixative. Although technologically more advanced, the basic procedures developed by Fox 
Talbot are used in all silver-based photography. In the era of the numeric photography, the 
light sensitivity of the silver salts and other silver compounds gets another meaning: The 
silver nanoparticle formation by photochemical induction or the preparation of light stable 
silver compounds comes into the focus of interest.  
 
The main interest turned again to the well-known antimicrobial effect of silver. In everyday 
life numerous products can be found containing silver:  
Silver today 
In a medical use: Elastoplast® Silver Healing™ bandages: The pads in these bandages 
contain silver ions. Silver Sulfadiazine: is an antibacterial and antifungal agent. It is used as a 
topical cream to prevent and treat skin infections on areas of burned skin. Silver Chloride has 
the ability to eliminate or flush out mercury from the body and it is used as a thin coating on 
the surface of medical electrodes for ECG machines.  
In other fields of life: Washing machines introduced by Samsung inject silver ions into the 
wash and rinse cycles to kill 99.9% of bacteria causing undesirable odours. Silver atoms, 
electrolytically removed of an electron, are injected during the wash and rinse cycles, 
allowing over 1017 silver ions to penetrate deep into the fabric to “sterilize” clothing without 
the need for hot water or bleach. These machines can wash about 3,100 loads using 31.1 
grams of silver metal. This new invention seems to be very practical in the household, but 
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nothing is known about the environmental consequences. Several kinds of silver containing 
(mainly as nanoparticles) underwear are sold on the market. One thing is common to all these 
products: they exploit the antimicrobial effect of silver. 
 
With the spreading use of silver, the question of the toxicity becomes an issue. As silver is 
part of the group of heavy metals, this question should be clarified. Silver is much better 
tolerated by the body than most heavy metals [3]. The concentration level where silver is 
efficient against bacteria but not harmful for the human organism is very important. We are 
not living in a “silver free” environment. Silver is the sixty-third most abundant metal in the 
Earth's crust; the average concentration of silver in water is 0.5 ppb, in soil it is 10 ppb. To 
illustrate the toxicity of the silver compounds some examples are given. For silver oxide the 
LD50 for rats at oral intake is 2820 mg/kg [188], and for silver nitrate the LD50 for mice at oral 
intake is 50 mg/kg [159]. (Silver metal) Oral LD50 (rat): >5000 mg/kg [4]. Studies 
concerning silver coated medical technologies report that silver ion concentrations higher than 
10 mg/L may be toxic to certain human cells [141] other studies shows higher limits 18 mg/L 
for AgNO3 [138]. The body of an adult contains approximately 2 mg of silver. Our daily 
intake of silver is 0.02-0.08 mg, of which approximately 10% is absorbed. The drinking water 
guideline for silver is 0.05 mg/L, if a guideline is fixed at all. At higher silver salt intake, the 
body may protect itself by converting it to insoluble silver chloride [5]. The toxicity of the 
insoluble salts is high, but silver ions are only present in low concentration, which it is not 
active against the micro organisms. Since the early part of the 20th century, doctors have 
known that silver or silver compounds can cause some areas of the skin and other body tissues 
to turn gray or blue-gray. The argyria occurs in people who eat or breathe in silver over a long 
period (several months to many years e.g. in silver mines). A single exposure to a silver 
compound may also cause silver to be deposited in the skin and in other parts of the body; 
however, this is not known to be harmful. It is likely that many exposures to silver are 
necessary to develop argyria. Once the disease develops, it generally remains permanent. The 
condition is not simply a "cosmetic problem". Discoloration of the skin seen in argyria is 
however not the most serious health effect of silver. In extreme cases it has been observed to 
cause brain damage [6], seizures [7], and death or a 
Silver in the body 
persistent vegetative state [8].  
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While silver is commonly used in every day life, silver compounds are also present in the 
medical use.  Different silver complexes are already subjects in research. It might be possible 
to design chemotherapeutic agents that employ silver complexes [9]. It has also been shown 
that silver chelates are more effective than silver salts as therapeutical agents. It was found 
that the chelated silver efficiency is much larger (ca.30 times) than the efficiency of the “free” 
silver [10]. Numerous silver compounds are studied for their antimicrobial activity. The 
antimicrobial silver compound and products can be divided into two main groups regarding 
the oxidation state of silver. The first group summarizes the compounds of silver salts and 
complexes containing silver ions. Several studies have been done on these compounds. Silver 
complexes can be prepared using amino acids or other biologically active molecules as ligand 
[11] or sulphur donor atom containing ligands [12,13]. Complexes have been successfully 
tested regarding their antimicrobial activity prepared from phosphates [14] cyanides [15] and 
carbenes [16] Naturally, silver salts are also present in the list of the antimicrobial agent [17-
19]. The “packing” of the silver complex is also important since it determines the stability and 
usability. Some silver complex containing composite [20,19], hydrogels [22], films [23,21] 
and oils [25] are known and used. The compounds/products based on silver nanoparticles 
belong to the second group. Several hundreds of silver nanoparticle containing 
compounds/products are known. The size of the nanoparticles, their production and 
stabilisation methods and their form in the substrates containing nanoparticles can be various. 
Nowadays, the use of these particles is trendy [26-28]; yet, their toxicity is also in the current 
societal discussion.  
Silver in medicine 
 
Biomaterials are materials and/or devices developed essentially for medical applications. 
Biomaterials must fulfil the mechanical and biological requirements for their use. They have 
to be sterilizable, solid, not degradable and easily manufactured. The most important 
requirement remains the biocompatibility. Biocompatibility of the implanted material is 
determined by the host response. This means that the implant material must not generate 
undesirable effects such as biofilm formation or infections, but should help the bio 
integration, e.g. Osseo integration. Therefore, the implant material should at best behave in 
the same way as the original body part that is supposed to be replaced by the implant. This is 
a huge challenge for the medical technical industry. There is an impressive diversity of 
implants and materials on the market, which facilitates finding the required implant for a 
Biomaterials and implants  
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patient. The most commonly used hip implants may have different forms: the metal neck, 
placed into the femur during the implantation, is made generally from titanium and has 
various forms and lengths to increase the stability. The surface roughness of this part of the 
implant can also vary to help the Osseo integration. The diversity of the materials used for the 
head and the cup is also large: The metal and polymer implants are the most commonly used 
hip replacement implants.  
Figure 1-3:  Scheme of a modern hip implant [29] 
 
 
 
 
 
Metal-on-metal implants do not wear out as quickly as 
the metal and plastic materials. The metal and plastic 
implants wear out at a rate of about 0.1 millimetres 
each year. The metal-on-metal implants loose only 
about 0.01 millimetres each year. The metal wear metal ions are however released into the 
blood, which might cause serious medical problems. Ceramic-on-ceramic implants are 
designed to be the most resistant in wear but some cases are known where implants broke 
inside the body. The newest group of the hip implants, using metal and highly cross linked 
polyethylene is designed to be most resistant against the wear. This diversity in material and 
geometry offers the patient individual treatment. The various choices, however might create 
confusion.  
Other implants: knee implants and dental implants have also a huge market. 
 
Figure 1-4: Scheme of a knee implant and a dental implant [30] and [31] 
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The diversity in the materials is also present for the knee and dental implants, but titanium 
metal remains one of the most used materials. Its mechanical characteristics are very good and 
easy to manufacture. The oxide surface is chemically stable and inert in the body. However, 
its Osseo integration is not as good as it should be. During the wear, small particles are 
removed from the surface, causing inflammation around the implant. The infection caused by 
the micro particles of titanium is just one of the series of problems. Bacterial biofilm 
formation and infection are most frequently the origin of an implant loosening. If an implant 
should be removed due to infection and/or inflammation another temporary implant is used to 
help the healing of the surrounding parts of the body. This temporary implant is generally 
mechanically not as stable as the definitive one, needing to be treated with antibiotics on the 
surface to help the healing process. Besides, complementary oral antibiotic treatment is also 
needed. At the end of the treatment, the temporary implant is replaced by a definite one. This 
whole process requires 3 operations, a long healing time and high medical costs. Prevention 
of the infection and biofilm formation, or using a material having an antimicrobial coating as 
replacement implant may thus decrease the healing time and the medical costs.   
 
Implant coatings
The purpose of such coated implant materials is to prevent the biofilm formation followed by 
infections. Out of 2.6 million orthopaedic implants inserted annually into humans in the 
United States, approximately 112,000 (4.3%) become infected. The annual infection rate for 
cardiovascular implants is even higher (7.4%). When considering all implanted devices, the 
number of implant-associated infections approaches approximately 1 million per year [32]. To 
avoid these undesirable side effects several coatings for implants have been developed. 
Coatings have been developed to reduce bacterial adhesion, which is the initial step of the 
biofilm formation (described later), by altering the physicochemical characteristics of the 
substrate. Thus, these coatings do not favour the bacteria-substrate interactions. These 
coatings are referred to as ‘‘passive’’ or anti-adhesive and include surfaces modified with e.g. 
poly(ethylene glycol) [33], poly(ethylene oxide) brushes [34], and hydrophilic polyurethanes 
[35]. Unfortunately, the activity of passive coatings reducing the bacterial adhesion is limited 
and varies depending on bacterial species. Other coatings have antimicrobial characteristics to 
prevent biofilm formation. One part of these coatings contains antibiotics on the surface [36] 
[37]. Vancomycine has been successfully attached on titanium surfaces and shows a good 
anti-microbial activity against S.aureus [38].    
:  
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Figure 1-5: Vancomycine attached on a titanium implant surface [38]  
 
 
Another approach modifies the surface using for example peptides [40-42] or flavonoids [43] 
to render it antibacterial. The acquired bacterial resistance against antibiotics makes these 
solutions vulnerable. A major part of the surface modification of the implant materials is 
realized with silver containing compounds. The most current method to have an antimicrobial 
silver coating is to use silver nanoparticles in the coating. These nanoparticles can be 
“packed” [39] for example in hydroxyapatite [44-45] or use silver metal as a deposit on the 
surface [46,141]. Also silver complexes are used as coating of the implant materials: [47,48]. 
Sheehan et al reported that silver coatings applied to model orthopaedic implants did not 
result in decreased S.epidermidis and S.aureus adhesion [49]. An explanation for the limited 
antibacterial efficiency of silver coatings is that they do not actively release silver ions. 
Notably, the antibacterial properties of silver have been attributed to its oxidized form (i.e., 
Ag+), a form of silver that is not necessarily present at a surface coated with metallic silver. 
Polymers that actively release silver in the oxidized state, however, have exhibited strong 
antibacterial activity [50]. Such coatings act as reservoirs of silver and are capable of 
releasing bactericidal levels of Ag+ for extended periods (>3 months) [51]. These materials 
can release silver ions from the polymer reservoir [52] or small silver nanoparticles [53] but 
the key issue in the antimicrobial activity of these silver containing coatings is the 
concentration of the released Ag+. 
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Infection remains a major problem of the long-term use of many implanted devices like joint 
prostheses, catheters or dentures [54]. Frequently, failure of such devices comes from bacteria 
biofilm built up on a surface of the device. This biofilm is extremely resistant to host defence 
mechanisms [55] and antibiotic treatment [56]. Often, the only solution is the surgical 
removal of the infected device. Bacterial adhesion on a surface of the biomaterial is the 
essential cause of the infection, however, the mechanism of this process has not been 
understood in detail. It has been shown that Coagulase Negative Staphylococci are the most 
commonly reported pathogens. These bacteria, most commonly S.epidermidis, are normal 
inhabitants of human skin. The most important characteristic of these bacteria is the ability to 
colonize by forming a thick, multilayered biofilm on a surface of the foreign-body [57]. 
S.epidermidis does not produce as many toxins as S.aureus but adheres fast to the surface and 
remains there under a protective layer of extra cellular material. The adhered mass of bacteria 
and its extra cellular polymeric material (slime) on a solid surface are called biofilm. The 
following figure (Fig.1-6) [58] shows a model of S.epidermidis biofilm formation and 
bacterial factors that play a role in this process. 
Bacterial adhesion and biofilm formation 
 
 
Figure 1-6: Scheme of the process of biofilm formation  
 
1 Introduction           
 
Novel silver containing antimicrobial coatings for implant materials: new applications of Ag(I) coordination networks 12 
Bacterial strains that do not produce slime are less adherent and less pathogenic. Bacteria that 
do not adhere quickly on a surface are rapidly killed by the cleaning mechanism of the body. 
Slime-forming bacteria are less susceptible to antibiotics (ex. Vancomycin) when they are on 
a surface.  
In a first phase of the biofilm formation, the bacterial adhesion is initiated by an attraction 
between the cell and a surface. The initial attraction is followed by an adsorption and 
attachment. From a physicochemical point of view, we can distinguish two types of 
interactions: long-range interactions (distances > 50nm) take place during the free movement 
of the bacteria described by mutual forces. The bacteria are transported to the surface by these 
forces. The short-range interactions (distances ≤ 5nm) become more important when the cell 
and the surface come into close contact. This can be a chemical bond or ionic and dipole 
interactions. In phase two, the molecular and cellular interaction between the bacteria and a 
surface become predominant. These kinds of molecular interactions reinforce the adhesion 
and act like a bridge between the surface and the cell wall. S.epidermidis has several 
polysaccharide adhesins that mediate the adhesion of this bacterium to various material 
surfaces. [58]. 
There are several factors influencing the bacterial adhesion. Here, some of these important 
influencing factors are described, focused on the general environmental and the surface 
characteristics. These environmental characteristics, e.g. time, temperature, bacterial 
concentration and flow condition or presence of an antibiotic, do affect the bacterial adhesion.  
Among others, the flow conditions are considered as one of the most important factors. 
Numerous works have been made studying this during the last decades. The flow conditions 
strongly influence the number of the surface attached bacteria [59] as well as the biofilm 
structure [60]. It was generally shown that higher shear rates generate a decrease in bacterial 
attachment and make the biofilm denser and thinner. After the bacterium reaches the surface, 
it is able to interact with the surface. The number of bonds joining the bacterium to the 
surface can vary. There is a balance between the force of the bonds and the force of the flow. 
If the shear stress is higher than the bonding force, the bond breaks up. If the number of the 
bonds decreases under a certain level, the bacterium begins to detach. There is an optimum 
flow rate regarding the biofilm formation where the delivery of bacteria by the flow is high 
enough and the shear stress low enough to make the best conditions [61]. As the number of 
bonds attaching the bacterium to the surface is variable, in a case of higher flow rates, the 
elevated shear stress on the attached bacteria forces them to increase the number of the bonds 
[62].  
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Among the environmental factors, one has to take into account: the effect of the electrolyte 
concentration and the pH [63]. Generally, the presence of an antibiotic decreases the biofilm 
formation [64]. However, the adhered S.epidermidis was less susceptible to antibiotic 
treatment than free cells [65]. This can be explained by the slowdown of bacterial metabolism 
inside of the biofilm, or the changed metabolism and selectivity of the bacteria on the surface, 
e.g. the multiplication of the antibiotics resistant mutants on the surface. For these strains, the 
conditions on the surface are then more favourable. This and the fact that only a small range 
of antibiotics is efficient against biofilm producing bacteria make the work of researchers in 
this field more demanding. 
The surface characteristics of the material are also a determinant factors in the biofilm 
formation. Surface chemistry influences the bacterial adhesion and proliferation. Different 
functional groups determine the surface charge and hydrophobicity that affect the behaviour 
of bacteria versus the surface. It was shown that on a negatively charged surface, the bacterial 
adhesion decreased, while a positively charged surface facilitated biofilm formation [66]. If 
the surface chemistry is modified, such as, with silver, plasma coatings or organic molecules 
like peptides or drugs, the bacterial adhesion is handicapped. These kinds of coatings have 
been described previously. Several surface modifying methods disadvantage the biofilm 
formation. The surface roughness also plays a key role in the process of biofilm formation. It 
has been found that irregularities on a smooth surface increase the bacterial adhesion [67]. In 
a case of PMMA, modified with silicon carbide paper, it has been shown that the bacterial 
adhesion increases with roughness, but a too rough surface has no significant influence on a 
biofilm deposit [68]. The initial distribution of the bacteria is random on a smooth surface, but 
follows some preferential direction on microrough surfaces. There is a relationship between 
the size of roughness and bacterial size, which affects the initial step of the bacterial adhesion, 
and the extra cellular polymer material production. If the parameters of the topography are in 
the same order as the bacterial dimension, it was shown that the bacteria attach easily and less 
extra cellular matrix is produced. Bacteria can thus act in response to the nano topography, 
can choose the most favourable direction of the attachment, the morphology and the extra 
cellular matrix production under the given nano environment [69].  
In biofilm formation the first step of bacterial adhesion is a reversible one. This is the time 
when the coating of the implant can effectively act. Hence, a 6 h post-implantation ‘‘decisive 
period’’ has been identified during which prevention of bacterial adhesion is critical to the 
long-term success of an implant [70]. After this period, an implant is particularly susceptible 
to surface colonization. It is very important to avoid the biofilm formation during this period, 
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and both, passive and active coatings, should be reliable. An active coating only could be 
effective if appropriate release of the active substance is realized [71].  
 
It has been previously described that the key step in the antimicrobial activity of the silver 
containing coatings depends on the concentration of the released Ag+. This means that in the 
action mechanism, the Ag+ plays a determining role; the silver metal is rather an inactive 
form. However, how does silver act inside the cell? 
Silver as antimicrobial agent and silver resistance  
Silver products have been used for their beneficial effects in medicine and in general hygiene. 
For more than a thousand years, silver has been used to heal and prevent diseases without 
knowledge of the working mechanism. In the last decades, silver has had a renaissance in 
clinical applications using its antibacterial properties, for treatment of burns [72,152] and in 
wound care. This renaissance and modern methods allow the scientists to complete this lack 
of knowledge.  
Since 1929, when Alexander Fleming observed the antibacterial effect of the penicillin, 
numerous different new molecules and antibiotics were developed. As long as antibiotics 
have been applied, bacteria have developed resistance against them. Resistance to an 
antimicrobial agent can occur either by “intrinsic” or acquired mechanism. Therefore, 
intrinsic resistance would involve natural resistance via the structure of the cell surface and its 
chemical composition. [73]. Acquired resistance to a wide range of antibiotics has been 
observed in a variety of micro-organisms [74]. One of the biggest challenges is to introduce 
compounds that prevent the development of bacterial resistance against them. Contrary to the 
antibiotics, it is also generally accepted that the antibacterial mechanisms of Ag+ are such that 
bacteria will not develop resistance [75]. Biocides (such as silver) and antibiotics have 
different modes of action. Biocides tend to target multiple sites on or within bacterial cells 
and have broad-spectrum activity. Antibiotics tend to target specific sites on or within 
bacterial cells and have a narrower spectrum of activity. It seems that the majority of the 
biocides acts on cell surface components of the bacteria and/or the cytoplasmic membrane 
[76]. Silver resistance is also postulated in the literature, but the number of resistant bacteria 
is largely inferior to the number of known bacterial resistances against antibiotics. The 
proteins and genes involved in bacterial resistance to Ag+ have been studied in recent years. 
These studies help to understand the working mechanism of silver, how silver ions react 
causing the antimicrobial effect. The works of S.Silver [77] are focused on the understanding 
of the process: how silver is eliminated from the interior of the cell, which genes and pumps 
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are responsible for this process. The described model proposes a key role for histidine as 
binding compound in the silver elimination process [78]. 
 
Figure 1-7: Scheme of the SilE protein 
[79] 
 
 
 
 
 
 
 
 
 
 
SilE is a small periplasmic Ag(I)-
binding protein that binds Ag(I) ions 
specifically at the cell surface, 
presenting the first line of resistance against Ag(I) toxicity. Studies with purified SilE protein 
using atomic absorption spectroscopy (AAS) and inductive-coupled plasma analysis showed 
very high specificity for Ag(I) binding. The SilE protein contains 10 histidine residues that 
are able to bind up to five Ag(I) cations, (Fig.1-7). [79] This mechanism does not correspond 
to a classical way of a resistance process known in the case of antibiotics, but to an efflux 
pump eliminating the silver ions from the cells and storing the harmful metal in a safe way.    
There are also studies done to find out how silver acts in the interior of the cells and which 
molecular biological steps are blocked or disturbed by it. The mechanism of the antibacterial 
action of the silver ions is discussed to be  closely related to their interaction with thiol groups 
[80,81] although other target sites are also proposed [82]. Studies on Pseudomonas 
aeruginosa PAOI bacteria, this bacterial strain had been found to be very sensitive to silver 
compound [83], have shown that sulphur containing amino acids, as cysteine and reduced 
glutathione are an effective neutralizer of silver nitrate. Other tested amino acids, not 
containing thiol groups, as cystine, methionine, glycine, glutamic acid, are coordinating silver 
ions via their N atoms, resulting in a coordination ratio 0.28-0.4 silver ions per nitrogen 
atoms. This value is much lower than the 3.1 coordination ratio measured by the thiol group 
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containing amino acids, which proposes an important role of the thiol groups in action of 
silver ions [84]. To gain insight into the inhibition mechanism of silver ions in a living cell, 
bacterial strains: a Gram- negative Escherichia Coli and Gram-positive Staphylococcus 
aureus and Staphylococcus Epidermidis were treated with silver nitrate and studied by 
electron microscopy and X-ray microanalysis, focusing on the morphological changes of the 
cells [85]. This work showed that the free state of DNA after the silver treatment changed to a 
condensed form. In this form, the DNA lost its replication ability and inactivates the bacteria. 
The condensed DNA is present in the centre of the electron light region of the cells. This 
electron light region is supposed to protect the DNA against harmful processes and the 
composition of this region is unknown, except the DNA being situated normally randomly 
inside. The X-ray microanalysis demonstrates the presence of silver in the cytoplasm, in the 
DNA and in the electron dense granules, which should correspond to silver, as well as the 
depositions of proteins surrounding the cell wall and the electron light region. Since the 
EDAX spectrum shows also the presence of S.epidermidis, they proposed that the silver ions 
interact with the thiol groups in proteins resulting in their inactivation. The gram-positive 
S.aureus is suffering a less important morphological change, thanks to the thicker cell wall 
protecting the cell against the penetration of the silver into the cytoplasm.  
Other works study the silver acting mechanism against bacteria focusing on the effect of 
silver on the respiratory chain of the bacteria [86]. The addition of around 10 µM AgNO3 to 
suspended or immobilized E. coli results in stimulated respiration before death, signifying 
uncoupling of respiratory control from ATP synthesis. This is a typical sign of the interaction 
of Ag+ with enzymes of the respiratory chain. Experiments using an alternative electron 
acceptor than oxygen, suggests that Ag+ inhibits at a low potential point of the chain, possibly 
the NADH dehydrogenase stage. Surface-enhanced Raman spectroscopy of bacteria treated 
with AgNO3 and sodium borohydride suggests that Ag+ binds preferentially to sites associated 
with flavin groups [87]. These are proposed as the major site of inhibition, and represent a 
NADH binding site. E. coli possesses only two different NADH dehydrogenases: the proton 
pumping NDH-I, containing FMN (flavin mononucleotide) and up to nine FeS clusters, and 
the noncoupled NDH-II, which contains FAD (flavin adenine dinucleotide) [92]. Both 
dehydrogenases appear as possible sites for Ag+ binding, containing cysteine residues that 
have a high affinity for Ag+ [84].  
Different theories exist on how silver can affect the respiratory chain, e.g. that it disturbs the 
citric acid cycle. This is one of the metabolic pathways of the cellular respiration, inside of the 
mitochondria. We call cellular respiration the complex processes taking place in the cells to 
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convert nutrients into adenosine triphosphate (ATP), which is the main form of energy in the 
cell, and release waste products. [88].  
 
Figure 1-8: Cellular respiration in a typical eukaryotic cell. [89] 
The citric acid cycle is the third step in the breakdown of sugars (carbohydrate catabolism). 
Glycolysis breaks glucose (a six-carbon-molecule) down into pyruvate (a three-carbon 
molecule). In eukaryotes, pyruvate moves into the mitochondria. It is converted into acetyl-
CoA by decarboxylation and enters the citric acid cycle inside the mitochondrial matrix. Here, 
it gets oxidized to CO2 while at the same time reducing NAD to NADH which can be used by 
the electron transport chain to produce further energy (ATP). To fully oxidize the equivalent 
of one glucose molecule, two acetyl-CoA must be metabolized by the citric acid cycle. Two 
waste products, H2O and CO2, are created during this cycle. The citric acid cycle is an 8-step 
process involving 8 different enzymes. Throughout the entire cycle, Acetyl CoA changes into 
Citrate, Isocitrate, α-ketoglutarate, succinyl-CoA, succinate, fumarate, malate, and finally, 
oxaloacetate. 
One of these enzymes is aconitase (aconitate hydratase) which catalyses the stereo-specific 
isomerization of citrate to isocitrate via cis-aconitate. The heart of the enzyme is an iron-
sulfur cluster which reacts directly with an enzyme substrate. This active [Fe4S4]2+ cluster 
may convert to an inactive [Fe3S4]+ form. Three cysteine (Cys) residues have been shown to 
be ligands of the [Fe4S4] centre. 
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Figure 1-9: Aconitase in complex with iron-sulfur cluster and isocitrate, [90] 
  
In the active state, the labile iron ion of the [Fe4S4] cluster is not coordinated by Cys but by 
water molecules. In this enzyme, the cysteine molecules which are very good complexing 
agents of silver, have a main role. Because of the cysteine molecules and the sulphur itself, 
the iron sulphur cluster might be also sensitive to silver ions. If silver ions disturb the function 
of this enzyme, e.g. by exchanging the iron or other interaction with the cluster, the metal can 
appear as antibacterial or toxic as it damages the cell. If the silver exchanges the iron from the 
cluster, the free iron behaves as a radical that can cause the death of the cell. Since the 
aconitase is directly involved in mtDNA stability and organization [91], it may enhance the 
activity of the silver.  
The following question remains open after the review of the literature concerning the working 
mechanism of the antimicrobial silver: which processes or enzymes are disturbed or/and 
blocked by the silver that manifests in the antimicrobial behaviour of this metal?  
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2 Subject of the thesis 
 
There is a high demand by the orthopaedic medical community for implant materials that are 
not susceptible to bacterial adhesion, biofilm formation and thus infection. The previously 
described examples do not offer a perfect solution. Hence, the aim of this work is to propose a 
new coating method for implant materials that prevent the biofilm formation and resulting 
infections in medical applications. 
Preparing antimicrobial silver containing coatings on implant surfaces is a complex challenge. 
It is an interdisciplinary activity combining chemistry, surface physics, material sciences, 
microbiology and medicine. The target coating should fulfil many requirements, as it is 
generally the case for materials used in human medicine. These requirements are:  
- chemically defined  
- light stable coating 
- mechanical stability  
- long-term activity 
- reproducibility  
- non-toxicity 
- bio integration 
- antimicrobial activity of the coated surface. 
The first step is to find the silver compound having the appropriate stability, solubility, and 
chemical characteristics. Working with silver coordination polymers has been one of the 
principle activities in our group. Several of these coordination networks have been 
synthesized and described by former group members: Dr. Adeline Y. Robin and Dr. Jorge 
Sagué Doimeadios. These descriptions are focused on the crystalline structure and the 
complexation behaviour of the compounds. However, these compounds haven’t been tested 
for their chemical stability and microbiological effect. Thus, a suitable Ag-coordination 
compound has to be identified with regard to solubility and stability. Then the compound 
should be attached on a surface in a way that it resists against chemical and mechanical 
impacts. The characterization of the coating has to be complete with respect to chemical 
composition and topography. The behaviour of the coating in biological media and its silver 
release needs to be analysed in detail. The silver ion release determines the antimicrobial 
and/or toxical effects, therefore the properties of the coatings have to be studied and 
optimized. Different implant substrates such as metal and polymers will be taken into 
account. The application of the silver as antimicrobial agent, and the understanding of the 
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action mechanism of the silver ions against bacterial cells are also part of this study. 
Therefore, the interaction of silver ions with short peptide sequences is studied. In this 
context, silver nanoparticles (AgNPs) formation became an issue. 
Finally, after the extensive chemical, topographical analysis and effectiveness of the coating -
both silver coordination polymers and nanoparticles - against bacteria are tested. For this 
purpose from a number of existing microbiological methods several will be used. These 
microbiological experiments are outside our chemical knowledge and material possibilities, 
and are thus made in collaboration with Dr. I. Hauser-Gerspach of the Oral Microbiology 
Laboratory of the University of Basle, Prof A.U.Daniels of the Orthopaedics Biomechanics 
Laboratory of the University of Basle and Prof. R.Landmann of the University Hospital of 
Basle.  
The aim of this work is to describe the chemical and topographical analysis of an 
antimicrobial silver coating from silver coordination polymer and silver nanoparticles. A 
flexible coating method is developed to control the silver release and the antimicrobial effect. 
Different short peptide sequences will be tested regarding their affinity to silver ions, giving 
some important information about the action mechanism of the silver ions as antimicrobial 
agents. Finally, the study is completed with in vitro and in vivo antimicrobial experiments. 
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3 Results and discussion 
3.1 
 
Ag compounds 
3.1.1 Introduction and description 
 
Working with silver coordination polymer networks is one of the main profiles of our group. 
In our previous works, these compounds were fully described [207,93,94] concerning their 
synthesis, crystallographic characterisation, IR and UV studies. Here, the previous results are 
briefly presented and completed with other data such as dissolution and light stability tests. 
Figure 3.1-1: General structure of 
the bidentate bipyridil ligands: 
Ln:  where (n:1, 2,3,…) 
 
 
This work focused on the first generation of the bisdentate bipyridyl ligands: the ethanediyl 
bis(isonicotinate) ligand synthesized and studied in our group. This ligand, containing two N 
and two O donor atoms and a flexible linker is capable of building up various structures by 
coordinating two or more metal ions. The L1 ethanediyl bis(isonicotinate) can adopt two 
conformations, anti and gauche resulting of the free rotation  around the ethyl group C-C 
bond.  
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Figure 3.1-2: Anti and gauche conformation of the L1 
     
The different conformations of the ligand in a coordination polymer can completely change 
their structure. Therefore, their chemical and physical characteristics could be dissimilar while 
the chemical composition of the compounds can be the same (polymorphism, isomerism). 
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[95] As the Ag metal ion has a flexible coordination sphere, the coordination number can vary 
between two and six, and the geometry from the simplest linear to octahedral. Silver ions with 
the ethanediyl bis(isonicotinate) ligand (L1) build up at least eight different coordination 
networks, [96] as shown in the following table (Table 3.1-1) :   
 
Table 3.1-1: Structural diversity of the polymer networks build up from Ag(I) and L1 
Name Cristallisation conditions: Ag salt; solvent Molecular formula Chain motif 
Adl3 AgNO3; THF/H2O {[Ag(L1)]NO3}n  
Adl4 AgNO3; THF/H2O {[Ag(L1)]NO3.H2O}n  
Adl5 AgNO3; THF/H2O {[Ag(L1)]NO3.2H2O }n  
Adl6 AgNO3; EtOH {[Ag2(L1)(NO3)2]}n 
 
Adl7 AgNO3; CH3CN {[Ag(L1)]NO3}n  
Adl8 AgCF3SO3; THF/H2O {[Ag(L1)] CF3SO3}n  
Adl9 AgClO4; THF/H2O {[Ag(L1)] ClO4}n  
Adl10 AgPF6; THF/H2O {[Ag(L1)] PF6}n  
 : silver ion : ligand 
 
Besides these polymer networks, the longer ligand (L2) readily forms ring structures with two 
silver ions and two ligands in a complex. [207] 
For the purpose of antimicrobial coatings, we would like to focus on the following three 
compounds: Adl3, Adl6 and Adl7 for further discussion. The compounds other than nitrate-
containing are excluded from the planned biological assays due to their toxic counter ions for 
the living species. The two compounds containing water molecules in the crystalline structure, 
Adl4, Adl5 have no long-term stability. The co-crystallizing water molecules can be released, 
which results in an instability of the structure. 
Even though the building blocs of the three compounds Adl3, Adl6 and Adl7 are the same, 
their crystalline structures are significantly different. Adl3 crystallizes in a monoclinic space 
group P21/n. The pyridine N-atoms coordinate to the silver ions creating a one-dimensional 
chain motif: the silver atoms are coordinating to two N atoms of two different ligands (L1). 
The conformation of the ligand is “anti” and the direction of the ligand between the silver 
atoms is alternating: going down to up then up to down as shown in Fig.3.1-3.  
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Figure 3.1-3: Crystalline structure of Adl3 
 
In Adl3, the nitrate anion acts as tridentate ligand towards two silver atoms. The nitrate acts as 
a linker between two silver atoms: each nitrate atoms are connected to two different silver 
ions and each cation is connected to two different nitrate anions. The most important bond 
lengths are the following: 
Bond  Lengths Å  
 Adl3 Adl6 Adl7 
Ag—N 2.232(2), 2.239(2) 2.226(7) 2.183(4), 2.189(4) 
Ag—
O(O2N) 
2.669(2), 2.724(2), 
bidentate 
 2.354(5), 
2.390(7) 
 2.599(5), 2.703(7), 
bidentate 
 2.800 (3), 
monodentate 
2.72(1) 3.044(4), 3.122(4), bidentate 
Ag—Ag 8.02 (3) 5.210  4.017(2) 
Table 3.1-2: Most important bond length of Adl3, Adl6 and Adl7 
 
Other additional interactions coexist between two chains. Some H-bonds were found between 
close ligand molecules, between the nitrate anions and pyridine hydrogen atoms or ethyl 
hydrogen atoms. A π- π interaction of rings at a distance of 3.62 Å is also observed. Although 
the Ag—Ag distance is too long to have a contact, the closest distance between two silver 
ions is mentioned in Table 3.1-2, because it will be important during the comparison of the 
different compounds. 
Adl7 crystallizes in the triclinic space group P-1 (no.2). In this case, similar as the previous 
one, the silver atoms are coordinated by two different ligands through their nitrogen atoms. 
The ligand molecules act thus as connectors between the silver atoms, the final motif being a 
charged one-dimensional chain. This compound is a polymorph to Adl3 showing the same 
arrangement of one-dimensional chains with bringing nitrate anions. Even so, many 
differences appear. The conformation of the ligand is “anti” as in Adl3 but here the direction 
of the ligands differs compared to Adl3: the direction is constantly up-to-down. Here, as 
shown before, the nitrate anions function as a linker between two chains. Each nitrate is 
connected to two different silver ions in neighbouring chains.  
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a,  b,  
Figure 3.1-4 a,b: Crystalline structure of Adl7 
 
Some comments about the inter-chain and layer interactions. These interactions are very 
different from the previously discussed Adl3 compound. The layers stack parallel in 
alternating their orientations.  
Comparing the bond lengths of Adl7 to the bonds of the Adl3 (Table 3.1-2), two data attract 
attention. First, that the Ag—N bond lengths are slightly shorter in the case of Adl7, and the 
Ag—Ag contact existing in the case of Adl7 but not in Adl3. These two characteristics point 
to the possible higher stability of the Adl7 compound. Further investigation should prove this 
hypothesis. 
Adl6 crystallizes in the monoclinic space group C2/c (no.15). There are eight asymmetric 
units (one silver atom, one nitrate molecule and one half ligand) in each unit cell, which 
means there are two silver atoms for one ligand molecule. Ligand molecules, silver atoms, 
and nitrate counter anions are organized so that a neutral two-dimensional motif appears. This 
motif is called a “fishbone”-like layer, Fig.:3.1-5.  
a,       b,   
Figure 3.1-5a,b: Crystalline structure of Adl6 
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The main difference of this structure and the previous ones is that the main one-dimensional 
chains are silver nitrate chains, linked together via the ligands. The bond lengths, shown in 
Table 3.1-2, confirm this major difference.   
Each silver atom is coordinated with one ligand L1 molecule and with two different nitrate 
counter anions. The bond lengths Ag—O(O2N) 2.354, 2.390 Å correspond to short silver 
nitrate distances showing a strong coordination bond. The silver-oxygen distances belong to 
the shortest ones known from the literature [97, 98, 99]. The conformation of the ligand is 
anti as in the two previous examples. Regarding the Ag-Ag interactions, the distance between 
the two silver ions is too long for any interaction (same situation as described for Adl3).  
Concerning the interactions between the layers and chains, just some weak interactions can be 
found. The layers are stacked parallel to each other to form on overall three-dimensional 
structure. Hydrogen bonds between two parallel ligand molecules have been observed. 
Furthermore, the nitrate anions are involved in hydrogen bonding to the surrounding pyridyl 
hydrogen atoms. The silver ion has, besides of the three short contacts within a plane, a fourth 
weak bond with a nitrate anion O, perpendicularly to the plane connecting to the other layer. 
On the other side of the silver atom, there is a metal-ring interaction to stack the layers 
together. No other interactions were found between two layers except these interactions 
involving silver atoms.  
Adl6 is expected to be very soluble, while the higher content of ligand in compounds Adl7 
and Adl3 makes them less soluble in aqueous media and thus more interesting for our study. 
This hypothesis demands some further investigations to prove the suitability of these 
compounds for the in vitro and in vivo biological assays. Based on this hypothesis, further 
investigations are focused on Adl7 in comparison with Adl3.  
3.1.2  Synthesis and characterisation 
Here, an easy way is described to synthesize and identify the compounds Adl7 and Adl3, and 
to study their dissolution in different media generally used in biological assays. Their light 
stability was measured to make sure that the silver is stable enough in the complex to avoid a 
fast reduction through light. Such colour change due to reduction of the compound is 
unfavourable regarding the medical use.  
Since the chemical composition of compounds Adl3 and Adl7 is the same, but their 
crystalline structure is different, the easiest and fastest way to identify them is to measure the 
powder X-ray spectra and compare them to their crystallographic data [93,94]. 
The powder X-ray spectra of Adl3, Adl6 and Adl7 are shown in Fig.3.1-6.  
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Figure 3.1-6: Powder X-ray spectra of Adl3, Adl6 and Adl7 
 
To obtain information on the solubility of the different Ag-compounds, important for 
biological assays, dissolution tests were performed. The solubility of the compound is crucial. 
If the silver leaking were too high, the effect of the silver would be so strong that it kills not 
only the bacterial cells but also damages the healthy eucaryotic cells. If the silver leaking is 
too low, we cannot observe the antibacterial effect. There is an antibacterial effect when silver 
ions can be released from the implant, which then penetrate the cell wall and enter into the 
cell, subsequently turning DNA into an inactive form and at the same time reacting with 
proteins [100,141]. For this test, two different biological media were used: the synthetic 
medium, prepared artificially (composition described in the experimental part) and the 
Müller-Hinton medium. The synthetic medium is composed of an important quantity of 
sodium and other chlorides and phosphates, a mixture of several amino acids and vitamins, 
and trace elements. The exact composition of the Müller-Hinton medium is unknown, being a 
natural product from meat infusion. Some milligrams of compound were weighed into a glass 
vessel and a given volume of medium was added. The flask was closed and shaken. At stated 
time intervals, the solution was removed, filtered and the silver concentration was determined. 
The precipitate was washed with ethanol, dried and a powder X-ray spectrum was made of the 
solid (Fig.3.1-11). The filtered solutions were analyzed for their Ag+-content using AAS 
(atomic absorption spectroscopy), comparing to a standardized AgNO3-solution. The 
measured silver concentrations are represented as a function of time in Fig.3.1-7a,b.  
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Figure 3.1-7a,b: Dissolution tests of Adl7 and Adl3 in MHB and SM medium 
 
Comparing the solubility of the two compounds in percentage, it is an order of magnitude 
higher for Adl3 in the case of the Müller-Hinton medium. The ten times lower solubility of 
Adl7 can be explained by the structure of its polymer network. As previously discussed, the 
ligand-Ag contacts are shorter and stabilize the structure by Ag—Ag contacts. During the 
dissolution of the silver compounds, the polymer network is cut into pieces and several 
different composition complexes can be found in solution [93]. Regarding the structures of 
these complexes, for example [AgL12]+  they are different for the Adl3 and Adl7 (Fig.3.1-8). 
 
 
 
 
Adl3  
 
 
Adl7 
Figure 3.1-8: Conformation of the [Ag(L1)2]+ of Adl3 and Adl7  
           
The resulting form of the complex of Adl3, has a dipole moment in contrast to Adl7 where the 
same complex is apolar. Thus, Adl3 should be more soluble in polar solvents as water and 
thus in aqueous biological media.  
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Concerning Adl3, the difference of the solubility in the two media is more than remarkable. 
The major part of the synthetic medium is a NaCl isotonic solution, and if the Ag leakage is 
high and fast, a precipitation formation of AgCl is probably immediate. On the other hand, 
more peptide, protein and other bio molecules can be found in the Müller-Hinton medium. 
These molecules can easily complex the silver ions and act as a masking agent to keep the 
silver ions in solution.  
In comparison, a solubility test for AgCl was carried out (Fig.3.1-9). While the solubility of 
Adl3 is much higher, the solubility of Adl7 and AgCl is comparable in SM. The solubility of 
AgCl in water is around 0.1mg/l, and this is about the same as in SM, as was measured by 
AAS. In MHB medium, the AgCl solubility is clearly higher, as shown in Table 3.1-3.  
 
Figure 3.1-9: Solubility of AgCl in SM and MHB Table 3.1-3: Solubility values of 
AgCl, Adl3 and Adl7 in the two 
media (SM and MHB) 
 
AgCl being an insoluble compound its LD50 value is high: Acute oral toxicity (LD50): 
>5000 mg/kg  for Guinea pig [206]. A similar value thus expected for Adl3.  
The solubility of the AgNO3 as a very soluble silver compound in water in the two biological 
media was tested. 
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Compound Medium Silver 
conc. 
(ppm) 
Adl7 MHB 1,3-
4,3 
SM 1,4-5 
Adl3 MHB 21-33 
SM 0-0,4 
AgCl MHB 0,1-
0,8 
SM 0,4-0 
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Figure 3.1-10: Solubility curve 
of AgNO3 in SM and MHB as a 
function of the concentration 
 
Added AgNO3 solubility in  solubility in  
(mol) SM (mol2/l2) MHB (mol2/l2) 
5.00E-07 1.27E-10 4.19E-07 
2.50E-06 3.31E-10 9.58E-06 
5.00E-06 1.18E-09 3.32E-05 
1.00E-05 2.28E-09 3.87E-05 
   
Table 3.1-4: Solubility values 
of AgNO3 in SM and MHB as a 
function of the concentration 
In Fig.3.1-10, the dissolution of AgNO3 is shown and the solubility values are calculated for 
the silver nitrate in the two media. During the solubility test a white precipitation has been 
observed in SM after addition of 5.00x10-7 mol AgNO3, while with the MHB medium, the 
solution became slightly cloudy after 5.00x10-6 mol AgNO3 was added. While the solubility 
of the AgNO3 in SM is in a same range as the solubility of the AgCl in water (10-10 mol2/l2), 
the solubility of the AgNO3 in MHB is a hundred times higher. This measurement confirms 
the hypothesis that the composition of the MHB medium favours the complexation of the 
silver ions contrary to the SM medium, which generates immediately a precipitate. 
The other main question regarding the behaviour of the compounds in contact with the 
biological media is: what happens during the dissolution process? Does the compound remain 
intact and just some Ag ions are released from the surface into the solution, or is there a 
complete change of the compound? What is the nature of the formed precipitate? Is it the 
proposed AgCl? If there is a passivation of the surface of the crystals, the surface is covered 
by the formed AgCl which inhibits the further dissolution, hence the solubility of the AgCl 
and Adl7 are similar The powder X-ray spectra, taken before and after the dissolution test, 
helps to answer a part of the previously asked questions. (Fig.3.1-11) 
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Figure 3.1-11: Powder X-ray spectra of the Adl7 before and after the dissolution tests 
 
The spectra show that the main product after the dissolution is AgCl, but there are also some 
other, non-identified products. To follow the transformation of the product, time dependent 
spectra (Fig.3.1-12) show that the dissolution of Adl7 and AgCl precipitation are almost 
immediate in MHB. This is even more significant in the case of SM. We can still observe the 
main peak of the Adl7 after 30 minutes in MHB, which is not perceptible any more in SM. 
That means that the speed of the dissolution-precipitation is probably higher in SM where we 
could find less Ag-complexing molecules.  
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Figure 3.1-12a,b: Time dependent powder X-ray spectra of the dissolution of Adl7 in SM 
and MHB media 
 
This experiment with Adl7 in solution does not answer the question of passivation. Further 
investigations of the compound as a coating would confirm or stand against the theory of the 
3 Results and discussion   
Novel silver containing antimicrobial coatings for implant materials: new applications of Ag(I) coordination networks 31 
passivation. The dissolution tests, confirm the structural analysis, i.e. the most suitable 
compound seems to be Adl7. The Ag concentration of the Adl7 solution (1,4-4 ppm) is in the 
range of the non-toxic concentration [141]. Further investigations should be made to confirm 
the biocompatibility of the compound.  
The stability of the compound is another relevant characteristic. The light sensitivity of silver 
containing materials is well known. Heavy decomposition of materials due to light may 
hinder their utilisation as coating for implant materials.   
To examine the light stability of different compounds, testing them in solution was more 
favourable since the crystal degradation is so slow that it renders the quantification difficult. 
For this purpose, solutions of our Ag-compounds in organic solvents were deposited on filter 
papers, and subsequently exposed to light (Philips 15W, from 10 cm distance) for 3.5 hours, 
in comparison to simple AgNO3. To test the influence of the crystalline structure and the 
counter ions effect we have chosen the following compounds: Adl7[Ag(L1)NO3]n (simple 
chain structure), Adl3: [Ag(L1)NO3]n (simple chain structure), Adl8: [Ag(L1)CF3SO3]n 
(structure with different counter ions, chain conformation the same as in Adl7, the Ag—N 
contact is slightly shorter than in Adl7 and no Ag—Ag contact occurs) Adl10: [Ag(L1)PF6]n 
(structure with different counter ions, chain conformation is the same as Adl3 but shorter 
Ag—N bond lengths)  and a new structure the J11: {2[Ag(L3)NO3]}n (ring structure) [207] 
The photos of the exposed filter papers are shown bellow (Fig.3.1-13-14): 
           
  AgNO3   Adl7   Bl AgNO3   Adl3 Adl8 Adl10     J11 AgNO3   Bl  
  Figure 3.1-13: Photos of the filter papers immerged in a solution of the different compounds 
and exposed to light for 3.5h          
 
  AgNO3        Adl3 Adl8   Adl110       J11          AgNO3    Bl 
 
  Figure 3.1-14: Quantitative colour measurements of the filter papers immerged in a solution 
of the different compounds and exposed to light for 3.5h  
 
Although the compounds are dissolved in acetonitrile, the silver ions remain coordinated by 
the ligands (previous MS measurements detected fragments of the silver complexes after 
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dissolution [93 pp.:94-95]). These fragments are less photodegradable than the silver ions in 
solution. The structure of the fragment determines the level of the photosensitivity of the 
silver compound. The chain conformation, the Ag—N bond length (as the longer bonds 
indicate weaker coordinating effect) and the existent Ag—Ag contacts, solidifying the 
crystalline structure in a level of inter layer and inter chain contacts, seem to be an influencing 
factor for the light stability. Comparing Adl7 and Adl3, the first is clearly more stable in light, 
the shorter Ag—N contacts and the Ag—Ag contact can explain the higher stability.  
Regarding the compounds with different counter ion, Adl10 has a similar chain conformation 
as Adl3 and slightly longer Ag—N bond lengths than Adl8, which has a similar chain 
conformation as Adl7. It is the same situation as Adl3 versus Adl7 with other counter ions, 
thus the stability of Adl8 is clearly higher than the one of Adl10. The counter ion effect seems 
not to influence the light stability. However, the strength of the Ag—N contact, the principal 
coordination bond, is fundamental. Therefore, the shorter it is, the more light stable is the 
compound. 
The general conclusion of this chapter is that Adl7 is the most suitable compound for the 
further experiments thanks to its good light stability and poor solubility. This compound has 
facile synthetic access, forming small and big crystals depending on the starting concentration 
(see also Chapter 3.2.3), which is also in its favour. The microbiological characterisation of 
the compound is described in Chapter 3.3.1.1.1. 
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3.2 
 
Coatings 
The general concept is to build up a resistant coating of our compound, primarily Adl7, on a 
surface to render it antimicrobial. In an ideal case, the compound is attaching on a surface via 
covalent bonds or at least with coordination binds to ensure a strong attachment. Thus, we 
aim to reach long-term efficiency and a slow leakage of the silver ions. Two methods of 
coatings will be tested in this chapter: the in-situ crystallization and layer-by-layer method. 
The coating methods were carried out as a function of time and concentration in order to test 
their influence on coverage and loading of the substrate with our compounds.  
To analyse the surface and describe the topography we have used different surface analytical 
methods such as AFM, SEM, XPS and powder X-ray. Concerning the substrates, for the basic 
characterisation of the coating, simple clean gold Au(111) surfaces were used, surface which 
is frequently used for physical and surface chemistry experiments. This is the most 
reproducible surface, which guarantees the reliability of our measurements. On Au(111) 
substrates, where atomically flat islands are generated by flame anneling, the conformation 
and orientation of the molecules, the attaching forces and the chemical composition of the 
surface are easy to study. This surface is one of the most used for STM and AFM 
experiments. The uniform composition of Au(111) makes it also a good substrate for XPS 
studies or other surface analytical methods. Other substrates used in medical environments 
were also studied: titanium and gold dental implant materials as well as titanium and steel 
internal medical implant materials are also used in the following studies.   
Some dissolution experiments were performed on a coating, as discussed in the previous 
chapter for the bulk compound. The aim of these tests is to study the silver leakage and the 
stability of the coating. 
3.2.1 Materials 
3.2.1.1 Chemical fixation by anchor molecules 
To build a solid coating on a surface, we need to guarantee the firm attachment of the 
compound on a surface. The best solution is a covalent bond between the substrate and the 
surface; this is the concept of the chemical fixation on a surface.  
For a model surface, Au(111) surface was used. To build up the coating of the silver polymer 
network on the surface, the compound should be firmly attached. To fix Adl7 on a gold Au 
(111) or a dental gold implant surface, a sulphur-containing molecule with an isonicotinate 
tail was synthesized. The sulphur atoms of the molecule form then covalent bonds with the 
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gold atoms, and then the polymer network can be formed using the isonicotinate end as a 
starting point. For this purpose, a disulfide molecule was synthesized since these molecules 
are much less sensitive than the mercaptane type molecules. They show no degradation in air, 
are easy to handle and to prepare. The carbon chain linking the sulphur and the isonicotinate 
residue was kept short even though there is no higher arrangement of the molecules on the 
surface (carbon chains formed from 8-10 carbons, with or without any aromatic groups have 
the tendency to stick together vertically making nice SAMs (self arranged monolayer) [193]). 
The synthesis of the bis 2-((4-pyridinylcarbonyl)oxy)ethyl disulfide molecule [101] is 
described in scheme (Fig.3.2-1). 
 
 
 
 
      
Figure 3.2-1: Scheme of the synthesis of the disulfide molecule and the surface treatment 
with it 
     
During the purification, the last step is a recrystallization. The crystalline structure of the 
bisulfide is the following: 
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Figure 3.2-2: Crystalline structure and packing of the disulfide molecule  
 
Description of the crystalline structure:  
The crystal shapes of the disulfide are thin plates. The ligand crystallizes in the monoclinic 
space group P2(1)/c. There are four ligands per unit cell. The ligands form a Z shape where 
the two isonicotinate tails are connected by the almost perpendicular disulfide part. The two 
isonicotinate tails are almost parallel. One pair of the parallel arranged Z shaped ligands 
(these layers are parallel with the y axis of the unit cell) is crossed by a third Z shaped ligand 
(situated in the same plane than the first pair) in a way that the isonicotinate acid tails of the 
ligands belonging to the pair and the crossing ligand are vis-à-vis. The zigzag layer builds up 
in this way. These zigzag layers stick together having generally around 4 Å distance between 
the layers. The pyridine rings in the zigzag layer are slightly tilted. The intra layer cohesion 
between the ligands is maintained by interactions between the isonicotinate carbonyl oxygen 
atom and the one H atom of the of the nearest pyridine ring of the next ligand the (H······O) 
distances are 2.655 and 2.666 Å. The principal inter layer interactions are the hydrogen bonds 
between the pyridine N and the H atom of the connecting CH chain between the sulphur and 
the isonicotinate tail with a distance of (H······N) 2.494 Å. The direction of this contact is 
parallel with the plane of the pyridine ring. Another weak interaction between carbon and 
hydrogen solidify the interactions between layers. (Fig.3.2-3) 
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Regarding the titanium substrates, another anchor molecule should be used. Since the titanium 
is a reactive metal, a TiO2 layer generates immediately on a surface exposed to air. 
Bibliographic data show that the isonicotinic acid molecule absorbs on the TiO2 surface [102]. 
Thus, this molecule can serve directly as an anchor molecule for the Ti surfaces. 
  
3.2.1.2 Substrates 
As model surface, an oriented gold Au(111) surface commercially available from ArrandeeTM  
Germany was used. The basic material, a borosilicate glass is usually 0.7 mm in thickness. 
These glass substrate is well suited for the flame annealing procedure to obtain Au(111) 
terraces with a 200-300nm thick final gold layer. With this method, a constant quality of the 
surface can be reached independently of the plates, and further cleaning procedures or pre-
treatment are not needed. 
Other substrates have been chosen for the deposition. These are typical metallic dental 
implant and restorative materials: titanium (99.9% Tritan, RematitanM, Dentaurum, 
Ispringen, Germany) and gold alloy (Au 71%, Pt 3.7%, Ag 12.7%, Cu 10.8%, Zn 1.1%, Ir 
0.1%; Neocast 3, Cendres+Metaux SA, Biel-Bienne, Switzerland). Both were used as 
polished (roughness Ra =0.24 mm) flat plates of 14x14 mm, the polishing being similar to that 
used for real dental applications. 
Number Atom1 Atom2 Length 
1 H2 O1 2.655 
2 O3 H5 2.666 
3 H9A N1 2.494 
4 N1 H9A 2.494 
5 C6 H7A 2.770 
 
 
Figure 3.2-3 : Main inter- and intralayer 
interactions between the disulfide molecules 
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More substrates for the in vitro and in vivo microbiological assays are delivered from the 
Robert Mathys Stiftung, Bettlach, Switzerland. The titanium and steel materials have two 
geometries: disk (ø:4.90mm; l:1.30mm) and cylinder (ø:2.00mm; l:3.30mm) with two 
different roughnesses. Since the titanium disks have a more suitable form for the in-situ 
crystallization, this substrate was used for most of the microbiological assays. The Ti cages 
used for the in vivo experiments are of the same material as the Ti disks, one-end-open 
(closed with a silicon cap during the experiment) empty cylinder (ø:10.00mm; l:30.0mm) with 
135 small ø:1.00mm holes to keep the flow of the cell fluid free.            
3.2.2 Coating methods 
Based on the preliminary analytical characterisations of the different silver polymer networks, 
the Adl7 compound has been chosen. The next step is to build up a solid crystalline coating of 
this compound on a surface. The crystallisation process should take place on surfaces of the 
different substrates. Two main coating methods, the in-situ crystallization for a continuous 
ongrowth and the layer-by-layer method, dip-coating with alternating solutions of AgNO3 and 
L1, were used.  
Generally, the coating process consists of three phases, cleaning, pre-treatment, 
crystallisation. Before deposition, the dental implant substrates, used several times, were 
treated with a solution of 30% ccH2O2 and 70% ccH2SO4 to remove all of the residues, were 
then rinsed abundantly with EtOH and distillated water, dried and kept under vacuum. All 
internal medical implant materials were washed with EtOH and water before the treatment. 
The gold plates were used immediately after flame anneling; additional cleaning procedures 
are not needed.  
The pre-treatment (= binding of the anchor molecule) was always carried out in the same way 
for the Au(111) surfaces: 5days, 5mM disulfide in EtOH/CH2Cl2 , 1/1 solvent mixture. The 
importance of the disulfide in the case of the Au(111) was proven. The coating without any 
pre-treatment is less stable and can be washed out more easily from the surface. In addition, 
the structure of the coatings shows more inhomogeneities. This unfavourable situation has not 
been observed in the case of the gold dental implant substrate since this material contains 
silver in the alloy. Direct coating can be employed there.    
During the in-situ crystallisation of our Adl7 compound, we have used the same solvent 
THF/EtOH, 1/1 mixture, as for the crystallisation of bulk Adl7 to guarantee the same structure 
on the surface. As described previously, the most reliable method to identify Adl7 is the 
powder X-ray analysis. A complementary powder X-ray spectrum of the treated Au(111) 
plates was carried out and it confirms the presence of Adl7 on the surface. (Fig.3.2-4)  
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Figure 3.2-4: Powder X-ray spectra of the Adl7 coation on Au(111) surface 
 
The concentration of the treating solution and the crystallisation time are varied, to study their 
influence on the desired loading. In a preliminary test, carried out under similar concentration 
conditions, both methods, in-situ crystallization and layer-by-layer deposition, gave very 
similar results in SEM analysis (Fig.3.2-5), leading to a nanocrystalline structuring of the 
surface.  
    
a, b, 
Figure 3.2-5a,b: SEM images of the surface coating prepared by multilayer (15x2mM 
AgNO3 15x2mM Lad) method 
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c,  
Figure 3.2-6a,b,c: SEM images of the surface coating prepared by in-situ crystallisation 
(2mM, 14 days) 
                   
The main difference between the achieved coatings is that by in-situ crystallisation, big macro 
structures (50-100µm) form accompanied by smaller nanocrystals covering the whole surface, 
whereas by layer-by-layer deposition, only nanostructures are present covering the surface. 
The nanostructure is present in both cases but is completed with bigger crystals during in situ 
crystallisation. This method gives the opportunity to reach a higher loading and less time 
consuming than the layer-by-layer method. This is not a negligible aspect considering the 
numerous samples needed for the biological assays.  
3.2.3 Coatings on Au(111) surface 
There are a many questions to be answered regarding the coatings: What kind of structure is 
present on the surface? How does the topography look? What is the loading of the different 
substrates? Does the compound stay on the surface or it is washed out easily? To clarify these 
questions, further investigations were done to understand the mechanism of the crystallisation 
and study the topography and the stability of the coating. AFM and SEM measurements were 
carried out on a coated surface of Au(111), allowing the investigation of the topology. XPS, 
AAS and additional SEM measurements were done to understand how the concentration of 
the treating solution and time of the crystallisation influence the loading and the topography 
of the surface. The powder X-ray measurement of the surface always proves the presence of 
Adl7. Further dissolution tests in biological medium were carried out to get acquainted with 
the stability of the coating. The following results have always been confirmed with at least 
three identical samples for statistical reasons. 
a, 
 
 
b, 
 
 
 
3 Results and discussion   
Novel silver containing antimicrobial coatings for implant materials: new applications of Ag(I) coordination networks 40 
3.2.3.1 Crystallisation and nanotopography 
The crystallisation process follows the classical way, described by Ostwald in 1896 [103]. 
The Ostwald ripening features on the surface are clearly seen with the WET SEM method 
(high resolution imaging of fully hydrated samples) (Fig.3.2-7). For this measurement, an 
AgNO3 solution was mixed with the ligand solution, in a special liquid cell for SEM, then the 
crystallization process was followed over several minutes up to hours [104]. A complete study 
will be described by Priscilla Brunetto in her thesis.  
     
Figure 3.2-7: WET SEM images of the crystallisation of Adl7 
 
AFM measurements revealed peak-like structures, which were analyzed with respect to their 
height and width (Fig.3.2-8).  
  
Figure 3.2-8: AFM measurements, profile and single peak image of the nanocoating 
 
The surface pattern corresponds to Ostwald ripening motifs on a two-dimensional surface 
with a main interpeak distance of 20–30 nm, a distance that is known to be ideal for cell 
ongrowth [105]. From the mean peak height of 11–14 nm, the average polymer chain length, 
supposed to be standing upright on the surface, could be determined as an octameric chain 
[Ag8L7]. From the width of the peaks, it can be concluded that more than one chain is 
attached to the surface to form such a peak. With approximations of the peak width of ca. 10–
20 nm, and the unit cell of Adl7, one can conclude that there are ca. 200–400 chains linked 
together within one peak. From the profile sequence in (Fig.3.2-8), it can be seen that the 
whole surface, also in between the peaks, is covered with product, even though at a lower 
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thickness. SEM pictures (previously shown) and further AFM measurements (later shown) of 
several Au(111) samples coated with different methods confirm this analysis as shown in 
(Fig.3.2-5,6). They also reveal the size distribution of the peaks on the surface. Several 
pictures were taken at different scales, and the peaks measured. Most, about 80%, of the 
peaks seen by AFM are ca. 10–20 nm in height and have a mean diameter of 10–20 nm. The 
unit cell volume of Adl7 being ca. 777 Å3, this leads to roughly 25000 units of Adl7 within 
one such peak. About 10% of the surface peaks are 50–80 nm in height and have a mean 
diameter of 20 nm (roughly 60000 repeat units of Adl7), whereas another 10% of the peaks 
are >100 nm in height and have a mean diameter of ca. 50 nm (ca. 500000 repeat units of 1a). 
The coating can thus be estimated to be roughly 12.5 mg/m2 compound (3.04 mg/m2 silver) or 
3x10-11 mol/cm2 concerning the nanostructure. This is very important information since the 
nanostructure should stay constantly on a surface while the macro structures risk leaving from 
the surface through mechanical and biological impacts. The surface nano-coating was thus 
impossible to detect with an analytical balance.  
Further AFM measurements were performed on different samples. The disulfide treated 
sample (Fig.3.2-9) shows some nm thick coating on the Au(111) surface. That excludes the 
presence of the monolayer which should not be thicker than 7-8Å. It shows larger aggregates 
of the compound and a dense coverage.    
      
Figure 3.2-9: AFM image and profile of the disulfide coated (5mM/ 5d) Au(111) plate  
 
The further AFM measurements on different samples (using low concentrations of the treating 
solution: 0,25mM Adl7 in THF/EtOH to avoid big macro structure formation, destroying the 
AFM tip) confirm that longer treating times, 7 days (Fig.3.2-12) versus 3h (Fig.3.2-10), result 
in a denser and thicker coverage on the surface with aggregate formation. Otherwise, the same 
nanostructure built up for both treating time. The 3h sample shows the previously described 
very homogeneous nanostructure, the first step of the crystallisation, and there is no time to 
build up bigger structures.  
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Figure 3.2-10: AFM images and profiles of the Adl7 coated (0,25mM/3h) Au(111) plate  
Concerning samples treated with higher concentrations, but with the same treating time 
(0,5mM Adl7 in THF/EtOH; 3h) (fig6), formation of larger structures and flat round 
structures can be observed with 10nm height and 0,4 µm in diameter (profile2) referring 
probably to the Ostwald ripening motifs.  
  
   
Figure 3.2-11: AFM images and profiles of the Adl7 coated (0,5mM/3h) Au(111) plate  
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Higher concentrations facilitate the crystal formation, and the growth of the homogeneous 
nanostructure is changed by aggregates formation. A thick layer of the compound covering 
solidly the surface can be found in such cases, as e.g. on a 7days sample (Fig.3.2-12). The 
thick layer formed after 7 days is accompanied by nanocrystals and big aggregates. In 
addition, macroscopic crystal formation starts to take place. 
  
  
Figure 3.2-12: AFM images and profiles of the Adl7 coated (0,25mM/7d) Au(111) plate  
 
From these data, it can be concluded that in each case a well-defined, nanostructured topology 
is formed on the substrate surface, and that with high probability, similar structural features 
are obtained on the polished substrates of the titanium and gold alloy. As the dental implant 
materials were polished prior to deposition of the compound, the surface of these substrates 
was too rough for AFM, which was therefore carried out for Au(111) samples only.  
3.2.3.2 Influence factors of the coating formation  
 
The topography described previously through AFM measurements is confirmed by SEM 
measurements. This method has been chosen also to follow how the loading is influenced by 
the concentration of the treating solution and the crystallisation time. Numerous plates are 
prepared, varying the concentration of the treating solution and the treating time. One part of 
the plates is incubated in biological media: in synthetic medium (SM) and Müller-Hinton 
medium (MHB). The prepared plates are analyzed by SEM, some of them also by XPS, 
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shown later. Their coating is then removed with HNO3, the silver concentration is determined 
and the loading (Ag on a surface in ng) is calculated. The results are listed in the Table 3.2-1 
and Fig.3.2-13,14,15.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2-1: Summary of the surface loading giving in Ag (ng) of the different samples 0.5-
2.0 mM treating concentration and 3-168h treating time, before and after dissolution (24h 
incubation in SM and MHB) 
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Figure 3.2-13: Surface loading of the 0.5mM treated samples before and after dissolution 
(24h incubation in SM and MHB )in function of the time 
 
 Coating: Ag (ng) on a surface 
conc 
(Ad7) 
time 
(h) orig (0.5) MHB (0.5) SM (0.5) 
0.5 3 0.432 0.437 0.336 
0.5 24 0.985 0.884 0.730 
0.5 72 2.754 1.764 1.687 
0.5 168 3.778 3.345 2.663 
1.0 3 2.176 0.364 0.412 
1.0 24 16.800 1.070 0.812 
1.0 72 51.323 23.960 17.474 
1.0 168 34.714 3.588 2.195 
2.0 3 55.800 11.068 19.138 
2.0 24 135.150 64.000 30.675 
2.0 72 211.475 80.100 39.275 
2.0 168 234.175 80.575 68.325 
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Figure 3.2-14: Surface loading of the 1.0mM treated samples before and after dissolution 
(24h incubation in SM and MHB) in function of the time 
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Figure 3.2-15: Surface loading of the 2.0mM treated samples before and after dissolution 
(24h incubation in SM and MHB) in function of the time 
 
3.2.3.2.1 Time dependence 
The coating was prepared using four different time intervals. The treating concentration was 
kept fixed, the change of the coating structure was followed by SEM and the loading 
concentration determined by AAS. The following four SEM images show Au(111) plates 
treated with 0.5mM Adl7 solution for 3 hours, 1day, 3 days and 7 days. The increase of the 
polymer network is evident (Fig.3.2-13) and comparing the images, the change of the 
topography manifests. 
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Figure 3.2-16: Sample 0.5mM/3h 
On the surface of the first sample, we can 
recognize deposits on the rims of the gold 111 
terraces. This is the initial step of the 
crystallisation; the irregularities initiate the 
crystal formation. The surface of the second 
sample is already one step further in a coating 
formation. There is a thin layer formed on the 
surface, this layer seems thicker above the 
boards. Larger crystals of 100-500nm appear on 
the surface and some µm aggregates 
sporadically. The number of these aggregates 
increase fast with time and on a 3 days sample 
many more can be observed. Comparing this one 
with the 7 days sample, the topography change is 
not as significant as the difference between the 1 
and 3 days samples. The loading quantification 
measurement proves that the crystal formation 
increases with time. The measurements show 
that the slope of the saturation curve becomes 
steeper and steeper with the concentration of the 
solution and the maximal loading, represented by 
the plateau of the curve, is reached earlier in the 
case of higher concentration. Comparing the 
curve of the 2mM treating concentration 
(Fig.3.2-15), the maximal loading is almost 
reached after 3 days contrary to the 0.5mM 
(Fig.3.2-13) treating concentration where 
reaching the maximal loading would need 
probably several weeks. This observation seems 
obvious if we take into consideration the fact that 
the crystallisation is slower in weak 
concentration. It is also interesting to compare 
the coating change with the concentration 
keeping the treating time constant. 
 
Figure 3.2-17: Sample 0.5mM/1d 
 
Figure 3.2-18: Sample 0.5mM/3d 
 
Figure 3.2-19: Sample 0.5mM/7d 
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If we observe together the three curves of the loading with the three different concentrations, 
we can set out that there is almost an order of magnitude difference in loading when the 
treating concentration increases twice. This is discussed in details in the next chapter. 
3.2.3.2.2 Concentration dependence 
The concentration of the Adl7 solution influences strongly how the coating forms on the 
surface. To describe the effect of the concentration on the coating, three different 
concentrations were used to treat the Au(111) plates. The prepared plates were measured by 
SEM and the loading concentration determined by AAS. The images here presented are the 
0.5mM, 1.0mM concentration and the 2.0mM samples after 3 days of treatment. Comparing 
the two lower concentrations, the size of the crystals is clearly higher in the case of the 
1.0mM sample, and the flat structures are not visible any more. Increasing the concentration, 
larger crystal structures built up on the surface in the same time interval. Moreover, the 
nanostructure is always present. 
  
Figure 3.2-20: Sample 0.5mM/3days Figure 3.2-21: Sample 1.0mM/3days 
 
a, b, 
Figure 3.2-22a,b: Sample 2.0mM/3days 
If the concentration is increased to 2.0mM, big, well designed crystals form on the surface.  
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3.2.3.3 Stability of Adl7 coating: dissolution test in two biological media 
 
The stability of the coating is very important in medical application. The coating should stay 
on the surface of the implant material after its implantation. Ideally, the treated implant 
material preserves the antimicrobiological effect, thus the silver containing material, to avoid 
the biofilm formation. The following dissolution tests are intended to study the behaviour of 
the Adl7 coating in a situation close to an in vitro biological assay. The dissolution tests are 
carried out in two biological media presented previously. The different Au(111) samples, with 
varying treating times and concentrations, are incubated in the media for 24h, then the plates 
are removed, washed and dried. The incubated Au(111) samples are analyzed by SEM. The 
remaining coating is then removed by HNO3 solution and the silver concentration is 
measured. The results are listed in Table 3.2-1, Fig.3.2-13,14,15. The crystalline structures on 
the surface can be divided into three different size regions: nanocrystals of some 10nms, 
middle size structures of some 10µms, and big well designed microscopic crystals up to 1-
200µm. The structures with different sizes behave differently during the incubation in media.  
The small structures are mechanically and chemically more stable. They remain on the 
surface after incubation. This is clearly shown on the Fig.3.2-13, and the Table 3.2-1. Mainly 
nanostructures are formed from the treatment with 0.5mM Adl7 solution. The crystal 
formation at this concentration is so slow, that, after 3h and 24h we can observe only 
nanostructures on the surface. The dissolution tests show that after 24h incubation in both 
media, the samples keep the nanostructured coating and no removal can be observed. This 
observation is confirmed by SEM measurements. In the following two images (Fig.3.2-23, 
24), the first one is the 2mM/3h plate incubated in MHB; the second is the same case, 
incubated in SM with the well known nanostructures present on both.  
  
Figure 3.2-23: Sample 2mM/3h incubated 
24h in MHB 
Figure 3.2-24: Sample 2mM/3h incubated 
24h  in SM 
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This nanostructure is completely built up just after one week if we use a weak concentration 
(0.5mM), while using the double concentration the nanostructure is built up after 3 hours. 
Middle size aggregates are then also more present on the surface. The washing out effect 
becomes more pronounced in the case of the two higher concentrations, hence the middle size 
and macro size structures seem to have a minor stability against biological media and shear.  
In cases where principally nanostructures and some middle size structures are present on the 
surface, the values of the Ag-concentration remained similar after incubation in both media. If 
higher concentrations and longer treating times are used the macro size crystals dominate the 
surface. In these cases, more coating remains on the surface after incubation in MHB than in 
SM. This fact seems to contradict the previous observation that the Adl7 compound is more 
soluble in MHB than in SM. The possible explanation is that the AgCl formation is more 
pronounced in the synthetic medium and the formed AgCl is washed off when the plate is 
removed from the medium and rinsed with ethanol. In any case, the AgCl formation was 
observed in both media concerning the free compound. Thus, the dissolution and the AgCl 
formation modify the surface of the crystals (Fig.3.2-25). 
  
 
Figure 3.2-25: Crystals on sample 
2mM/3days no incubation 
  
Figure 3.2-26: Crystals on sample 
2mM/3days, MHB incubated for 24h 
Figure 3.2-27: Crystals on sample 
2mM/3days, SM incubated for 24h  
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The AgCl layer formation is more pronounced in the case of SM. The hypothesis of the 
passivation made after the free Adl7 dissolution tests has been confirmed by the coating 
dissolution tests. Upon the passivation after the incubation in the medium the surface of the 
crystal changes, large crystals can break and leave the surface but the subsequent nano-
structure remains intact. These large crystals are not as well adhering on the surface as the 
small structures and remain only partially after the incubation in the medium. (Figure 3.2-28) 
 
Figure 3.2-28: Crystals washed out sample 
2mM/3h incubated in MHB for 24h (The 
imprint of the original crystals is visible on a 
surface nevertheless one part remains on the 
surface.)  
 
 
3.2.3.3.1 Silver release during the dissolution test 
The silver concentration of the solution just above the coated substrate is crucial from the 
biological point of view. The measurements show (Table 3.2-2) that the silver concentration 
does not reach the 5ppm limit in the solution in both media, which is exactly in the ppm range 
determined for the free Adl7 compound.  
 
 
 
 
 
 
 
 
Table 3.2-2: Silver 
concentration of the solution 
above the samples after 24h 
incubation time 
 
 
Sample  
Ag conc.ppm in 
MHB 
Ag conc.ppm in 
SM 
Samp0.5mM/3h 0.0000  0.0000  
Samp0.5mM/1d 0.0000  0.0000  
Samp0.5mM/3d 0.0000  0.0000  
Samp0.5mM/7d 0.0000  0.5697  
Samp1.0mM/3h 0.0000  0.0000  
Samp1.0mM/1d 0.0000  1.0291  
Samp1.0mM/3d 1.7597  0.8154  
Samp1.0mM/7d 1.1412  1.0571  
Samp2.0mM/3h 4.7042  1.8134  
Samp2.0mM/1d 3.0908  1.7462  
Samp2.0mM/3d 4.3457  3.1580  
Samp2.0mM/7d 3.0235  1.2756  
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As it was expected, the silver concentration is slightly higher in the Müller-Hinton medium 
and doesn’t depend much on the loading of the plates. The concentration of the silver ions 
present in the solution depends more on the concentration of the other molecules masking the 
silver ions and keeping it in solution. These kinds of molecules are more frequent in the 
Müller-Hinton medium. When loading is weak, the major part of the compound is in the 
nanostructures and no silver can be observed in solution (the concentration is under the 
detection limit (0.2 ppm taking into consideration the dilution)).  
3.2.3.3.2 Conclusions 
To conclude the results of the dissolution tests some principal observations should be 
outlined: Changing the treating time and the concentration of the treating solution, the 
topography of the substrate coating can be designed. If the well-designed macro structures are 
frequent on a surface, the Ag release is maximal (the loading exceeds ca. 50ng Ag per plate) 
and similar for the bulk compound. In contact with biological media, the nanostructures have 
the tendency to stay on the surface, while the macro structures are washed out. To reach an 
intermediate release, the medium sized structures e.g. some µm aggregates and crystals, are 
preferable. The lower concentration favours the slower crystallisation with a smaller and more 
compact crystal formation. Further microbiological investigations will decide which are the 
most suitable coating conditions.      
3.2.3.4 Chemical analysis of the coated surface: XPS measurements 
 
While the topography is well described by the two previously mentioned methods AFM and 
SEM, further XPS measurements help to analyse these surfaces chemically. 
The XPS measurements are performed on different substrates. Several coated Au(111) plates 
as model surface were measured. Since the AFM and SEM measurements underline the 
importance of the concentration and the treating time, the following substrates were used for 
the measurements: 
   
Sample name Treat.concentration Treat. time Incubation in medium 
sample2: 0,25mM 3h no 
sample3 1mM 3d no 
sample 4 2mM 3h no 
sample5 1mM 3d MHB/24h 
sample6 1mM 3d SM/24h 
 
Table 3.2-3: Samples for XPS measurements  
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Samples 5 and 6 will also take part in the previously described dissolution tests in different 
biological media. Here, the chemical change on the surface resulting from the incubation in 
these biological media is studied. Thanks to this technique, we can learn more about the 
atomic state of the elements, on the surface calculate their repartition and evaluate the 
proportion of these elements in different chemical environments. This technique is shortly 
presented before the profound evaluation of the results.  
Photoelectron spectroscopy utilizes photo-ionization and energy-dispersive analysis of the 
emitted photoelectrons to study the composition and electronic state of the surface region of a 
sample. Traditionally, when the technique has been used for surface studies it has been 
subdivided according to the source of exciting radiation into:  X-ray Photoelectron 
Spectroscopy   (XPS) using soft x-ray (200-2000 eV) radiation to examine core-levels and 
Ultraviolet Photoelectron Spectroscopy (UPS) - using vacuum UV radiation (10-45 eV)  to 
examine valence levels. Photoelectron spectroscopy is based upon a single photon in/electron 
out process and from many viewpoints, this underlying process is a much simpler 
phenomenon than the Auger process. In XPS, the photon is absorbed by an atom in a 
molecule or solid, leading to ionization and the emission of a core (inner shell) electron. The 
kinetic energy distribution of the emitted photoelectrons (i.e. the number of emitted 
photoelectrons as a function of their kinetic energy) can be measured using any appropriate 
electron energy analyser and a photoelectron spectrum can thus be recorded. For each and 
every element, there will be a characteristic binding energy associated with each core atomic 
orbital i.e. each element will give rise to a characteristic set of peaks in the photoelectron 
spectrum at kinetic energies determined by the photon energy and the respective binding 
energies. The presence of peaks at particular energies therefore indicates the presence of a 
specific element in the sample under study - furthermore, the intensity of the peaks is related 
to the concentration of the element within the sampled region. Thus, the technique provides a 
quantitative analysis of the surface composition and is sometimes known by the alternative 
acronym, ESCA (Electron Spectroscopy for Chemical Analysis). The exact binding energy of 
an electron depends not only upon the level from which photoemission is occurring, but also 
upon the formal oxidation state of the atom and the local chemical and physical environment. 
Changes in either one or other give rise to small shifts in the peak positions in the spectrum - 
so-called chemical shifts. Such shifts are readily observable and interpretable in XP spectra 
because the technique is of high intrinsic resolution (as core levels are discrete and generally 
of a well-defined energy) and is a one electron process thus simplifying the interpretation. 
Atoms of a higher positive oxidation state exhibit a higher binding energy due to the extra 
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electric interaction between the photo-emitted electron and the ion core. This ability to 
discriminate between different oxidation states and chemical environments is one of the major 
strengths of the XPS technique. In practice, the ability to resolve between atoms having 
slightly different chemical shifts is limited by the peak widths that are governed by a 
combination of the following factors. Especially the intrinsic width of the initial level and the 
lifetime of the final state, also the line-width of the incident radiation - which for traditional x-
ray sources can only be improved by using x-ray monochromators and the resolving power of 
the electron-energy analyser take part in these factors. In most cases, the second factor is the 
major contribution to the overall line width. 
The sample measurements were carried out with the help of Dr. T. de los Arcos, Dept. of 
Physics of the University of Basle. The measurements of our samples take place in a high 
vacuum chamber and several points on the surface are addressed. At the beginning of every 
measurement, an overview was registered to screen the sample concerning which elements are 
found on the surface. (Fig.3.2-29)   
  
Figure 3.2-29: Summary of the survey spectra of the Samples 2,3,4,5 and 6   
 
The major elements Ag, O, C were found as well as the S from the disulfide in most of the 
samples. The S2p peak is not present in the spectrum of sample4, possibly because the 
coverage is so dense that this technique does not allow detecting the disulfide attached 
directly on the surface. Similar for sample6 where a big amount of AgCl formed on the 
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surface and hides the disulfide. The Cr as well as the Si signal in some samples is coming 
from the substrate. The N peak is so weak that it can not be recognized on a survey. 
In Table 3.2-4, the respective concentrations of the elements are presented. For some 
elements, more than one component was found. These components signify different chemical 
environments for the element in question.  
Table 3.2-4: Calculated atom % of the different elements of different binding energies 
 
The main peaks of the elements are measured and analyzed regarding their chemical shift and 
their components. 
The main peak for silver is the Ag3d: the BE is 268.1eV, just slightly higher than for Ag3d of 
bulk, of the silver metal situated in the same region around BE 268eV 
(http://srdata.nist.gov/xps/). This is in good agreement with the literature data [106]. This 
slight shift may be explained by the increase in the electronic density around the Ag+ ions due 
to coordination. The electron draining of the silver ions from the nitrogen atoms of the 
isonicotinic acid units through their close interactions result in this  shift in the direction of the 
higher binding energies. 
The relative concentration of silver comparing to the Au peak is clearly higher in the case of 
the samples with a longer treating time (samp3, 5, 6), meaning that the coverage of the 
surface with the silver polymer complex compound is higher. The two samples incubated in 
biological media (SM and MHB) show slightly lower Ag concentrations. During the 
incubation in the media, one part of the Adl7 compound reacts with the Cl- forming an AgCl 
precipitate, which is washed out during removal from the solution and the cleaning with 
 Au4f Ag3d O1s C1s S2p 
Sample 
2 
BE (EV) 83.87 367.9 533.1 284.9 286.2 161.8 
at% 35.3 5.7 44.3 14.8 - 
Only Au/Ag 86 14    
Sample 
3 
BE (EV) 83.93 368.1 530.3 531.9 284.6 285.5 288.5 161.9 
at% 30.5 16.3 22.6 30.5 - 
Only Au/Ag 65 35    
Sample 
4 
BE (EV) 83.85 567.9 530.1 532.5 284.8 286.1 - 
at% 40.9 8.3 37.3 13.5 - 
Only Au/Ag 83 17    
Sample 
5 
BE (EV) 83.91 368.1 530.7 531.8 535.8 284.9 285.8 288.5 161.8 
at% 34.3 10.3 22.5 22.9 - 
Only Au/Ag 77 23    
Sample 
6 
BE (EV) 83.81 368.1 530.7 532.0 533.3 285.4 286.7 288.5  
at% 16.8 8.1 33.5 31.6 - 
Only Au/Ag 68 32    
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EtOH. The loss of Adl7 from the surface is pronounced in the case of SM, which is confirmed 
by other analytical methods (previously described dissolution tests AAS). 
The main oxygen peak, O1s, reveals two components: one around 530.3-7eV and one around 
532.0eV. In the case of the not incubated samples, this can be assigned to a carbonyl oxygen 
C=O and an ether oxygen C-O-C respectively. The fitting shows almost a 1:1 distribution 
between the two types of oxygen, which fits perfectly the ligand molecule: 2 carbonyl oxygen 
and 2 ether oxygen atoms per molecule. One more peak shows up around 533,1-3eV  in the 
case of the incubated samples. This component can be assigned to H-bonded oxygen: H2O or 
–OH [107]. 
The C1s signal also shows three different peaks, one 284.9eV for C=C/C-C 
(aromatic/aliphatic carbons), 286.7eV for C-N and 288.5eV C=O. The fitting (Fig.3.2-32) 
shows a good correspondence for the first two peaks: the first one is twice as high and in the 
molecule L1 we have 8 C=C/C-C carbon and 4 C-N. Although the third carbon peak is a bit 
smaller than expected, the three different states of the carbon were detected. 
 
 
 Figure 3.2-30: O1s, Au4f, Ag3d, S2p, C1s and Cr2p signals of the different samples  
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Figure 3.2-31: Fitted O1s signal    Figure 3.2-32: Fitted C1s signal  
of sample3       of sample3 
 
The XPS results are in a good agreement with the previous experiments, such as the 
dissolution test and the concentration dependence of the loading. These measurements offer a 
direct proof for the chemical change of the coating after incubation in a biological media. The 
significant change of the O and C peak of sample5 (similar but not as pronounced by the 
sample6) proposed an interaction of the coating with organic molecules.  
 
3.2.4 Coatings on gold and titanium dental implant materials 
 
The two substrates described previously as gold alloy and Ti 99% are typically used for dental 
application. Both surfaces are polished as applied generally in medicine. To coat these 
samples with Adl7 several conditions were tested for the in-situ crystallisation coating 
method. The pre-treatment with the disulfide for the gold substrate and the isonicotinic acid 
pre-treatment for the titanium substrate seemed to be a logical choice to attach our 
coordination polymer to the surface. Since the gold alloy contains 12,7% of silver, this should 
help the attachment of the polymer network, with possibly no need for an anchor molecule. In 
the case of the Ti substrate, the pre-treated samples with isonicotinic acid showed better 
results. The TiO2 is a slightly basic surface, and attaches the carboxylic part of the 
isonicotinic acid. This way the N-donor atom can coordinate the Ag+ and be the starting point 
of the polymer network. A long treating time has been used, two weeks, with a high 
concentration: 2mM complex solution in EtOH/THF 1/1 solvent mixture as used previously. 
The following light microscopic pictures Fig.3.2-33 show that the loading is very high, the 
surface is covered by small, some mm-sized crystals.   
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Figure 3.2-33a,b: Light microscopic images of the treated plates 
  
 a, Gold plate treated 2mM/14d b, Ti plate treated 2mM/14d 
 
The form of the crystals on the gold surface looks slightly different from the titanium, but the 
loading and the distribution are about the same. To analyse the topography of the surface, 
SEM measurements were carried out. AFM measurements are not possible because of the 
high roughness of the samples.  
The coated gold and titanium substrates are used for flow chamber experiments is a typical 
assay in oral microbiology for testing dental materials. In these assays, the test materials are 
exposed to a bacterial suspension in human saliva for 60min. After the explosion, the bacteria 
attached on the surface of the test material are counted and the living and dead ones are 
distinguished. A detailed description of the experiment is found in Chapter 3.3.1.3. The SEM 
measurements are done on the samples before and after the flow chamber experiment. It gives 
good information about the solubility of the compounds since no other dissolution tests were 
carried out. The composition of the previously used biological media is so different to the 
human saliva used for the flow chamber experiment that it makes no sense to compare. The 
loading of the plates before the flow chamber experiment is very similar for the gold and the 
Ti plates: ~2000 mg/m2, which is at the same level as the loading of 2mM/7d treated Au(111) 
surface. To describe the topography, further SEM measurements were carried out. 
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Figure 3.2-34a,b: Gold substrate treated 
2mM/14d before flow chamber experiment 
Figure 3.2-35a,b: Gold substrate treated 
2mM/14d after flow chamber experiment 
a, a, 
b, b, 
 
As the images show, part of the macrostructures stay on the surface after the flow chamber 
experiment. The quantity of these macrostructures is much less than the original loading. 
Regarding the size of the crystals on the surface, three main groups with the previously 
described size distribution can be distinguished. The well shaped macro crystals of several 
100µm visible to the naked eye, the middle size crystals and flat aggregations with some µm 
in size, and the nanostructure 50-100 nm. These three main groups behave differently in the 
flow chamber. While the nanostructure remains on the surface, the middle size aggregates 
seem all to be leaving from the surface. One part of the macro crystals remains on the surface, 
another part is removed and remains in pieces in the liquid of the flow chamber. The silver 
concentration measurement of the chamber liquid shows a big difference between the filtered 
and unfiltered solutions. The sample without any filtration gives around 1.5 ppm 
concentration for Ag (the mistake of the measurement is unusual high due to the 
inhomogenity of the samples). The concentration of the filtered sample (0.22µm filter was 
used) was 0.17 ppm. This one order of magnitude difference between the filtered and 
unfiltered samples can have two possible explanations. The silver coordination polymer 
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network removed from the surface remains in larger pieces than 0.22µm. Since the employed 
filter removes the bacteria from the solution, it also removes the silver attached to the 
bacteria. Probably, these two effects combined result in this difference of the silver 
concentration of the filtered and not filtered solution. 
 In the case of the Ti treated substrates the same behaviour of the crystals can be observed. 
The SEM images of the treated Ti plates before and after the flow chamber experiment are 
shown below: 
Figure 3.2-36a,b: Ti substrate treated 
2mM/14d before flow chamber experiment 
Figure 3.2-37a,b: Ti substrate treated 
2mM/14d after flow chamber experiment 
a, a, 
b, b, 
 
The nanostructures stay on the surface as well as on portions of the damaged macrocrystals. 
The middle size structures are washed out from the surface. Here, almost the complete 
absence of these aggregates is observable. The SEM measurements after the flow-chamber 
experiment show that bacteria are present on the surface. With this technique, is it impossible 
to distinguish between killed or living bacteria. For this purpose another method is described 
during the presentation of the microbiological assays in Chapter 3.3.1.3 
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The complementary XPS assays confirm the silver concentration on the surface. The other 
elements are not so concentrated, as these would be visible on a survey spectrum. The 
presence of the S in the same concentration in both samples is from the organic 
contaminations or from the cleaning process. The N and C atoms are found in higher 
concentration in the treated samples as was expected from the complex polymer since these 
are the main elements of the ligand L1. 
  
Figure 3.2-38: XPS spectra of the gold substrate treated 2mM/14d   
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3.2.5 Coatings on titanium and steel restorative implant materials 
 
For metallic implants, e.g. hips and knees, either titanium or stainless steel is used in western 
countries. In this study, both of these materials were tested. The previously described silver 
polymer network is used to build up a coating on the surface of these materials. Regarding the 
geometry of the substrates two different forms, disk and cylinders, have been coated for in 
vitro and in vivo biological assays. Cages prepared from the same material developed for 
implantation were used for in vivo experiments. Two different roughnesses were tested of 
each material. Since the roughness of the material influences, the biofilm formation [108,24] 
the experiments were carried out on rough titanium (TiR), smooth titanium (TiS), rough 
stainless steel (StR) and polished stainless steel (StPol) surfaces. The materials used for cages, 
disks and cylinders were anodized commercial pure titanium (cpTi; ISO 5832-2) and electro 
polished and grid-blasted stainless steel (SS; 1.4441, ISO 5832-1). A smooth finished surface 
was obtained by vibratory finish and electro polishing. A rough surface was achieved by grid 
blasting with white corundum (Al2O3, grain size 0.84–1.2 mm). The original surface 
passivation method of these materials determines the elemental construction of the surface. 
Thus different pre-treatment methods for choosing the anchor molecule, were tried (e.g. 
several acids, as the isonicotinic acid used for the dental Ti substrate). To choose the 
appropriate concentration and treating time, numerous samples were prepared with different 
treating conditions and tested by a microbiological assay in order to find out which are the 
most antimicrobial potent samples. (The microbiological assays are covered in Chapter 
3.3.1.2.4) After discovering the appropriate treatment method, a time dependent screening 
was carried out. SEM measurements were done to analyse the surface topography of the 
treated substrates and dissolution tests in order to understand the solubility and the stability of 
the coating on these surfaces. 
3.2.5.1 Titanium rough and smooth restorative implant materials 
 
The substrates treated with different methods were tested by microbiological assay. (The 
detailed description of these experiments are found later in Chapter 3.3.1.2.4) The best result 
is obtained by the simple in-situ crystallisation method without any pre-treatment. In contrast 
to the polished titanium dental implant, which has a simple TiO2 surface, these restorative 
implant materials are treated differently. This can be the reason that the previously used 
method works less well here than the simple crystallisation. In the time dependent trials, the 
screening window was from 3h to 10 days and the microbiological assays showed that the 
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maximal effect was already reached after 3 days. For the further experiments, mainly titanium 
disks were used since this geometry is more convenient for the in-situ crystallization. The 
cylinders showed higher inhomogenity in the microbiological results, probably due to their 
different positions and thus irregular coatings during the crystallisation. The different 
samples, treated for 3days with in-situ crystallization, were studied by SEM and the silver 
loading was determined. After incubation in different biological media analysis were made 
for both, on the titanium disks and in the media after 24h.  
SEM measurements  
For the tests, two different concentrations were used, namely 1mM and 2mM of Adl7 and 
3days treating time. The following images show the coated rough Ti disks: 
Figure 3.2-39a,b,c: Ti rough (TiR)  
treated 1mM/3d 
Figure 3.2-40a,b,c: Ti rough (TiR)  
treated 2mM/3d 
 a,  a, 
 b,  b, 
 c,  c, 
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The typical structures are present: macro crystals of several hundreds of micrometers, flat 
aggregates of smaller compact crystals of 10-100 micrometers and nanostructures with 
crystals under 100 nm. The two smaller scale structures are similar in both concentrations in 
their occurrence and form, while the form of the macro-crystals shows a remarkable 
difference. More compact crystals form from the 1mM concentration solution thanks to the 
slower crystallisation process. The occurrence of the macro-structures seemed also different 
during the SEM measurements: fewer macro crystals have been found on the surface of the 
1mM treated disks. The AAS measurement to determine the silver quantity on a surface 
confirms this hypothesis. (Table 3.2-5) 
The smooth titanium disks show a high similarity to the rough ones regarding their 
topography and the loading. The typical size distribution of the compound could be observed 
on the smooth surface. In addition, the form of the macro crystals of the different 
concentration treated samples varies as described previously. Thus, just some images are 
presented here to show the existence of the nanostructures Fig.3.2-41b. In order to 
demonstrate that the crystallisation process follows the classical way: the Ostwald ripening 
motifs around the macro-crystals are clearly visible Fig.3.2-41a. 
 
 a,  b,  
Figure 3.2-41a,b: Treated Ti smooth (TiS) 1mM/3d 
 
The SEM measurements show similar images of the coating for the two substrates with 
different surface roughnesses. In addition, the AAS measurements determine similar value for 
the silver concentration on the surface: the smooth plates are just slightly less loaded. 
The loadings of the Ti substrates are listed in the Table 3.2-5. The loading increase with 
concentration is similar for both titanium substrates with different roughnesses.  
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Table 3.2-5: Surface loading of the titanium substrates before and after dissolution test 
Ti disks Ag loading and dissolution tests
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   Ag loading in ng on a surface after treatment 
  1mM 2mM 
SM 
1mM 
SM 
2mM 
MHB 
1mM 
MHB 
2mM 
TiR 7.902 30.411 0.342 1.615 0.179 1.433 
TiS 8.425 34.123 0.262 0.735 0.201 0.487 
 
Dissolution tests 
For the dissolution tests, the same method as previously described by the gold surface was 
used. TiR and TiS disks were used, each treated with two different concentrations, 1mM and 
2mM, for three days. The dried coated samples were submerged in two different biological 
media and after 24h removed from the solution, dried and analysed by SEM. The silver 
quantity on the surface was determined.  
The titanium rough samples don’t show a significant difference after the incubation in the two 
media Fig.3.2-42,43a,b,c. The quantity of the silver complex remaining on the surface is 
similar, and so it is for the topography. The here presented sample (2mM / 3days treatment) 
incubated on the media show only a minor variance. The sample removed from SM contains a 
little bit less macrostructures and more middle-sized aggregates than the substrate from the 
Müller-Hinton medium. The nanostructure seems intact in both cases Fig.3.2-42,43c. 
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Figure 3.2-42a,b,c: TiR disks 2mM/3d 
incubated in SM for 24h  
Figure 3.2-43a,b,c: TiR disks 2mM/3d 
incubated in MHB for 24h 
a, a, 
b, b, 
c, c, 
 
The silver loading determination shows also that the 1mM treated samples behave in a similar 
way in the two media, and only the nanostructure remains on the surface. As has been 
observed, during the previous measurements the surface coating of the macrocrystals is 
significantly damaged by the biological media, and these crystals are covered by AgCl 
precipitation. This is more pronounced in the case of the synthetic medium. (Fig.3.2-44a,b,) 
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a, b, 
Figure 3.2-44a,b: Surface of the macro crystal after 24h incubation in MHB (a) 
and in SM (b) 
 
Concerning the smooth titanium disks, the dissolution tests were carried out in the same way, 
and the results can be seen in Table 3.2-5 comparing to the titanium rough disks. Although, 
after the crystallisation, the treated smooth and the rough surfaces look much the same, their 
dissolution tests show a significant difference. On a 1mM treated smooth surface after the 
dissolution test in both media, no macrocrystals are found and the medium size structures are 
also absent. Only some nanostructures remain on the substrates removed from the MHB. The 
concentration of the silver during the AAS measurements was just slightly above the 
detection limit of the machine. 
a, 
Figure 3.2-45a,b: TiS disks 1mM/3d 
incubated in SM for 24h  
 
 
 
 
 
 
Figure 3.2-46: TiS disks 1mM/3d 
incubated in MHB for 24h 
b,  
   
In the case of the 2mM samples the situation is not so critical as the SEM images show: 
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a, 
 
Figure 3.2-47a,b: TiS disks 2mM/3d 
incubated in MHB for 24h  
 
 
 
 
 
 
 
Figure 3.2-48: TiS disks 2mM/3d 
incubated in SM for 24h 
b,  
 
This observation is confirmed by the AAS measurements: the silver concentration after 
incubation in biological media. On a rough surface, there is more than double of compound 
than on a smooth surface.  
The crystallisation process is independent of the roughness of the surface, but the chemical 
and mechanical stability are higher on a rough surface. The different sizes of crystals hold 
stronger on a rough surface and are washed out less easily.  
Silver release during the dissolution test 
The silver concentration in different media after the incubation of the Ti disks was 
determined. (Fig.3.2-48 and Table 3.2-6) Results of both roughnesses show the same clear 
tendency: the silver concentration in a medium is much higher in the case of the 2mM 
samples, which is explained by on the much higher original loading of these samples as 
compared to the 1mM samples. The silver concentration is significantly higher in all cases in 
the Müller-Hinton medium, this also follows the previously observed higher solubility of the 
compound in this medium.  
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Figure 3.2-49 and Table 3.2-6: Silver concentration in the media after 24h incubation of the 
different coated substrates 
  
This tendency is more significant than it has been observed previously for the gold plates. The 
absence of the attaching anchor molecule could be a possible explication of this phenomenon. 
The compound behaves more as the free compound.       
3.2.5.2 Smooth and rough stainless steel restorative implant materials 
 
Although the microbiological tests of the steel samples (shown in Chapter 3.3.1.2.4) did not 
show as good results as the titanium substrates, the silver loading on a surface was determined 
and some SEM measurements were carried out. In the SEM images of the treated rough steel 
substrates, the surface appears very similar to the titanium samples. The crystalline structures 
with three sizes are present. The nanostructure in the case of 1mM treatment is very sparse 
and difficult to distinguish from the structure of the untreated surface. 
This fact can indicate that the silver compound doesn’t attach in a strong way on the steel 
surface. The silver loading measurements (Table 3.2-7) seem to confirm this supposition 
since the loading is appreciably lower than on the titanium or the gold surface loading. 
 
Table 3.2-7: Silver concentration on steel disks 
 
Ag loading on a 
surface (ng) 
  1mM 2mM 
StR 3.942 10.448 
StPol 4.400 20.347 
 
Ag concentration in ppm after dissolution in a medium
TiR 1mM
TiR 2mM
TiS 1mM
TiS 2mM
TiR 1mM
TiR 2mM
TiS 1mM
TiS 2mM
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Ag concentration in 
ppm  
 after dissolution in 
  SM MHB 
TiR 1mM 0.000 0.703 
TiR 2mM 0.760 6.415 
TiS 1mM 0.000 1.379 
TiS 2mM 0.485 4.142 
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Figure 3.2-50a,b,c: StR disks coated 
1mM/3d  
Figure 3.2-51a,b,c: StR disks coated 
2mM/3d  
a, a, 
b, b, 
c, c, 
 
 
 
 
 
 
 
Figure 3.2-52: StR disks uncoated 
 
On the surface of the polished steel samples other differences have been observed. The 
nanostructure is absent in the case of the 1mM treated samples, but present at higher 
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concentrations. The middle size crystals and aggregations are not as well formed as on the 
previous substrates. 
 
Figure 3.2-53a,b,c: StPol disks coated 
1mM/3d 
Figure 3.2-54a,b,c: StPol disks coated 
2mM/3d 
a, a, 
b, b, 
c, c, 
 
 
 
 
 
 
 
Figure 3.2-55: StPol disks coated 
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3.2.6 Coating on other surfaces 
 
The implantable medical devices are not only composed of metal parts, also other materials 
like ceramics and polymers are used. Hence, other surfaces than metal were treated with the 
silver polymer network Adl7.  
 
 
 
 
 
 
 
 
 
Figure 3.2-56: Chemical architecture of T-Gel 
resins  
 
To simulate a polymer surface like PEG, TentaGel resin was used, as is generally used in a 
solid state peptide synthesis (see Chapter 3.4.3). Polystyrol beads with grafted PEG surface 
are suitable to couple amino acids or other acids on the surface. (Fig.3.2-56) 
The isonicotinic acid coupled T-Gel resin (detailed description is shown in Chapter 3.4.1) 
behaves as a polymer surface covered with isonicotinic acid. The acidic side of the molecule 
is connected via a peptide bond to the surface of the bead and the pyridine end remains free. 
The isonicotinic acid functions as an anchor molecule and plays the same role as the disulfide 
in a case of the gold plate namely to attach the first silver ion. The so prepared surface was 
used to build up a coating as previously described. Both of the coating methods, in-situ and 
dip coating were used. The in-situ crystallisations took place in a weak concentration solution 
(0.2mM) to avoid crystallisation other than on the surface. For comparison, the multilayer 
method was used to build up a crystalline structure on the surface.  
Some SEM images of the beads surfaces were taken and EDAX spectra recorded to prove the 
presence of the silver compound on the surface.  
 Figure X :  
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a, b, 
Figure 3.2-57a,b: Isonicotinic acid coupled T-Gel resin, layer-by-layer method 
(12xAgNO3→L →…)  
 
a, b, 
Figure 3.2-58a,b: Isonicotinic acid coupled T-Gel resin, in-situ crystallisation 
(0.2mM/14days) 
 
As it can be observed on the images, both methods worked and allow building up a crystalline 
coating on the surface. The multilayer method results in a higher but less crystalline coverage. 
The in-situ crystallisation shows better formed and larger sized crystals rising up from the 
surface.   
In addition to isonicotinic acid coupled beads, other peptide coupled T-Gel resins were tested. 
The Ac-L-His-rac-ACHC-L-Tyr-NH-T-Gel tripeptide (detailed description see in Chapter 
3.4.3) shows a good complexation with silver (see Chapter 3.4.3), hence, it is apparently a 
good anchor molecule. This tripeptide coupled T-Gel was subject of the in-situ crystallisation 
(2mM/14days). 
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a, b, 
Figure 3.2-59a,b: Peptide coupled T-Gel resin, in-situ crystallisation (0.2mM/14 days)   
 
Small 20-50nm crystals are covering the surface in a nice homogenous distribution on a T-Gel 
bead. The loading of the T-Gel resins were measured by AAS and shown in Table 3.2-8.  
 
  LOADING  
  mgAg/m2 mg Ag/mg beads mM Ag/mM molecule 
TGIso_cryst 80 0.004 0.09 
TGIso_LbL 263 0.014 0.31 
TG440_cryst 84 0.005 0.10 
 
Table 3.2-8: Surface loading of the different coating on T-Gel beads: 
isonicotinic acid coupled in-situ crystallized (TGIso_cryst) and layer-by-layer 
treated (TGIso_LbL) and peptide coupled in-situ crystallized coatings. 
 
The loading received by the dipcoating method is much higher than it is in the in-situ 
crystallisation. The silver concentration on the surface obtained by layer-by layer deposition 
is similar than on the gold plate treated with 1mM Adl7complex solution for 1d. The in-situ 
crystallisation results in a similar loading than on the gold surface after a 7days treatment of 
0.5mM Adl7 solution. All of the coated T-Gel beads were tested for their antimicrobial 
activity (shown in Chapter 3.3.1.1.1) 
These examples show that the described two methods are able to build up the coating on other 
than metal surfaces. Thus, varying the silver complexing anchor molecule, the silver polymer 
network can be grown on numerous surfaces. 
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3.2.7 Conclusions 
 
The different substrates coated with the Adl7 silver polymer network were analysed with 
different surface analysis methods, like AFM, SEM, XPS and powder X-ray measurements. 
The silver amount on surfaces was determined by AAS. The change of the coating with the 
treating time on one hand and the increase of the complex concentration of the treating 
solution on the other hand was followed with the above mentioned methods. Tests were 
carried out to study the behaviour of the surface coating against biological media.  
The coating on Au(111) is described in detail since all of the analytical methods are suitable 
for this surface. The here obtained results are extrapolated, compared and confirmed for other 
substrates by appropriate methods. Depending on the chemical composition of the surface the 
coating method is slightly adapted for each substrate In every case that the Adl7 polymer 
network was applied only the pre-treatment methods were changed, so that the attachment of 
the polymer network could be optimized. 
Concerning the topography of the surface after treatment, these following general 
conclusions can be made for all tested substrates:  
- Nanocrystals build up on the surface, which have a compact form and are small in size 
(50nm). This nanostructure is very homogenous on an Au(111) surface. Most of the 
nanocrystals seen by AFM and SEM are ca. 10–20 nm in height and have a mean 
diameter of 10–20 nm, hence the loading of the surface containing this nanostructure 
could be calculated: the estimated nanocoating for silver is roughly 3.04 mg/m2 (12.5 
mg/m2 for the compound).  
- Middle size crystalline structures with some tens micrometers fall under this second 
group. These are larger compact crystals or flat aggregates covering the surface after a 
long enough treating time (at least 1 day for 0.5mM Adl7) or with higher 
concentration of the treating solution (≥1.0 mM for Adl7). 
- The macro structures, big well designed crystals of several 100 micrometers, appear 
when higher concentrations of the treating solution are used (≥1.0 mM for Adl7). 
These crystals are more frequent, but less compact using the highest concentration, 
2mM, for the compound. 
 
Besides the surface topography of the substrates, the silver loading of the surfaces is the main 
determining factor concerning the future medical use. Comparing the loading of the Ti plates 
and the gold surface, the concentration is calculated in mg/m2 units and shown in Table 3.2-9.  
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Table 3.2-9: The surface loading 
comparing all substrates treated for 3 
days 
 
 
 
TiR: rough titanium; TiS: smooth titanium; Auplate: Au(111) surface; StR: rough steel; StPol: 
polished steel; 
 
The gold and titanium restorative implant materials have very similar values in contrast to the 
steel substrates, which have a definitely lower loading. The treatment with 0.5mM Adl7 
solution results in a complete covering with nanostructures and some middle size aggregates. 
The loading is determined by these two types of structures. The 1.0 mM solution results, 
besides of a fully coverage by the nanostructure, mainly in middle size structures and some 
rare, compact, well-designed structures on the surface. Thus, the loading is determined mainly 
by the middle size structures. The surfaces treated with the highest concentration solution 
show mainly fine, well-designed macro-crystals jointly with the nanocrystals and the middle 
size structures. Since the macrostructures represent a big mass of the compound, these 
macrocrystals determine then the loading.  
Dissolutions tests were carried out to study the stability of the coating against dissolution 
effects in biological media. The summary of these tests is presented in the Table 3.2-10 
 
Ag LOADING IN mg/m2 ON A SURFACE AFTER TREATMENT 
  
  0.5mM 1mM 2mM SM 1mM in %  SM 2mM in %  MHB 1mM in %  MHB 2mM in %  
TiR  403 1550 17 4.3 82 5.3 9 2.3 73 4.7 
TiS  429 1739 13 3.1 37 2.2 10 2.4 66 3.8 
Auplate 23 424 1748 198 46.7 325 18.6 144 34.1 662 37.9 
StR  201 532         
StPol  224 1037         
 
Table 3.2-10: Comparative table of the dissolution tests of the different substrates  
 TiR: rough titanium; TiS: smooth titanium; Auplate: Au(111) surface; StR: rough steel; 
Stpol: polished steel; SM: synthetic medium; MHB: Müller-Hinton medium 
 
The more Adl7 silver polymer network is present initially on a surface, the more remains after 
the incubation in a biological medium. The percentage of the compound remaining on a 
surface is around 2-5% in the case of the Ti surfaces. A higher quantity of the remaining 
compound in the case of the gold surface can be explained by the used of anchor molecules 
(disulfide pre-treatment). This molecule guarantees the strong attachment of the compound on 
Ag loading in mg/m2 on the surface after treatment 
  0.5mM/3d 1mM/3d 2mM/3d  
TiR  403 1549  
TiS  429 1738  
Auplate 23 424 1747  
StR  201 532  
StPol  224 1037  
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the surface. Although the volume of medium versus the treated surface size ratio was higher 
in the case of the titanium plates, it cannot explain the large difference. Hence, the positive 
effect of the anchor molecule is obvious.  
Concerning the chemical changes taking place on the surface during the incubation in 
biological media, some observations could be made. In both media, the silver chloride 
precipitation is significant. This is the main product remaining on the surface of the substrates 
as well as on the macrostructures after the incubation. Microscopically sized Adl7 crystals are 
damaged by the solution, their surface is covered by the AgCl, and the major part of the 
macrostructures is washed out from the surface. This is also true for the medium size 
structures. The nanostructures seem to resist best against the biological media.  
The silver concentration in media after 24h the incubation is listed in the Table 3.2-11.  
 
 
 
 
 
 
 
Table 3.2-11: Ag concentration in two different media after 24h incubation of the treated 
samples 
TiR: rough titanium; TiS: smooth titanium; Auplate: Au(111) surface; StR: rough steel; Stpol: 
polished steel; SM: synthetic medium; MHB: Müller-Hinton medium 
 
As expected, the silver concentration was higher in the Müller-Hinton medium and was in a 
same region as it was determined for the free compound. It was also anticipated that the silver 
concentration of the solution is increasing with the quantity of compound on the surface. The 
less loaded samples (1mM treating solution) have a release of less than 2ppm for silver, which 
is important information from the biological point of view. The silver concentration is clearly 
higher, around 5ppm, in the case of the 2mM treated samples. These dissolution tests serve as 
a model for the biological environment and test the stability of the coating without taking into 
consideration the flow and other mechanical effects. The microbiological assays will answer 
the question as to which concentration is necessary to reach a good antimicrobial effect 
without any toxic side-effects.  
In any case, the Adl7 crystalline coating has a low solubility, a limited release and a good 
stability on the surface. These favourable characteristics are more pronounced with the use of 
an anchor molecule. It’s easy to design the coating respectively to the silver loading on the 
Ag concentration 
 in ppm after dissolution in: 
   SM MHB 
TiR 1mM 0.000 0.703 
TiR 2mM 0.760 6.415 
TiS 1mM 0.000 1.379 
TiS 2mM 0.485 4.142 
AuPlate 1mM 0.568 1.760 
AuPlate 2mM 3.158 4.346 
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surface, which makes this silver polymer network a suitable candidate for further 
microbiological assays. The topography and the loading determine the silver release, thus the 
1mM/3h, 2mM/3days treatment is used for small surfaces. In the case of larger surfaces or 
substrates destined to external use other methods are used. For Au and Ti dental implant 
materials –external use- 2mM/14days treatment is used to increase the surface loading. For Ti 
cages (in vivo assays) 1mM/3days is applied to avoid the high local Ag concentration. 
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3.3 
 
Microbiological in vitro and in vivo assays 
The purpose of the silver coating is to avoid the biofilm formation on the surface of the 
implant material, and thus to prevent the septic loosening of the implant. Forming an 
antimicrobial coating can hinder the preliminary bacterial adhesion and further bacterial 
multiplication causing septic failure [109,110,167, 140]. The developed silver coordination 
polymer coating was tested with different microbiological methods to prove the antibacterial 
efficiency of the coating. First, the free compound, Adl7 is tested by the isothermic micro- 
and nano- calorimetric method. This method follows the heat of the bacterial growth as a 
function of time. This is a good way to get information of the antibacterial effect, also of 
insoluble materials such Adl7 and Ag-treated T-Gel beads. For this kind of material, the 
classical way of the MIC determination, plating in agarose gel, is not suitable. During IMC 
measurements, S.epidermidis bacterial stain was used in BHI (Brain Heart Infusion) medium. 
Some complementary tests were done with S.Aureus. The inhibition zone experiments were 
carried out with AgNO3 solution, followed by some preliminary assays, and the different 
treated substrates as the Au(111) surface, the titanium, and steel restorative implant materials. 
In these assays, several bacterial strains were tested, S.epidermidis: wild type and ica, 
S.Aureus and also E.Coli to compare the effect of the silver on gram+ and gram- bacteria. 
The microbiological characterization of the treated dental implant materials (gold alloy and 
pure titanium plates) were carried out in a flow-chamber, which is a typical method in oral 
microbiology to test the adherent dead and living bacteria on the different substrates. In these 
assays, S.Sanguinis, as one of the known early dental colonizers, suspended in sterilized 
human saliva, was used. The in vivo experiments were carried out on treated titanium cages 
designed for this aim using the same material as the titanium disks and cylinders in the plating 
experiments. 
 
Sterilization 
Since some of these methods require a preliminary sterilisation of the coated substrates, 
different sterilisation methods have been tried on the coating. If the coated plate is rinsed with 
EtOH (70%), the coating remains intact. Indeed the rinsing of the substrates after the removal 
from the crystallization solution is made with EtOH. This sterilisation method is generally 
used during the in vivo experiments. Autoclaving (110°C for 1/2h) has been tested on treated 
titanium dental implant sample and around 10-20% of the coating remains on the surface. 
(Fig.3.3-1)  
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a, b, 
Figure 3.3-1: Titanium plates after (a,) and before (b,) autoclaving 
 
In this chapter all of these previously mentioned microbiological methods are described, 
together with their results for the silver compounds on different substrates. The 
complementary chemical tests, such as the silver concentration determination in the inhibition 
zone or in the bacterial fluid, are also presented.  
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3.3.1 In vitro experiments 
3.3.1.1 Isothermal microcalorimetry (IMC) experiments 
 
Calorimetry is attracting increased attention in life sciences [111], because heat flux 
accompanying action of the living microorganisms is tightly connected with both kinetic and 
thermodynamic processes [112]. In microbial investigations, calorimetry is particularly 
valuable because it can provide insights into rapid metabolic changes and allows the velocity 
and efficiency of growth and product formation to be quantified in a non-invasive way. The 
enthalpy balance can reveal the formation of unknown, unexpected by-products. These days, 
calorimetry is a well-established method and a broad spectrum of devices is commercially 
available, including vessels ranging in volume from a few micro litres to several millilitres 
(nano and micro calorimeters) or even litres. However, most calorimetric determinations of 
velocity and efficiency of microbial growth and product formation are highly complicated 
[113] and therefore not widely used in microbiological laboratories. The simplest calorimetric 
set-up follows the heat flux of microorganisms growing in a static, sealed ampoule. Critics 
against to use this approach in microbiological determinations include problems as oxygen 
supply limitations, pH shifts, lack of homogeneity and sedimentation [114].Other studies 
indicate that the simplest calorimetric set-up can be used to obtain reliable and reproducible 
data about the kinetics of anaerobic growth processes [115].  
The application of calorimetry as a routine method in microbiology laboratories seems to 
have a promising future, given exciting recent developments in miniaturised 
‘nanocalorimeters’ [116] or integrated circuit calorimeters [118] with the increasing 
commercial availability of multi-channel calorimeters [119] At the beginning of the years of 
2000, the calorimetric method was proposed to measure and quantify bacterial growth as a 
function of different feeding and environmental factors. For the growth of 
chemoorganoheterotrophic bacteria -which have the potential to catalyse the degradation of 
harmful organics and synthesise harmless, valuable products- the bacteria have to adjust their 
utilisation of Gibbs energy, and thus their heat flux and network of reaction fluxes, to cope 
with sub- or supra-optimal environmental factors, which frequently fluctuate with varying 
amplitude and frequency. The heat of the growing process was measured, and using the 
measured enthalpy with the help of special mathematical tools the changes of metabolic 
fluxes in response to specific stresses could be quantified. [120]  
At the University of Basel, the Laboratory of Orthopaedic Biomechanics offers the facility to 
use this technique to determine microbiological processes on surfaces. The IMC 
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measurements were made in close collaboration with the group of Prof. A.U.Daniels. The 
IMC method was first developed by A.U. Daniels to study why by some patients, subject of 
implant loosening. The main cause of this problem is the micron-size wear polymer and metal 
particles generated by the mechanical use of the hip implant surfaces. These particles, 
sometimes, elicit a persistent inflammatory response, eventually leading to bone absorption 
around the implant and clinical failure due to implant loosening. The response of cultured 
macrophages to small particles did indeed differ for metal and polymeric hip implant 
materials [121]. Further microcalorimetric experiments showed that heat flow growth curves 
in a given culture medium are different for different microorganisms, and heat flow curves for 
a given microorganism are different in different media. This means that IMC also has 
potential for identification of the type of microorganism present in a specimen. [122] In 
general, IMC can be several times faster than conventional culture plate methods, and also 
simple and safe. Other works were made on microbial contamination in blood platelet 
products. [123]. The heat of adhesion of bacteria to surfaces of dental implant surfaces was 
measured with success. [124]  In this work, glass beads were used to model the enamel 
surface. The heat produced by the growing of the S.Sanguinis cells, suspended in human 
saliva, in presence of different quantities of glass beads was determined by the calorimeter. 
This heat was compared with the growing heat of the stationary microorganisms, thus the 
adhesion on the glass surface could be determined. Other works were made studying the 
antibacterial effect of Ag+. The MIC values of silver nitrate on E.Coli and S.Aureus were 
determined by the microcalorimetric method. The MIC of silver nitrate in LB (Luria-Bertani 
broth) for E.coli (104CFU/ml) is 8 mg /l as determined by the broth dilution method. The MIC 
of silver nitrate in BHI for S.aureus (104CFU/ml) is 256 mg/l as determined by the broth 
dilution method. Both methods, microcalorimetry and visual interpretation, returned the same 
results [125].  
All the IMC measurements were performed on TAM III™ thermostats, equipped with multi 
channel microcalorimetry. This calorimeter, a heat flow type calorimeter, works by 
channelling the heat produced or consumed by a reaction in the sample through heat flow 
sensors comprised of thermoelectric modules, and converse the heat on an electrical signal 
which is proportional with the heat change. The TAM III thermostat maintains the outside 
temperature hence the outstanding sensitivity. The calorimeter is a twin type (Fig.3.3-2), 
consisting of both a sample and a reference side. The measured value is the difference in heat 
flow between sample and reference. This twin principle reduces baseline noise by eliminating 
any small fluctuations of the thermostat resulting a good sensitivity and reliability. 
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Figure 3.3-2: Scheme of the twin type calorimeter  
 
 
 
 
 
 
 
 
This technique was used to determine the antimicrobial activity of the 
insoluble compound Adl7 against S.epidermidis in BHI. The same 
conditions were applied during the measurements of the TGel samples. One 
part of these samples has Adl7 built on the surface by crystallisation or 
layer-by-layer method. TGel samples having silver nanoparticles generated 
on the surface by peptides were also tested. The results are presented in the 
following chapters.  
 
3.3.1.1.1 IMC measurements on silver coordination polymers     
 
In figure Fig.3.3-3 the heat flow curves of the growth of the S.epidermidis in BHI medium are 
presented and compared with the heat flow of the bacterial solution in presence of Adl7 
compound. A weighted amount of Adl7 was suspended in the BHI medium, then the bacterial 
strain was added and the vessel was sealed and put directly into the calorimeter. Adl7 was 
present in 4 vessels in different concentrations. 
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Figure 3.3-3: Heat flow curves of bacterial growth of 
S.epidermidis in presence and without Adl7 compound  
 
 
 
 
 
 
 
From these 4 vessels, bacterial growth can be observed after 36h in one and after 42h in a 
second vessel. In the two other vessels, no bacterial growth took place during the 48hours of 
the measurement. This is a very good result, supposing a good antimicrobial effect for Adl7 
since this compound, in this concentration, inhibits the bacterial growth for at least 20h, or, in 
the better case, it can block their growth. 
Adl7 was compared with the most common silver precipitate, AgCl, since this is the main 
product after the dissolution of Adl7 in synthetic and biological media. By the dissolution 
tests and SEM measurements, the AgCl precipitate forms on the surface of the crystals. It 
would be preferably to exclude the doubt if only the antibacterial effect of the AgCl could be 
observed during the measurements or if it is a real effect of Adl7. Therefore, Adl7 was 
compared to different amounts of AgCl, bacteria alone and blank. 
Channel Compound 
Ch 31 Adl7, 4.1 mg 
Ch 32 Adl7, 4.3 mg 
Ch 33 Adl7, 5.4mg 
Ch 34 Adl7, 8.5 mg 
Ch 43 S.epidermidis  
Ch 44 S.epidermidis 
Ch 45 S.epidermidis 
Ch 46 BHI 
Ch 48 BHI 
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Figure 3.3-4: Heat flow curves of 
bacterial growth of S.epidermidis in 
presence of Adl7 compound and AgCl 
salt  
 
 
 
 
The results (Fig.3.3-4) obviously show that AgCl has just a weak effect (the bacterial growth 
is delayed by some hours) against S.epidermidis, contrary to Adl7, which inhibits the bacterial 
growth during the 85 hours of the measurements.  
Since the Adl7 has an antimicrobial activity, it is preferable to test the surfaces coated with 
this compound. The Au(111) plates are too large to test them in these vessels of the 
calorimeters. Therefore, the Adl7 compound attached on a T-Gel surface was tested. This 
IMC technique is suitable to measure if the compound attached on polymer beads has the 
same effect as the free Adl7. For classical microbiological assays, the plating method is not 
suitable for testing these small particles.  
The prepared, dried and weighed T-Gel beads were suspended in the BHI medium, then the 
bacterial strain was given into the vessel, which is sealed directly and put into the calorimeter. 
The samples of the two surface treatment methods to build up the Adl7 on isonicotinic acid 
coupled T-gel are compared with the untreated, iso-TG, the Ag+ incubated but not reduced 
iso-TG, the light reduced iso-TG and the free Adl7, as shown on Fig.3.3-5.  
Channel Compound Ag conc. mM  
Ch 30 Adl7; 3.7mg  0.008  
Ch 23 AgCl; 4.9mg 0.034  
Ch 24 AgCl; 5.4mg 0.038  
Ch 25 AgCl; 4.8mg 0.034  
Ch 37 S.epidermidis (3ml) -  
Ch 38 S.epidermidis (1ml) -  
Ch 39 Sterility control (BHI) -  
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Iso-TG: LR, Ag+, no Ag+, and Adl7 on iso-TG
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Figure 3.3-5: Heat flow curves of 
bacterial growth of S.epidermidis in 
presence of bulk Adl7 compound 
compared to the heat flow curves in 
presence of the differently coated 
polymer surfaces: 
Ag+ iso-TG: isonicotinic acid coupled TG 
beads complexed with Ag+ 
Adl7 on iso-TG(LbL): isonicotinic acid 
coupled TG beads coated with Adl7, 
layer-by layer method 
Adl7 on iso-TG(cryst): isonicotinic acid 
coupled TG beads coated with Adl7, in-
situ crystallization method 
LR iso-TG: isonicotinic acid coupled TG 
beads complexed with Ag+, AgNPs 
generation by light reduction 
 
The no silver containing iso-TG has no effect on the bacterial growth, as it was expected. The 
best antibacterial effect has the Adl7 coating, which was built up with the dip coating method 
on iso-TG. This has the same effect as the free Adl7, and the bacterial growth is blocked by 
these products during the time of the measurements. The other method used to treat the iso-
TG surface with the Adl7, namely the crystallisation method, has a weaker antibacterial effect 
than the previous one. In anyway, there is a microbiological activity for both Adl7 coated iso-
TG. The difference of the two coating methods should be an explanation of this variation in 
the bacterial growth. The fact that the loading resulting from the dip coating method is almost 
3 times higher than the loading after the classical crystallization on iso-TG is supposed to be 
Channel Compound 
Ch 13 iso-TG; 5.3mg 
Ch 14 Ag+  iso-TG; 3.1mg 
Ch 15 Ag+  iso-TG; 4.9mg 
Ch 16 Ag+  iso-TG; 4.8mg 
Ch 20 Adl7 on iso-TG (LbL); 5.9mg 
Ch 21 Adl7 on iso-TG (LbL); 5.6mg 
Ch 22 Adl7 on iso-TG (LbL); 6.3mg 
Ch 23 Adl7 on iso-TG (cryst); 5.9mg 
Ch 24 Adl7 on iso-TG (cryst); 7.0mg 
Ch 25 Adl7 on iso-TG (cryst); 5.0mg 
Ch 29 LR iso-TG; 5.5mg 
Ch 30 Adl7; 3.7mg (3ml) 
Ch 37 S.epidermidis (3ml) 
Ch 38 S.epidermidis (1ml) 
Ch 39 Sterility control (BHI) 
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the cause of this difference, because the Ag+ release of the sample is proportional with the 
loading. The Ag+ incubated and the light reduced iso-TG has the same antibacterial effect. It 
is much weaker (the bacterial growth is just delayed by 6-8hours) than the Adl7 containing 
beads. The silver concentration on the surface is much lower, thus the release of Ag+ is also 
lower. 
A different anchor molecule, His-Achc-Tyr-TG, is also used to build up the Adl7 on the 
surface of the T-Gel beads. These beads were also tested and compared with the simple Ag+ 
incubated peptide-TG and with similarly prepared samples using isonicotinate anchor 
molecule (Fig.3.3-6)  
His-Achc-Tyr-TG: Ag+ and Adl7 on the surface, iso-TG Adl7 
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Figure 3.3-6: Heat flow curves of 
bacterial growth of S.epidermidis in 
presence of bulk Adl7 compound 
compared to the heat flow curves in 
presence of the differently coated 
polymer surfaces: 
Ag+ His-Achc-Tyr-TG: His-Achc-
Tyr coupled TG beads complexed 
with Ag+ 
Adl7 on His-Achc-Tyr-TG(cryst): 
His-Achc-Tyr coupled TG beads 
coated with Adl7, in-situ 
crystallization method; Adl7 on 
iso-TG(cryst): isonicotinic acid 
coupled TG beads coated with 
Adl7, in-situ crystallization 
method 
Channel Compound 
Ch 17 Ag+ His-Achc-Tyr-TG; 5.3mg 
Ch 18 Ag+ His-Achc-Tyr-TG; 4.4mg 
Ch 19 Ag+ His-Achc-Tyr-TG; 7.7mg 
Ch 23 Adl7 on iso-TG (cryst); 5.9mg 
Ch 24 Adl7 on iso-TG (cryst); 7.0mg 
Ch 25 Adl7 on iso-TG (cryst); 5.0mg 
Ch 26 Adl7 on His-Achc-Tyr-TG (cryst); 6.4mg 
Ch 27 Adl7 on His-Achc-Tyr-TG (cryst); 5.3mg 
Ch 28 Adl7 on His-Achc-Tyr-TG (cryst); 5.6mg 
Ch 30 Adl7; 3.7mg (3ml) 
Ch 37 S.epidermidis (3ml) 
Ch 38 S.epidermidis (1ml) 
Ch 39 Sterility control (BHI) 
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The peptides incubated with Ag+ have a higher effect against the bacterial growth: two out of 
the three parallel samples were completely blocking the growing process during the time of 
the measurements. The effect is high thanks to the silver, present in ionic form on the surface 
and in a high concentration (high uptake), thus easy to release. The samples with the two 
different anchor molecules are behaving in a same way. These samples delay the bacterial 
growth by ca. 15-18h on average. This is the same result as received in the previous 
measurements. The two samples have the same Adl7 loading on the surface, which results in 
a similar antibacterial effect. 
To conclude the measurements regarding the Adl7, some principal remarks should be made:  
-The free Adl7 has a very good antibacterial effect on S.epidermidis in BHI, much higher than 
the common AgCl precipitation. The surface passivation of Adl7 by the AgCl has not a 
remarkable effect.   
-The Adl7 attached on polymer surface has also a good impact on the bacterial growth. The 
effect depends on the loading on the surface hence the concentration of the Adl7. 
-The antibacterial effect seems to be a direct factor of the silver ion concentration in the 
solution, because the Ag+ incubated samples, where just ions are present on the surface (and 
these ions are easy to release) show a high activity.   
Further IMC investigations were done on other T-Gel beads to test the antimicrobial effect of 
the AgNPs generated by solid state peptides.  
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3.3.1.1.2 IMC measurements on AgNPs generated on solid surface by peptides 
 
IMC measurements carried out on TG samples focus on the sequence AcHis-Achc-TyrNH-
TG. This sequence has good photo reducibility, thus the two reducing methods could be 
compared. The uptake of the peptide is rather high, resulting in a high Ag+ concentration on 
the surface. The different samples, Ag+ incubated, light reduced (LR) and chemically reduced 
(CR) samples were prepared. The dried beads were weighed directly into the IMC glass 
vessel, then it was suspended in the BHI medium. The bacterial suspension was added, the 
vessel sealed and the measurements could begin. In the first step, the chemical and light 
reduced beads were compared. (Fig.3.3-7)   
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Figure 3.3-7: Normalized heat flow 
curves of bacterial growth of 
S.epidermidis in presence of AgNPs 
containing TG-beads  
LR His-Achc-Tyr-TG: His-Achc-Tyr 
coupled TG beads complexed with Ag+, 
AgNPs generation by light reduction 
CR His-Achc-Tyr-TG: His-Achc-Tyr 
coupled TG beads complexed with Ag+, 
AgNPs generation by chemical reduction 
 
 
Channel Compound 
Ch 43 LR His-Achc-Tyr-TG, 4.8 mg 
Ch 44 LR His-Achc-Tyr-TG, 4.6 mg 
Ch 45 LR His-Achc-Tyr-TG, 4.8 mg 
Ch 46 CR His-Achc-Tyr-TG, 7.2 mg 
Ch 47 CR His-Achc-Tyr-TG, 7.1 mg 
Ch 48 CR His-Achc-Tyr-TG, 5.9 mg 
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As it can be observed in Fig.3.3-7, the light reduced samples have a higher activity than the 
chemically reduced ones. This higher activity is probably due to the remaining, non-reduced 
silver ions present on the surface beside of AgNPs, since the reduction is not complete in the 
case of the LR. Due to the silver ions, the Ag release of these beads is higher and increases 
the antimicrobial effect. 
To exclude the possibility that peptide coupled T-Gel beads and the not coupled, only 
acetylated T-Gel beads have some activity against bacteria, both were tested in comparison 
with the LR His-Achc-Tyr-TG. The normalized heat flow values in function of the time are 
presented on a Fig.3.3-8.  
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Figure 3.3-8: Normalized heat flow 
curves of bacterial growth of 
S.epidermidis in a presence of AgNPs 
containing TG-beads  
LR His-Achc-Tyr-TG: His-Achc-Tyr 
coupled TG beads complexed with Ag+, 
AgNPs generation by light reduction 
His-Achc-Tyr-TG: His-Achc-Tyr coupled 
TG beads  
Ac-TG: Acetylated TG beads 
 
 
 
 
 
 
 
Channel Compound 
Ch 21 LR His-Achc-Tyr-TG 
Ch 22 LR His-Achc-Tyr-TG 
Ch 23 LR His-Achc-Tyr-TG 
Ch 24 LR His-Achc-Tyr-TG 
Ch 25 LR His-Achc-Tyr-TG 
Ch 26 LR His-Achc-Tyr-TG 
Ch 30 His-Achc-Tyr-TG 
Ch 31 His-Achc-Tyr-TG 
Ch 32 His-Achc-Tyr-TG 
Ch 33 Ac-TG 
Ch 34 Ac-TG 
Ch 35 Ac-TG 
Ch 39 S.epidermidis (x3) 
Ch 40 S.epidermidis (x3) 
Ch 41 S.epidermidis (x3) 
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As the results show, none of the control samples has any antibacterial effect, the bacterial 
growth takes place at the same time even if acetylated or peptide coupled T-Gel beads are 
present in the bacterial suspension. This is in contrast with the LR His-Achc-Tyr-TG, which 
has a clear activity. Since this antibacterial effect depend on the concentration of the active 
substance (e.g. antibiotics), various quantities of the LR His-Achc-Tyr-TG were tested in 
parallel and the results are represented in a heat flow vs. time graph (F.3.3-9)  
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Figure 3.3-9: Heat flow curves of 
bacterial growth of S.epidermidis in a 
presence of AgNPs containing TG-beads  
LR His-Achc-Tyr-TG: His-Achc-Tyr 
coupled TG beads complexed with Ag+, 
AgNPs generation by light reduction 
 
 
 
 
 
 
 
Unfortunately, no relation could be found between the beads concentration (in the range of 4-
7mg) and their activity against S.epidermidis. This surprising result is probably due to the 
inhomogenity of the light reduced samples. Since the sample is not stirred during the 
irradiation, the AgNPs formation is inhomogeneous. AAS measurements revealed a high 
dispersion in the concentration of the silver ions versus the AgNPs on the surface after light 
Channel Compound 
Ch 37 LR His-Achc-Tyr-TG, 4.8 mg 
Ch 38 LR His-Achc-Tyr-TG, 4.6 mg 
Ch39 LR His-Achc-Tyr-TG, 4.8 mg 
Ch 40 LR His-Achc-Tyr-TG, 7.2 mg 
Ch 41 LR His-Achc-Tyr-TG, 7.1 mg 
Ch 42 LR His-Achc-Tyr-TG, 5.9 mg 
Ch 43 S.epidermidis  
Ch 44 S.epidermidis 
Ch 45 S.epidermidis 
Ch 46 BHI 
Ch 48 BHI 
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reduction. Hence, the silver ion concentration seems to be the main responsible for the 
antibacterial activity, and it can show a high variation on the surface.   
The iso-TG has been tested in connection with the Adl7 attached on T-Gel surface, and it 
would be interesting to compare it with LR His-Achc-Tyr-TG, setting up a bridge between the 
two measurement series. The Fig.3.3-10 presents the results of this comparing measurement.  
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Figure 3.3-10: Normalized heat flow 
curve of bacterial growth of S.epidermidis 
in a presence of AgNPs containing TG-
beads  
LR His-Achc-Tyr-TG: His-Achc-Tyr 
coupled TG beads complexed with Ag+, 
AgNPs generation by light reduction 
LR iso-TG: isonicotinic acid coupled TG 
beads complexed with Ag+, AgNPs 
generation by light reduction 
 
 
 
 
The light reduced His-Achc-Tyr-TG shows a higher effect to inhibit the bacterial growth than 
iso-TG prepared in the same way. The LR iso-TG delays the bacterial growth by ca 7h (the 
same time was determined for this sample during the previous measurements) contrary to the 
ca 15h delay caused by the  LR His-Achc-Tyr-TG. The measured silver uptake is much higher 
Channel Compound 
Ch 21 LR His-Achc-Tyr-TG 
Ch 22 LR His-Achc-Tyr-TG 
Ch 23 LR His-Achc-Tyr-TG 
Ch 24 LR His-Achc-Tyr-TG 
Ch 25 LR His-Achc-Tyr-TG 
Ch 26 LR His-Achc-Tyr-TG 
Ch 27 LR iso-TG 
Ch 28 LR iso-TG 
Ch 29 LR iso-TG 
Ch 39 S.epidermidis (x3) 
Ch 40 S.epidermidis (x3) 
Ch 41 S.epidermidis (x3) 
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by the second peptide, which can explain this difference in the activity. The antibacterial 
effect of the LR His-Achc-Tyr-TG is comparable with the effect of the TG samples having 
Adl7 on the surface by crystallisation method. The loading of the latter is much higher 
regarding the silver concentration but there is a big difference in the form of the silver. In the 
case of the LR His-Achc-Tyr-TG peptide, induced AgNPs and Ag+ can be found on the 
surface. The Adl7(cryst) on iso-TG contains only silver ions in the coordination polymer. 
Hence the determining factor for the antimicrobial activity seems to be the Ag+ present in the 
reaction solution. 
3.3.1.1.3 Conclusion of the IMC measurements 
 
The antimicrobial activity of different samples was tested using the microcalorimetric 
method. S.epidermidis, as the main responsible bacteria for the biofilm formation, was used in 
BHI medium. The free Adl7 as well as the surface attached compound show a good activity 
against these bacteria, contrary to the AgCl precipitate, which has a very weak effect. The 
AgNPs containing T-Gel beads show activity against bacteria only if there are some free 
silver ions, which can be found on the surface beside of the AgNPs. The silver release of the 
AgNPs as well as of the AgCl is so weak that it is not enough to show any antimicrobial 
effect. The antimicrobial activity is in a direct relation with the silver concentration in the 
reaction suspension, hence the silver release of the substance. These results are encouraging 
the further in vitro and in vivo microbiological testing of the coated substrates.  
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3.3.1.2 In vitro microbiological assays: inhibition zone experiments  
 
 In the previous chapter, it has already been mentioned that the variety of the microbiological 
assays is large, and the most suitable testing method should be chosen especially for the 
defined sample. In the case of the insoluble Adl7 compound and the T-Gel beads, the 
inhibition zone assays seemed to be suitable. To test the antimicrobial effect of the coated 
substrates, another, less specific method is needed. As the susceptibility of the antibiotics is 
often tested by the classical plating method, this method seems to be appropriate for our 
purpose as well. Using this technique, several bacterial strains in different concentrations can 
be used and a large number of samples can be screened. It gives the opportunity to test sample 
series on the different substrates offering the same conditions. A large screening of the coated 
samples, prepared in different conditions (treating time, treating concentration) was done. 
Several bacterial strains were used, e.g. gram+ and gram- bacteria, different strains of 
S.epidermidis etc.  
3.3.1.2.1 General description 
Many methods were developed to test bacterial cells, yeast cells and antibiotics. The plating 
method is one of them and it is generally used in microbiology. This technique is suitable to 
determine the presence of different bacterial strains in a sample, to count these bacteria or 
colonize them. It is also often used to determine the concentration of an active substance 
where this inhibits the bacterial growth.  
An agar plate is a sterile Petri dish that contains a growth medium: typically agar plus 
especially developed nutrients, used to culture microorganisms. Not only the composition of 
the nutrients is destined to the target microorganism but selective growth compounds may 
also be added to the media, such as antibiotics.[126] Individual microorganisms/bacteria 
placed on the plate will grow into individual colonies. A bacterial colony is defined as a 
cluster of organisms growing on or within a solid medium, which is cultured from a single 
cell. The participants of the colony are genetically identical to the individual starting organism 
(except for the unavoidable, generally low rate of mutation,). The growth of the colony is 
depending on the nutrient and the environmental circumstances. Like other growth media, the 
compositions of agar used in plates may be classified as either defined or undefined. The 
defined medium is being synthesized from the individual chemicals as required by the 
organism so that the exact molecular composition is known, as e.g. the synthetic medium 
(SM) used and described for the dissolution tests. The undefined medium is made up from 
natural products such as beef infusion, where the precise composition is unknown.  
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Agar plates may be formulated as either permissive, allowing the growth of all present 
bacteria, or restrictive or selective, with the purpose to allow the growth of a particular 
participant of the present organisms. This correlates to some degree with defined and 
undefined media. Undefined media are made from natural products and contain an unknown 
combination of organic molecules. These are typically more permissive than the defined 
media in terms of serving the needs of a wider variety of microorganisms. Defined media can 
be precisely designed, to determine organisms with very specific properties. 
Müller-Hinton agar is a microbiological growth medium that is commonly used for antibiotic 
susceptibility testing. It typically contains [127]: 
 
pH adjusted to neutral at 25ºC.   
*when susceptibility testing is done on Streptococcus 
species 
 
 
In the case of Adl7 coated substrates, the assays take place on permissive agar plates where 
the inhibition of the bacterial growth around the substrates is measured. The agar plates are 
prepared using 15ml liquid MHA agar (or SM agar in the case of AgNO3 solution and the 
bacterial count of adherent and planktonic bacteria), cooled to a temperature of approximately 
50°C, which is mixed with different concentrated bacterial suspensions. The aimed bacterial 
concentrations are 104, 106 and 107 CFU/ml (CFU: colony-forming unit, this is a measure of 
viable bacterial numbers, which allows to know the bacterial load). This 15ml mixture is 
layered on a Petri dish, the coated or uncoated samples are placed into the middle of the 
suspension, under the agar and the plate is covered. The plates are incubated for 24h at 37ºC. 
Then, the inhibition zone around the samples is measured. The bacteria present in the medium 
begin their multiplication thanks to the nutrients and the appropriate temperature. Where a 
substance, which blocks the bacterial multiplication, is present, no bacterial growth can be 
observed. In this area, the agar suspension remains clear contrary to where the bacterial 
growth takes place, and the suspension becomes turbid. The area of the inhibition becomes 
visible and easy to measure. The Fig.3.3-11 shows the principle of the technique: 
Conc. (g/l) Composant 
2  beef infusion  
17.5 acid digest of casein 
0.15 starch  
17 agar 
50 sheep blood* 
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Figure 3.3-11: Scheme of the plating experiment, around the coated plate an inhibition zone 
can be observed where the bacterial growth is inhibited.   
 
The inhibition zone around the plate was measured and the results of the different coated 
substrates were compared. During the assays, several bacterial strains were tested. 
The Staphylococcus strains: S.epidermidis, S.aureus. These bacteria are mainly responsible 
for the biofilm formation and the post operative infections of the implants. Staphylococcus is 
a genus of Gram-positive bacteria. Under the microscope, they appear round and form in 
grape-like clusters contrary to streptococcus forming linear clusters. The Staphylococcus 
genus includes just thirty-three species. [128] Most are harmless and can be found normally 
on the skin and mucous membranes of humans and other organisms. Although, S.epidermidis 
is usually non-pathogenic, patients with a weak immune system are often at risk for 
developing infections. These infections can be both nosocomial (from hospitals) and 
community acquired, but they are more prevalent in hospital patients. S.epidermidis is also a 
major trouble for people with catheters or other surgical implants because it is known to cause 
biofilms that grow on these devices causing infections. [129] The capability to form biofilms 
on implanted devices is a major virulence factor for S.epidermidis. The capsule of the surface 
proteins (binding blood and extra cellular matrix proteins together) known as polysaccharide 
intercellular adhesion (PIA), is made up of sulfonated polysaccharide and allows other 
bacteria to bind to the already existing biofilm, creating a multilayer biofilm. The biofilm of 
staphylococci is mainly composed of polysaccharide intercellular adhesin (PIA), whose 
biosynthesis is encoded by four ica genes [130]. Currently, ica is considered to be the main 
responsible for staphylococcal biofilm. Rupp et al. have shown, in a catheter model, that 
biofilm-negative (ica) staphylococci are less virulent than isogenic wild-type (WT), ica-
positive strains. [131]. Landman et al tested the susceptibility of titanium and steel implant 
Au(111) 
MHA with cultured bacteria 
(starting conc.104, 106 or 
107 CFU/ml) 
Inhibition zone, the bacterial 
growth is blocked around the 
plate, the size of the IZ is 
given in mm 
No inhibition zone, no 
antimicrobial activity 
against the applied bacteria  
Coated plate Uncoated plate 
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materials to WT and ica-  S. aureus and S.epidermidis. They measured the minimal infective 
dose and the number of planktonic and adherent bacteria in vitro and in vivo on the devices. 
[108] This study revealed that the presence of ica genes had a strong effect on biofilm in vitro 
and a weak effect in vivo. The bacterial adhesion and multilayer clustering on titanium and 
stainless steel was affected strongly by biofilm in vitro and weakly in vivo. The implant 
material has just a weak effect on biofilm formation.  Both WT strains, but not ica- strains, 
showed multilayered biofilm formation. S.epidermidis, despite its known stronger ica RNA 
expression and PIA production than the S.aureus [131], produced just slightly higher CFU 
numbers of planktonic and adherent bacteria after injection with WT (ica+) than with ica– 
bacteria. The effect of the ica genes was only weakly visible in S. aureus infection. The 
biofilm formation doesn’t play an exclusive role in the implant-associated infections. S. 
aureus caused a persistent infection only with a very small number of bacteria, which was 
independent of biofilm formation. In contrast, S.epidermidis caused an infection only if a 
considerable bacterial load was introduced during surgery so that a multilayered biofilm could 
be formed.  
As the importance of the ica genes is not negligible in biofilm formation and thus in infection, 
our experiments were made with both ica- and WT strains of S.epidermidis and S.aureus. 
Beside of these Gram-positive bacteria one Gram-negative strain E.Coli was also tested. Most 
E. coli strains are harmless and part of the normal human intestinal flora. The bacteria can be 
grown easily and its genetics are relatively simple and easily manipulated, hence it is the best-
studied, prokaryotic model organisms. These characteristics and because it is a Gram-negative 
strain makes it a good test bacteria for our aim. 
Some complementary experiences were also carried out to determine the adherent and 
planktonic bacteria on and above the treated implant materials. In this assay the different 
substrates were incubated for 4 h in a determined concentration bacterial solution in SM. 
Then the sample is removed, and the bacteria present in the solution are counted as well as the 
bacteria adhered on the surface (by removing the attached bacteria by sonication from the 
surface).  
The assays were carried out first using AgNO3 solution. To determine the most appropriate 
sample preparation method and find out the best loading regarding the antimicrobial activity 
of Adl7 on the different substrates, several experiments were done. After the evaluation of the 
results of the method development, more assays were done with the most active samples. 
Since the diversity of the substrates, Au(111) plates, Ti disks and cylinders with two 
roughnesses, stainless steel disks and cylinders with two roughnesses would result in a high 
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repetition number, these assays were focused on the Au(111) substrate, as model surface, and 
Ti rough disks, because it is the same material as the Ti cages used for the in vivo 
experiments.    
The microbiological assays are completed by chemical measurements to determine the silver 
concentration in the inhibition zone in order to  assess the antimicrobial effect of the silver.  
3.3.1.2.2 Preliminary  AgNO3  assays 
As previously described, the ica genes have a main role in the biofilm formation, and so the 
isogenic biofilm negative strains (Δica) and the WT of both bacteria were tested. Different 
concentrations of AgNO3 solution in EtOH were tested. The concentrations of the solutions 
were 200, 100, 10, 5 and 2,5 µg/ml for AgNO3 (127, 63, 6,3, 3,2 and 1,6 µg/ml respectively 
of silver). The results of the measurements are shown in Fig.3.3-12-13. 
 
Figure 3.3-12a: Silver inhibited growth of S.epidermidis (strains1457; WT and ica) b: Silver 
inhibited growth of S.epidermidis (strains 047 Wt and ica), three bacterial concentration were 
used: 104, 106 and 107 CFU/ml 
a, 
b, 
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Figure 3.3-13: Silver inhibited growth of S.aureus (strain 113; WT and ica), three bacterial 
concentrations were used: 104, 106 and 107 CFU/ml 
 
 
In figures Fig.3.3-12,13, it can be observed that the silver has a higher activity on 
S.epidermidis than on S.aureus. In the case of S.epidermidis, the 2,5 µg/ml concentration of 
AgNO3 solution inhibits the bacterial growth, while S.aureus is not sensitive to this 
concentration, but only as of 10 µg/ml AgNO3 concentration. For both bacterial strains, no 
significant difference can be observed between the WT and ica bacterial strains. This 
observation points out that the silver is efficient against bacteria ready to generate biofilm and 
against bacteria that do not build up biofilms. Hence, the protective biofilm formation, which 
hinders the efficiency of certain antibiotics against biofilms, does not appear in the case of 
silver. Concerning the silver concentration in the solutions the, 1,6 µg/ml concentration silver 
corresponds to 1,6 ppm silver (this unit is used by the AAS measurements to determine the 
silver concentration in solution). If this value is compared with the silver release values 
measured previously during the dissolution tests: the 1mM/3d treated samples 
(Au(111),TiR,TiS) release silver in the same concentration region: 0,7-1,8 ppm in MHB 
solution without bacterial suspension. The 2mM/3d treated samples reach the active silver 
concentration against S.aureus (4,1-6,4 ppm) in MHB. These results encouraged us to do 
further experiments on the coated substrates.  
3.3.1.2.3 Microbiological assays on Au(111) substrate 
 
During the surface characterisation, the coated Au(111) plates were used as model substrate. 
After the complete chemical and topographic analysis of the coated gold surfaces, it is 
important to test their antimicrobial activity. Although, gold is not used as restorative implant 
material (some gold containing material is used in dental applications), testing the activity of 
the coating serves as important information and can be extrapolated to other materials. Some 
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preliminary assays were done on Au(111) plates and the 1mM concentration has been chosen. 
Then, time-dependent screening was done for the disulfide pre-treated and not pre-treated 
1mM samples. The results of the assays are shown in Fig.3.3-14. 
IZ, Au(111) 1mM/1h-14d 
10
15
20
25
30
1h,                 3h,                5h,                1d,                 3d,                7d,                14d 
Samples
IZ
 (m
m
)
DiS104CFU DiS106CFU DiS107CFU
NoDiS104CFU NoDiS106CFU NoDiS107CFU
Figure 3.3-14: Inhibition zone as a function of the treating time of the coated plates (pre-
treated: Dis, and without pre-treatment: NoDis) using three different bacterial concentration, 
104, 106 amd 107 CFU/ml 
 
It is interesting to observe on the graphic that the inhibition zone around the gold plate does 
not change dramatically with the time of the coating treatment. In the case of the disulfide 
pre-treated samples, the curve generally ascends slightly and the slope slows down at around 
3 days. In contrast, the not pre-treated samples seem to have less activity after 14days of 
treatment than the 7 days samples. Not only the form of the curve is different for the two 
sample preparation methods but also the inhibition zones are generally larger in the case of 
the not pre-treated samples, except for the descending part of the curve. A probable 
explication of this difference can be that the absence of the anchor molecule makes the 
coating easier to release the silver, yet at the same time it becomes less stable. Thus, with a 
very high loading, the coating loosens and has a weaker effect. Thus, the stable coating (with 
anchor molecule) results in a more homogeneous silver release. To understand the method of 
action of these coatings better, the silver concentrations in the inhibition zone were 
determined by AAS measurements. During the sample preparation the dissolved agar was 
split in two, one part was filtered, removing the bacteria, and the other part was measured 
without any filtering. The results of the measurements are shown in the three graphics of 
Fig.3.3-15.  
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Figure 3.3-15: 
Silver 
concentration in the 
inhibition zone as 
function of the 
treating time of the 
plates, measured 
for filtered and 
unfiltered solutions. 
The plates were 
treated with two 
methods, with (BS) 
and without pre-
treatment.  
Three bacterial 
concentrations were 
used 104 (a), 106 
(b) and 107 (c) 
CFU/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some principal observations can be made from the graphs. Generally the filtered samples 
contain much less silver than the respective unfiltered samples. (The silver concentration of 
filtered samples is often around the detection limit of the AAS.) In the filtered samples, the 
bacteria and particles larger than 40µm are removed, so that only the ionic silver and/or its 
CFU 10 on 4 
0.0
0.1
0.2
0.3
0.4
0 1 2 3 4 5 6 7 8time
Ag
 n
or
m
 in
 IZ
BS;Ag nofilt BS;Ag f ilt Ag no f ilt. Ag f ilt.
1: 1 h
2: 3 h
3: 5 h
4: 1 d
5: 3 d
6: 7 d
7: 14 d a, 
CFU 10on6
0
0.1
0.2
0.3
0.4
0 1 2 3 4 5 6 7 8time
Ag
 n
or
m
 in
 IZ
BS;Ag nofilt BS;Ag f ilt Ag no f ilt. Ag f ilt.
1: 1 h
2: 3 h
3: 5 h
4: 1 d
5: 3 d
6: 7 d
7: 14 d
b, 
CFU 10on7
0.0
0.1
0.2
0.3
0.4
0 1 2 3 4 5 6 7 8time
Ag
 n
or
m
 in
 IZ
BS;Ag nofilt BS;Ag f ilt Ag no f ilt. Ag f ilt.
1: 1 h
2: 3 h
3: 5 h
4: 1 d
5: 3 d
6: 7 d
7: 14 d c, 
3 Results and discussion   
Novel silver containing antimicrobial coatings for implant materials: new applications of Ag(I) coordination networks 101 
small complexes are present. In the unfiltered samples, all of the silver containing residues are 
present and measured. The variation of the filtered and unfiltered samples is coming from the 
≥ 22 µm silver containing material. Principally, the silver ions seem to attach to the bacteria 
since only the inhibition zone was removed and the Ag concentration measured. The fact, that 
for the 104 CFU/ml bacterial concentrations, the samples contain less silver in the inhibition 
zone than the samples of the two higher concentrations, confirms that the major part of the 
silver is bacterial attached silver. Another general remark can be made regarding the samples 
with different coating methods. Analysing the silver concentration of the filtered samples, the 
pre-treated samples show less silver in the inhibition zone. Since the value of the filtered 
samples is representative of the ionic silver, the samples without any anchor molecule release 
more ionic silver than the samples having a well attached coating. Although the loading of the 
gold plates varies between 2 and 60 ng Ag/plate, the silver concentration in the inhibition 
zone is maximal 0,4 ng. That means that the silver release is controlled by the solubility of the 
compound in the medium and only slightly influenced by the bacterial concentration.    
After these successful assays with S.epidermidis, other bacterial strains were tested, such as 
the biofilm negative and positive strains of the gram positive S.epidermidis and S.aureus and 
the gram negative E.Coli. The coating of the gold plates was made as follows: after the 
disulfide pre-treatment, the crystallisation was made in 1mM Adl7 solution for 3h. The results 
of the agar plate experiments are shown in Fig.3.3-16. 
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Figure 3.3-16: Inhibition zones around the coated Au(111) plate (1mM Adl7 treated for 3h). 
S.epidermidis, WT and ica, S.aureus, WT and ica, E.Coli, biofilm + and – bacterial strains 
were used in three concentrations,   104, 106 and 107 CFU/ml.  
 
Although all the used bacterial strains are susceptible to the silver coating, the gram positive 
bacteria show slightly larger inhibition zones around the coated plates than the gram negative 
E.Coli, but the difference is not significant. The same minor difference is present between the 
behaviour of the WT and the ica negative strains of the same type of bacteria towards the 
silver. The silver coordination polymer coating seems to be equally active on biofilm 
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producing bacterial strain (WT) and ica type strains. This is true for the S.epidermidis, known 
for having a more pronounced biofilm forming ability. The same observation was made 
previously for the AgNO3 experiments. It means that the Adl7 released silver ions are 
behaving the same way and having the same antimicrobial activity as the silver ions of a 
soluble salt. It is a big benefit that our Adl7 coating releases silver ions at a determined level 
while it does not load the organism with a too high concentration of heavy metal.  
3.3.1.2.4 Microbiological assays on coated titanium and stainless steel implant 
material 
 
The Au(111) substrates were used as a model surface and give good results, encouraging 
further assays on other implant materials. The titanium and stainless steel restorative implant 
materials were described previously and the coatings on these substrates were characterized. 
The aim of the microbiological assays is to choose the most active coating against bacteria. 
Similar methods (classical plating method and adhesive and planktonic bacterial count) are 
used to test the antimicrobial effect of the coating as previously shown. First, several 
treatment methods were tested to choose the direction of the further experiments. Then, the 
method development was fine tuned: the time of the treatment is determined. Further 
experiments with different bacterial strains are planned to confirm the results of the gold plate 
experiments.    
The different treatment methods were tested against S.epidermidis and the inhibition zone 
experiments are shown in the Fig.3.3-17. The M1 and M2 samples were pre-treated with 
isonicotinic acid solution (5mM) for 3 and 8 days respectively, then the crystallisation was 
done on the surface from 2mM [Ag(L1)NO3] solution during 10 days for the M1 samples and 
from 1mM [Ag(L1)NO3]  solution during 20 days for the M2 samples. The M5 samples were 
prepared the same way as M2 but the pretreating was done with pyridine-4-boronic acid 
instead of the isonicotinic acid. The simplest preparation method was M4, where the coatings 
were made by in-situ crystallisation from 2mM [Ag(L1)NO3] solution during 14 days.   
 
The samples are  
M1: Isonic. acid 5mM/3d + Ladl/AgNO3 2mM/10d 
M2: Isonic. acid 5mM/8d + Ladl/AgNO3 1mM/20 days 
M4: Ladl/AgNO3 cryst, 2 mM/14d 
M5: Pyridine-4-boronic acid 5mM/8 days+ Ladl/AgNO3 1 mM/20 days 
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Figure 3.3-17: Inhibition zones around the different coated Au(111) plate. S.epidermidis 
bacterial strain was used in four concentrations,   104, 105, 106 and 107 CFU/ml. 
 
 
The inhibition zone experiments show that M1 and M4 demonstrate the best activity against 
S.epidermidis. The concentration of the treating solution seems to be clearly the key factor; 
hence the loading of the surface determines the antimicrobial activity. Although the plating 
method doesn’t show a difference between the samples prepared with these two methods, the 
bacterial count assays (the bacterial CFU of the S.epidermidis is determined after infection 
and incubation on the surface, adherent bacteria, and in the bacterial suspension, planktonic 
bacteria) showed a significant difference. In Fig.3.3-18 just one example is shown:   
 
CFU linear change     CFU log change 
 
Figure 3.3-18: Planktonik and adherent bacterial number around and on the different coated 
Au(111) plates. S.epidermidis bacterial strain was used in 4.5 x 105 CFU/ml 
 Fold change adh./ plankt. cfu on titanium cylinders
M1 M2 M4 M5
0
2
4
6
8
10
adherent bacteria
planktonic bacteria
treatment
inoculm 4.5 x 10e5
 Fold change adh./ plankt. cfu on titanium cylinders
M1 M2 M4 M5
0.1
1
10
adherent bacteria
planktonic bacteria
inoculm 4.5 x 10e5
treatment
         
 
 
   
         
 
 
   
         
 
 
   
         
 
 
   
      
3 Results and discussion   
Novel silver containing antimicrobial coatings for implant materials: new applications of Ag(I) coordination networks 105 
 The M4 shows a clear advantage over the M1, in not only keeping the surface clean of 
bacteria but also blocking the bacterial growth in the solution. This experiment definitely 
favours the M4 sample preparation method. This is an interesting observation because it 
contradicts the expected result, namely that the sample preparation method using an anchor 
molecule results in a more stable coating than without anchor molecule. Interestingly, there is 
also no difference between the 1mM (M2) or 2mM (M1) treated samples regarding the 
bacterial count. To find the optimum sample preparation, all the results were taken into 
consideration and the M4 designed as the best method. Now that the treatment method was 
fixed, the 2mM complex solution was used to crystallize the Adl7 compound on different 
substrate surfaces (TiS, TiR, StPol, StR) during various time intervals: between 3 hours to 10 
days. Examples of the inhibition zone experiments of these samples are shown in Fig.3.3-19.   
 
Figure 3.3-19: Inhibition 
zones around the 
different coated titanium 
and steel discs and 
cylinders. The substrates 
were coated with 
[Ag(L1)NO3] for 3h to 
10days. S.epidermidis 
bacterial strain was used 
in three concentrations,   
104, 106 and 107 CFU/ml. 
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On titanium, increased inhibition of S.epidermidis growth can be observed with prolonged 
crystallization. On steel, smaller inhibition zones were observed than on titanium, and there is 
no enhancement of the growth inhibition with increased crystallization time. Comparing the 
different surfaces, the coated rough Ti samples have a slightly higher effect than the smooth 
samples and the same is true for the steel rough disks versus the smooth disks. The contrary is 
true for the steel cylinders. There is a significant difference between the bacterial growth 
inhibition of the titanium samples and the steel samples. Generally the coated titanium has 
much higher effect than the coated steel samples. If the loading of these samples are recalled, 
this is not surprising as the loading of the titanium samples are almost the double than of the 
steel sample. Although the loading of the smooth samples is slightly higher than the loading 
of the rough samples, the antimicrobial effect does not reflect this difference. Here, probably 
the stability of the coating (higher by the rough samples than by the smooth samples) plays a 
determining role. The cylinders show the different results and can not be interpreted because 
the form of the samples hinder the homogenous crystallization, hence a homogenous coating 
on the surface. Further experiments will be done on treated titanium disks samples with 
different bacterial strains to confirm the coating efficiency on the titanium surface.   
 
3.3.1.2.5 Conclusions on in vitro inhibition zone experiments 
 
The classical plating technique was used to test the antimicrobial activity of the silver 
coatings. AgNO3 solution was used for preliminary tests. As model surface, the Au(111) 
plates were tested in different conditions and several bacterial strains were used. The silver 
coating is efficient against all of the used bacterial strains (S.epidermidis, S.aureus, E.Coli). 
Biofilm positive and biofilm negative strains were compared. In the case of the S.epidermidis 
the silver coating has a slightly higher activity against the biofilm positive (wild type) strains, 
while by the S.aureus the difference is minor. Generally, there is no significant difference 
between the efficiency of the coating against biofilm positive and negative strains. Regarding 
the silver concentration in the inhibition zone of the bacterial growth, the silver concentration 
is increasing with the bacterial CFU of the agar. The silver concentration of the filtered 
samples does not show this tendency, hence the major part of the silver is attached to bacteria. 
The coatings, which used anchor molecules to fix the Adl7 crystalline layer, release less ionic 
(not bacterial attached) silver. For real restorative implant materials, titanium and stainless 
steel, the sample preparation method was optimized and the most efficient coating method 
was determined. The importance of the loading is proven. The more silver is present on the 
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surface, the larger the inhibition zone around the substrates. This effect is not visible in the 
bacterial count of the adherent and planktonic bacteria. Here, the quality rather than the silver 
concentration of the loading plays the major role in the antimicrobial activity. Taking into 
consideration all the results the sample preparation method was fixed for the further in vitro 
and in vivo experiments. The material and the surface of the titanium cages used for the in 
vivo experiments are identical to the titanium disks/cylinders of the in vitro experiments. 
 
3.3.1.3 Flow chamber experiments 
 
Flow chamber experiments are a generally used method in oral microbiology for the study of 
dental plaque formation. All of these experiments were carried out in a close collaboration 
with Prof. Jürg Meyer and Dr. Irmgard Hauser-Gerspach (Institute of Preventive Dentistry 
and Oral Microbiology, University of Basel) 
Adhesion, colonization and growth of oral bacteria on tooth surfaces lead to the oral biofilm, 
called dental plaque [132]. Depending on the composition of the plaque, it can be the cause of 
dental caries and periodontal diseases [133]. The first step of the oral biofilm formation is the 
same as for the biofilm formation namely bacterial adhesion. The early bacterial adhesion 
may determine the later plaque composition [134]. Streptococcus sanguinis is one of the early 
colonizers on exposed tooth surfaces and dental materials [135]. Thus this species was used 
during the flow chamber experiments. The first adhered bacteria are of great importance in the 
subsequent stages of dental plaque formation, determining sites for attachment, or modifying 
the environment for the further colonizers. Plaque is not only present on natural teeth but also 
on the surface of the dental restorative materials and other implant components. Adhesion of 
S. sanguinis to human enamel, glass slides and commonly-used dental restorative materials 
has been observed in vitro during one hour in a flow chamber [136]. In this study, the 
bacterial adhesion was observed as an isolated process. Further IMC measurements were 
carried out to describe the bacterial adhesion process on glass surfaces [137]. Other flow 
chamber experiments were done to study several orthodontic bonding materials. The biofilm 
formation initial step, the bacterial adhesion, was tested on these materials and the efficiency 
of their antimicrobial treatment was studied in parallel flow chambers [138].    
The experiments take place in a flow chamber where 4 plates can be measured at the same 
time. The treated samples are always measured in parallel with an untreated sample from the 
same substrate and a glass plate as a blank. The scheme of the flow chamber is presented in 
Fig.3.3-20. 
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Figure 3.3-20: Scheme of the flow chamber experiment 
 
This flow chamber is suitable for anti-microbial testing on dental materials [139]. In a 
reservoir (Tank), a single bacterial strain, Streptococcus sanguinis DSM 20068 (German 
Collection of Microorganisms and Tissue Culture Cells, Braunschweig, Germany), suspended 
in sterilized human saliva, collected from volunteers, was added. The saliva collection and 
treatment is made as described previously [142]. The treated samples, together with non-
treated blanks, were exposed during 60 min at room temperature to a flow rate of the bacteria 
saliva suspension of 0.8 ml/min, which corresponds roughly to physiological oral conditions 
of low shear [143]. The flow is maintained by the pump and the system is placed on a shaker 
adjusted to 260 impulses/min in order to maintain the homogeneity of the bacterial 
suspension.[144] Thereafter, the plates, treated and untreated equally, are removed and 
analyzed microscopically. The vitality of adhered bacteria is evaluated by applying a dual 
fluorescent staining (Live/Dead BacLight Bacterial Viability Kit; MoBiTec, Lucerne, 
Switzerland) according to Decker et al., [145,146] which allows differentiation between vital 
and dead bacterial cells. The tested plates are removed from the flow chamber and carefully 
dipped into distilled water in order to eliminate planktonic and loosely attached cells and the 
detached compound from the surface. After rinsing the plates, they are covered with 7.5 ml of 
staining solution for 15 min at room temperature in the dark in order to colour the bacteria 
attached on the surface. The cells were analyzed by epifluorescence microscopy (PROVIS 
AX70, Olympus AG, Volketswil, Switzerland). A total of twelve digital images (ColorView, 
Olympus AG, Volketswil, Switzerland) using two filters [blue excitation at 450–490 nm 
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(FITC) and green excitation at 546 nm (rhodamine)] are obtained for each sample and the 
percentage of dead adherent cells are calculated.  
To find out how the anti-bacterial activity of the Adl7 treatment on the dental restorative 
materials changes with the treatment method, several different treatment conditions were 
tested. The treated plates were placed into the flow chamber, then the results were evaluated 
and the best conditions found. The best treatment method for the gold plate is a 14 days 
crystallisation in a 2mM [Ag(L1)]NO3 in THF/EtOH (1/1) solution. The titanium plates are 
pre-treated with 5mM isonicotinic acid in CH2Cl2/EtOH (1/1) solution for 5 days, then the 
EtOH washed plates are placed in 2mM [Ag(L1)]NO3 in THF/EtOH (1/1) solution for 14 
days for crystallization. The detailed description of the coating is shown in the Chapter 3.2.4. 
The loading of the plates is 2000mg/m2, which is high, but these samples are for external use. 
The treated samples were photographed before and after flow chamber (F-C) experiment 
(Fig.3.3-21,22): 
a, b, 
Figure 3.3-21a,b: Coated gold plates before (a) and after (b) F-C experiment 
a, b, 
Figure 3.3-22a,b: Coated titanium plates before (a) and after (b) F-C 
experiment 
 
As shown in Fig.3.3-21,22, the majority of the big crystals were washed out, but a good 
portion remained attached on the surface. The previously described AAS assay show that the 
silver concentration of the non filtered chamber suspension is 10 times higher. This could 
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mean that a part of the silver ions are attached to the bacteria and removed by the 0.22µm 
filter. There are probably larger crystalline residues in the suspension, but these are not 
present in the decanted AAS sample, yet the middle sized floating aggregates can increase the 
signal. After the surface treatment method was fixed, each material was tested in at least four 
independent experiments to reach a reliable result. 
The coated and uncoated samples were also evaluated by SEM measurements. With a special 
fixation method, the bacteria were fixed on the surface while the other components of the 
saliva suspension were removed. The plates were dried and SEM images were done. (Fig3.3-
23,24). 
   
a, c, 
b, d, 
Figure 3.3-23: Adl7 coated Au-alloy substrate (left a,b) and uncoated Au-alloy 
substrate (right c,d) after F-C experiment   
 
a, 
b, 
c, 
d, 
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Figure 3.3-24: Adl7 coated titanium sample (left a,b)  and uncoated titanium sample 
(right c,d) after F-C experiment 
 
The number of attached bacteria on the surface is obviously higher in the case of the uncoated 
samples (both gold and titanium substrates). The bacteria have a tendency to colonize on the 
untreated samples. Although, the SEM images do not give information about the bacteria 
being dead or alive at the moment of removal from the flow chamber, the aggregation of the 
bacteria on the surface can be an indication that these were living bacteria. On the coated 
samples, more single, or pairs of bacteria can be observed, and, besides of the cells, the 
residue of the original coating is present. Since this method is not capable to differentiate the 
living and dead bacteria, the previously described microscopic method was used to evaluate 
the results.  
The epiflourescence microscopic images of the treated and untreated substrates after the flow 
chamber experiment are shown in Fig.3.3-25,26. The images of the representative sectors of 
both dental materials are presented. Many bacteria, attached to the untreated materials, were 
stained green because they were still alive. On the treated samples most bacteria were stained 
red, indicating that they were dead at the time of staining. 
 
a, b, 
Figure 3.3-25a,b: Uncoated (a) and coated (b) Au-alloy substrate  
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a, b, 
Figure 3.3-26a,b: Uncoated (a) and coated (b) titanium substrate 
 
From the analysis of dead and alive bacteria on the treated metal surfaces, it can be concluded 
that compound Adl7 has definitely an anti-bacterial effect on S.Sanguinis cells under the 
given conditions. The treated substrates show a reduction of adherent live bacteria of more 
than 90% for gold alloy and for titanium as compared to the corresponding non-treated 
samples. Based on the SEM measurements, not only the living and dead bacteria ratio is 
strongly decreased thanks to the surface coating, but the number of the attached bacteria is 
also diminished on the treated surfaces as compared to the untreated samples.  
 
3.3.1.4 Conclusions 
The different in vitro experiments all confirmed the antimicrobial effect of the silver 
coordination polymer, Adl7, against several bacterial strains. The silver concentrations 
measured in the different bacterial suspensions were in a safe range of 1-15 ppm encouraging 
the further in vivo experiments of this compound.  
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3.3.2 In vivo experiments 
 
In vivo experiments were carried out based on the previous work of Prof. R. Landmann [108]. 
The same mice and tissue cage models were used with the coated titanium cages as previously 
described. The experiment is shortly described: with EtOH sterilized coated and uncoated 
titanium cages are subcutaneously implanted in the back of a mouse. Then, inocula, a 
bacterial suspension 106 CFU S.Epidermidis/cage, is injected percutaneously preoperatively. 
The tissue cage fluid is removed after 2, 6, 9, and 15 days after the implantation and the 
bacteria present in the fluid are counted and the silver concentration is determined.  
Preliminary experiments were done using coated Ti disks placed into the cage, but the surface 
of the disks is much smaller compared to the surface of the cage, hence the effect of the 
coating was not perceptible. Then, the titanium cages were treated to build up the Adl7 
coating on it. 1mM concentration of [Ag(L1)NO3] treating solution was used for 3 days 
crystallisation. Then, the cages were removed from the solution, rinsed with EtOH, and dried 
under vacuum. The loading of the cage is 27mg/mm2, which is much less than the loading of 
the 1mM/3d treated titanium disks (ca. 400mg/mm2). The crystallisation on the cage is not so 
ideal and the surface/treating solution ratio is 5 times less than in the case of the titanium 
disks. These two unfavourable conditions could cause this decrease of the loading. Although 
the loading is not high, the coating contains 54 ng silver/cage, which can be enough to have a 
local antimicrobial effect. The results of the in vivo experiments are shown in a Fig.3.3-27. 
 
 
Figure 3.3-27: Combined data of the cage experiments: clean (uncoated) WT (biofilm+), 
clean (uncoated) Δica (biofilm-), AgNO3 (coated) WT, AgNO3 (coated) Δica 
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Figure 3.3-28: Combined data 
(WT and ica) of the surface 
adhered S.epidermidis bacteria 
numbers on coated and uncoated 
cages after explantation. 
 
 
 
 
 
 
 
 
 
The microbiological assays show a significant antimicrobial effect of the coating after 9 days, 
when no bacteria could be found in the tissue cage fluid. The adherent bacteria count was very 
low on the treated cages in the case. No adherent bacteria were found in the case of 5 treated 
cages. 
Concerning the silver concentration measurements, the two measurements gave rather 
different results. The average values are presented in the Fig.3.3-29.  
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Figure 3.3-29: Silver concentration of the tissues cage fluids after 
implantation, 2, 6, 9, 15 days, in the case of ica and WT bacterial 
strains 
 
Although the standard deviation of the results is high which is generally the case on biological 
assays some tendencies are remarkable. The concentration of the silver is decreasing with the 
time but does not reach zero at the end of the 2 weeks. This means that the slow leakage of 
Sample 
Ag conc. 
(ppm) Stdev 
WT clean 0 - 
WT clean 0 - 
WT clean 0 - 
WT clean 0 - 
ica clean 0 - 
ica clean 0 - 
ica clean 0 - 
ica clean 0 - 
WT Ag 3.80 3.12 
WT Ag 2.55 1.45 
WT Ag 2.36 2.41 
WT Ag 1.02 1.11 
ica Ag 12.36 10.61 
ica Ag 3.76 3.37 
ica Ag 1.79 1.73 
ica Ag 0.95 0.75 
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the silver is not finished after two weeks. The removed cages were tested to measure the 
silver remained on the surface. It means that with acid treatment we remove the possibly 
remained coating after the in vivo experiments. These measurements also showed a rather big 
variance between the cages: the remaining silver concentration on the surface was 1 and 9 
mg/mm2 with an average of 4 mg/mm2. These results are very promising but further 
investigations are necessary to confirm the data of the chemical measurements.   
The leukocyte cells were also investigated, to study the influence of the Adl7 on the immune 
system (Fig.3.3-30).  
a,
 b,  
Figure 3.3-30: Total leukocyte numbers (a) and viability (b) in the cage fluid after 
implantation 2,6,9 and 15 days 
 
After a short decrease of the viable leukocytes and their number in the tissue cage fluid, their 
number and viability increases again after ca. 3-6 days. This shows that our samples have 
good bio integration in the case of the coated Ti cages, thus a good biocompatibility with the 
host immune system. 
3.3.3 Conclusions 
 
All different microbiological assays confirmed the anti-microbial characteristics of Adl7 bulk 
compound and coating. Several different substrates were tested, from polymer surface to 
dental implant materials. The efficiency of the coating depends on the silver loading and the 
stability of the coating. The Adl7 coating shows higher antimicrobial affinity than the silver 
nanoparticles generated on polymer surface. The antibacterial effect depends on the released 
silver ions in the solution. Although the silver nanoparticles are small enough to have good 
contact with the surrounding solution, they do not release enough silver ions to have a good 
antimicrobial effect. In contrast, if silver ions are present on the surface, as for the silver 
coordination polymer or by the silver ions attached by the peptides, the anti-microbial activity 
is significant. The silver release of the coating was 1-15 ppm depending on the loading and 
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the used microbiological assays. The major part of the silver released by the coating is 
attached to the bacteria and just a minor part remains in ionic form in the solution. Thus the 
toxicity of the coating might be low. This should be confirmed by further cell viability assays. 
The higher stability of the coating, prepared by methods using an anchor molecule, is 
confirmed by the inhibition zone assays of the gold plates: less ionic silver could be found in 
the bacterial free solution. The most tested bacteria strain was the S.epidermidis, which is the 
main responsible for the biofilm formation and implant related infections. The biofilm 
positive and negative strains were tested and the two strains seem to be susceptible against 
silver, with no significant difference between the two. This is true for both S.epidermidis and 
S.aureus bacterial strains. It means that the biofilm is rather not protective against silver. To 
complete the list of the bacterial strains, the gram negative E.Coli was tested in the inhibition 
zone assays and one strain of Streptococcus Sanguinis was tested in the flow chamber 
experiments. Both experiments confirmed the general antimicrobial activity of the silver 
polymer complex. This characteristic makes Adl7 a perfect candidate for the further in vivo 
assays. The in vivo assays made on mouse models gave a positive result for  S.epidermidis. 
No more bacteria could be found in the fluid around the implanted Adl7 coated titanium cages 
after 9 days from the implantation and infection. In addition, the number of the adhering 
bacteria was decreased dramatically.  
All these microbiological results propose to continue, making further assays such as cell 
viability and toxicity assays with the aim to use the silver coordination compound as coating 
for implant materials. Such tests were carried out by another PhD student of our group, 
Priscilla Brunetto. They show that Adl7 is also a potent antimicrobial compound against yeast 
cells, and that fibroblast cells survive and proliferate in presence of Adl7 coated Au(111) 
plates and Ti disks. The detailed results will be described in P.Brunetto’s thesis.     
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3.4 
 
Molecular mechanism of Ag+ 
To learn more about the molecular mechanism of silver ions, it is important to know which 
amino acids play a role in the process of the attachment and transport of the silver ions in the 
cell. Histidine is the most studied amino acid in connection with silver. Its function in the 
silver resistance is well known [79]. Detailed description of the silver resistance is presented 
in the Introduction (Chapter 1). Other amino acids could also have an impact regarding the 
silver transport into the cell.  
The purpose of the experiments in this chapter is to find out which amino acids or short amino 
acid sequences could be involved in silver ion binding and/or transport. In our studies, the 
nanoparticle formation will be used for the detection of bound silver. The idea is to reduce the 
attached silver to make it visible, and thus use it like a marker. This method is not only useful 
to determine the affinity of the different amino acid sequences towards the silver. At the same 
time, other analyses are carried out to characterize the AgNPs (silver nanoparticles will be 
abbreviated by AgNPs) regarding their size and distribution and test their antimicrobial 
effects (Chapter 3.3.1.1.). Attaching AgNPs on a surface via peptides can also be a solution to 
render an implant surface antimicrobial. The size and form of the nanoparticles are expected 
to be the determining factors for the microbiological characteristics. Creating a surface 
coating by size-controlled nanoparticle generation, the microbiological properties of the 
surface could be tuned.  
Over the last decade, a lot of progress has been made in the development of methods for 
synthesizing and controlling the size and shape of metallic nanocrystals. [148] Nobel metal 
particles have been used in several different applications such as catalysis, biological 
diagnostics, imaging and other optical applications, for their unique optical properties 
[147,149,150]. The most studied Nobel metal is the gold and much less work is focusing on 
AgNPs. Although the silver plays an important role in medicinal and photochemical 
applications, is somehow neglected due to the lack of comprehension of its role in the 
involved processes.  
Several different ways are known for the preparation of AgNPs,. The particle synthesis 
usually starts from a soluble metal salt, which is treated with a reducing agent. A stabilizing 
agent is used to prevent the further growth and aggregation. One of the simplest ways to 
fabricate Nobel metal nanoparticles called citrate reduction where citrate acts both as a 
reducing and stabilizing agent [151]. Photochemical methods are also known to induce the 
formation of AgNPs [153,154] In this case, the use of a separate stabilising agent is necessary. 
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The development of the biologically inspired processes for nanoparticle synthesis is currently 
in the focus of interest. The fungus, Aspergillus flavus, treated with silver nitrate solution, 
accumulates AgNPs on the surface of its cell wall [155] and several strains of the fungus 
Fusarium oxysporum can fabricate nanoparticles as well [156,212]. These methods are rather 
slow, but other rapid microbiological methods using bacteria can be found in the literature. 
[157] The role of the stabilizing agent can be played by the organic matrix of the bacteria 
[158]. Looking at less complex biological systems, different natural and artificial proteins are 
used in the fabrication of nanoparticles, for example nitrate reductase [160] engineered 
protein cages [161] or different oligopeptides [162-164]. The common point of these last 
examples is that the peptides contain tyrosine whose reducing character is well known 
[165,166]. These peptides can stabilise the nanoparticles and/or serve as supramolecular 
gelators [164] to decrease the mobility of the particles. Thus, Shinkai and co-workers used 
supramolecular organogels as templates to form helical nanofibers [168-170]. Using the same 
technique, Hanabusa and Stupp developed transition metal nanotubes [171-173]. Except for 
these latter examples, most of the research is done in solution. Other works dealing with 
biological structures and silver are more focused on its use [174] than on the synthesis of the 
NPs or on the selectivity of the proteins regarding their effect to generate AgNPs. Since the 
use of AgNPs is increasing due to the renaissance of silver as antimicrobial agent, the 
nanoparticle generation in-situ on a surface could be an interesting subject also for a possible 
medical use. This chapter has therefore two main objectives:  
-studying short peptide sequences, bound on solid phase, regarding their affinity to silver ions, 
which can help to understand the molecular mechanism of the antimicrobial property of Ag+   
-analysing the AgNPs generated on the surface of polymer beads, their size distributions and 
microbiological effects to suggest a further medical or even technical use. 
As a first step, a model experiment was built up to develop an effective method for the 
detection of the silver ions attached on the surface. A good silver complexing model molecule 
(isonicotinic acid) was coupled to a TentaGel resin. The method development was done on 
this substrate. Two reduction pathways of silver were investigated to detect the attached silver 
ions and generate AgNPs on the surface. A combinatorial chemistry approach helped to 
determine the active amino acids and short amino acid sequences (tripeptides) that are able to 
bind silver ions. Then, several tripeptides were synthesized to analyse the AgNP size and 
distribution as a function of the amino acid combinations.   
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Combinatorial experiments and other experiments concerning solid state bound peptides were 
made in close collaboration with Prof. Helma Wennemers and her group, Dr. Kirsten Belser, 
Dr. Gregory Upert and Conelious Pfumbidzai.  
3.4.1 Preliminary experiments with isonicotinate grafted T-Gel resin 
 
To find the appropriate method to study the affinity of the different peptides for silver ions, a 
model system was prepared. To a TentaGel resin, which is generally used for solid state 
peptide synthesis, isonicotinic acid was coupled. This substrate has been described in a 
previous chapter. Since the affinity of the pyridine tail of the isonicotinic acid to the silver 
ions is well known [93], this T-gel resin was used as an active substrate able to bind silver 
ion. T-gel resin is incubated in a 0.05M AgNO3 aq. solution for 15 min, in a volume of the 
solution that the Ag+ concentration is approx. 10x higher regarding the isonicotinic acid 
loading on the resin to guarantee a 100% uptake. Typically, for 30mg coupled T-Gel beads, 
2ml 0.05M AgNO3 aq. solution is used. If the quantity of the treated beads is reduced, the 
volume of the silver nitrate solution is reduced respectively. The incubated resin was then 
washed 5 times to remove the remaining free silver ions, and the reduction of the silver was 
carried out. The photochemical (light) reduction method (generally abbreviated further as LR) 
means that the wet resin is irradiated with normal light, 15W, for 8h from a 10cm distance. 
For the chemical reduction method (generally abbreviated further as CR), the wet resin is 
mixed together with 0.05M Na-ascorbate aq. solution, then the resin is washed to remove the 
excess of the ascorbate.  
Some control experiments were first carried out to demonstrate the efficiency of this method 
in detecting attached silver on a surface. Acetylated T-gel resin was prepared as a negative 
control since the carbonyl group coordinates weakly to the silver ions. The original T-gel 
resin, which has an amino group, was used as a positive control as the amino group 
coordinates well with the silver ions. Acetylated T-gel resin (Ac-TG) was mixed to the 
isonicotinic acid coupled T-gel resin (Iso-TG) and the NH2-terminated T-gel resin (NH2-TG) 
in similar ratios. Then, the mixture was treated with AgNO3 and irradiated with light. 
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Figure 3.4-1a,b,c: Scheme of the isonicotinic acid coupled (iso-TG1), acetylated (Ac-TG2) and 
amino functionalized (NH2-TG) T-gel beads (a), and their mixture after incubation in AgNO3 
solution and irradiation (b,c)  
 
 
In Fig.3.4-1 can be observed that the isonicotinic acid coupled T-gel (iso-TG) beads have a 
nice reddish colour after the light treatment (light reduction abbr. LR) and a greyish colour for 
the amino functionalized T-gel beads (NH2-TG). The number of the coloured and colourless 
beads is around 50% each. This experiment encourages further investigations using the 
reduction method to detect silver. Thus, the colour change of the beads is a good sensor for 
the attached silver. The coloured beads indicate also nanoparticle generation on the surface.  
 
   
Figure 3.4-2: Optical microscopic and SEM images of Ag+ incubated, light reduced (LR) iso-TG 
 
   
Figure 3.4-3: Optical microscopic and SEM images of Ag+ incubated, chemically reduced (CR) 
iso-TG 
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The optical microscopic images (Fig.3.4-2,3) show a neat difference: the light reduced (LR) 
beads are red and spotted, while the chemically reduced (CR) are grey and more 
homogeneous. The colour of the nanoparticles depends on their shape and size [175]. The 
SEM images (Fig.3.4-2,3) confirm the size difference of the AgNPs on different coloured 
beads. The light reduced beads are inhomogeneous and the size distribution of the particles is 
also inhomogeneous (100-1000nm). Some hundreds of nm crystals can be found on the 
surface with bigger well designed crystals. On the other hand, the chemically reduced beads 
show a homogeneous coverage with nanoparticles of a size around 50nm, always arranged in 
big flat aggregates. Identically loaded beads show different NP formation, depending on the 
used reduction method. The reduction characteristics of the light and the Na ascorbate method 
are dissimilar. The speed of the LR, which takes place over 8h, is slow in comparison with the 
fast chemical reduction (minutes). Thus, during the light reduction, there is enough time for 
the crystal formation resulting in well designed silver crystals. The almost immediate 
nanoparticle formation through CR does not allow slow crystallisation, resulting in small 
nanoparticles. 
The fast reduction does not allow for the silver ions to move on the surface in order to group 
together and build up larger structures. The autocatalytic reduction of the silver ions towards 
nanoparticles, well know from photography, is also negligible. Since the photo reduction is a 
long process and irradiation is not homogeneous on the surface of the beads(only from the 
top), the reduction of the silver ions is probably not complete in the case of LR.  
3.4.1.1 XPS measurements 
XPS measurements were carried out to learn more about silver behaviour on the surface and 
during the reduction process. This measurement reveals the chemical environment and the 
oxidation state of silver in different reduced and not reduced samples. Other chemical 
elements present on the surface (the ligand atoms principally), were also analyzed. 
Four samples were prepared for the measurement: isonicotinic acid coupled polymer, Ag 
treated, light reduced, and chemically reduced isonicotinic acid coupled polymer. Overview 
spectra show that spectra all used elements can be found. (Fig.3.4-4) 
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Figure 3.4-4: XPS survey spectra of the iso-TG, the AgNO3 incubated iso-TG (no reduction), 
the AgNO3 incubated and light reduced iso-TG and the AgNO3 incubated and chemically 
reduced iso-TG 
 
To learn more about the atomic state of the elements, the peaks were measured one by one 
(Fig.3.4-5) and compared with literature data. Almost all of the spectra show shifted peaks 
due to the charging effect (conducting Si wafer+insulating beads and ligand). The shifts have 
been corrected to the charging effect. The correction is based on the value of the C1s peaks. 
The position of the most intense carbon peak was assigned according to what was expected 
given the known composition of the material. All of the other peak positions were corrected 
with respect to this peak. The shift corrections were between 0.4-0.9 eV, which is an 
acceptable shift resulting from the charging effect.   
The Ag3d peaks in the case of the chemically reduced beads are not broad, and only one 
component is present. The position of this peak shows a good correspondence with the bulk 
silver with 367,8 eV binding energy (=BE). The relative concentration of the silver seems 
much higher in this sample, compared with the light reduced or not reduced samples although 
the real concentration is the same in all Ag-treated samples. The probable explanation of this 
phenomenon is that during the chemical reduction, the previously ligand complexed silver 
ions move to the surface of the beads, making large aggregates of silver metal nanoparticles 
(as confirmed by the previous SEM measurements). The escape depth of the e- being ~ 5 nm, 
that means that silver attached inside the functionalized PEG spacer (Fig.3.2-56 in Chapter 
3.2.6) is invisible for the X-rays, hence the measured silver concentration on the surface is 
much lower.  
The unreduced sample reveals a Ag3d peak with a slightly higher BE level (368.1eV) in good 
agreement with the results of the previous measurements on the Adl7 silver complex polymer 
compound (Chapter 3.2.3.4). The lines are broad, probably due to a second component of 
silver that can be recognized at BE 369.0 eV. This can be attributed to an Ag cluster upon 
cluster formation due to a reduction of the Ag-ions caused by the X-ray radiation during the 
XPS recording. The light reduced beads show a much more complicated Ag3d spectrum with 
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at least two different silver compounds, one of them with a binding energy of 368.4 eV. This 
compound can be a silver cluster with an inferior size of clusters than in the previous sample. 
The second component, with binding energy of 371.1eV, is a silver having a changed 
chemical environment in which the electronic density must be much higher than for Ag+ in a 
complex bond.  This big shift can be explained by the formation of a very small cluster (3-4 
Ag) or dimers. Supposing to have Ag+-Ag+ interactions which is already half way to the 
reduced Ag0, this can resemble the Ag-Ag pairs observed in other Ag-coordination polymer 
networks described by us [207][93]. 
The N1s peaks are on the same place by all of the samples, at 399.7-9eV. These peaks are so 
broad that they might correspond to two types of N present in the molecule. These are the 
pyridine N of the isonicotinic tail and the N of the peptide bond through the isonicotinic acid, 
which is bonded to the T-Gel beads.  
The C1s peaks show two different components of ca. 50% distribution each. One peak at 
284.8 eV is attributed to C=C/C-C bonds (carbons in aromatic/aliphatic environment) and the 
second one at 286.5 eV BE is attributed to the C-N/C=O bonds. 
The O1s spectrum shows everywhere a single broad peak around 532.8eV binding energy. 
We should always see the O1s from the substrate SiOx, as is confirmed by the Si 2p spectra. 
There is probably overlap with a O1s signal from other compounds. These different oxygen 
atoms have a binding energy in the same area. The value of 532.8eV is higher than the value 
expected for the C=O oxygen atoms (around 532eV), but is slightly lower than these of the 
absorbed H2O oxygen atoms. It can be more attributed to a C-O or an H-bonded O. The area 
covered by this broad O1s peak from ~531.6 to 534.0eV and can thus afford no further 
information.  
3 Results and discussion   
Novel silver containing antimicrobial coatings for implant materials: new applications of Ag(I) coordination networks 124 
 
 Figure 3.4-5: N1s, O1s, Si2p, C1s, Ag3d peaks of the four samples 
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3.4.1.2 Conclusions 
Following the preliminary experiments, some important remarks should be made: 
-both reduction methods are suitable to detect the silver ions attached to the surface of the 
beads: colouration of the beads signifies the AgNPs formation from the silver ions  
-after reduction, the colour of the beads is different in case of the two reduction methods, LR 
(light reduction) generates red, while CR (chemical reduction) generates grey colour in the 
case of iso-TG. In addition, the obtained nanoparticles causing the colour of the beads are 
different depending on the two methods.  
-the nanoparticle size, form and distribution are representative of the reduction method: the 
light reduction results in well designed crystalline nanoparticles, while the chemical reduction 
generates well distributed small aggregates on the surface; 
-the LR method represents a partial reduction of the silver ions. Crystalline structures (some 
100 nm) of small clusters and ions can be found on the surface of the beads. This is in contrast 
to the CR, where the AgNPs are formed within minutes.  
In further investigations, both reduction methods are used. First a combinatorial assay with a 
tripeptide library was carried out, and the reduction methods are used as marker reaction 
during the screening. Then, the analysis of the library, the active sequences, were determined 
and the synthesized tripeptides were tested regarding their silver affinity and AgNP 
formation. 
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3.4.2 Combinatorial experiments 
 
As a simple biological model, tripeptides were used to study the selectivity of the different 
structures regarding their affinity to silver ions and to better understand the role of the amino 
acids in the AgNPs formation. For the nanoparticle formation, the silver ions attached to a 
surface were reduced in two different ways: with the light reduction (LR) method and the 
chemical reduction (CR) method. To gain insight into molecular interactions of silver ions 
with peptides, we used a combinatorial approach and prepared an encoded split-and-mix 
peptide library (library1) [176, 177] split-and-mix synthesis [178, 179]. Here, a short 
description is given to explain the basics of the combinatorial approach and the synthesis of 
an encoded split and mix library.  
3.4.2.1 Solid phase peptide synthesis and combinatorial chemistry 
Since the Nobel Prize winner Merrifield pioneered solid phase synthesis in 1963, the peptide 
synthesis has changed radically. Merrifield’s Solid Phase synthesis concept, first developed 
for biopolymers, is used in every field where organic synthesis is involved. Merrifield 
developed a series of chemical reactions that can be used to synthesize proteins. The direction 
of synthesis is opposite to that used in solution. The intended carboxy terminal amino acid is 
anchored to a solid support. Then, the next amino acid is coupled to the first one. To prevent 
further chain growth at this point, the amino acid, which is added, has its amino group 
protected. After the coupling step, the protecting block is removed from the primary amino 
group and the coupling reaction is repeated with the next amino acid. The process continues 
until the peptide or protein is completed. Then, the molecule can be cleaved from the solid 
support and any groups protecting amino acid side chains are removed. Finally, the peptide or 
protein is purified to remove partial products and products containing errors. For this purpose, 
a RinkAmid resin is used. The peptide can also be left on the solid support. Just the side chain 
protecting group are removed and peptide containing beads are used for further experiments. 
TentaGel resin is used for this aim.   
Combinatorial synthesis on solid phase can generate very large numbers of products, using a 
method described as mix and split synthesis. This technique was pioneered by Furka and has 
since been exploited by many others since its first disclosure. The method works as follows: a 
sample of resin support material is divided into a number of equal portions (x) and each of 
these is individually reacted with a single different reagent/amino acid. After completion of 
the reactions, and subsequent washing to remove excess reagents, the individual portions are 
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recombined; the whole is thoroughly mixed, and may then be divided again into portions. 
Reaction with a further set of activated reagents/amino acids gives the complete set of 
possible dimeric units as mixtures and this whole process may then be repeated as necessary 
(for a total of n times). The number of compounds obtained arises from the geometric increase 
in potential products; in this case x to the power of n. A simple example of a 3 x 3 x 3 library 
gives all 27 possible combinations of trimeric products. If X, Y and Z were amino acids, the 
final products would be tripeptides. The compounds can be tested whilst still attached to the 
bead or as a mixture following cleavage from the solid phase. The library is then tested to 
determine the most active sequences. As the quantity of the substance present on one bead is 
very low (ca.100 pmol), defining the sequences present on a bead would need a complicated 
analytical method. To facilitate this step, an encoded library is prepared. The encoded library 
contains several tag molecules as a marker. These molecules are representatives for the 
determined reagent/amino acid in a determined position. The present tag molecules will give 
the information which reagents/amino acids are on the beads and in which order. These tag 
molecules should be easy to work with and to detect with an analytical method. Other 
characteristics of these molecules are also important, namely that during the reaction it should 
be inert and detectable in small quantity. [180] It should be also easy to cleave from the 
beads. These tag molecules were developed [176] containing a polyhalogenated aromatic 
alcohol residue and a photo-cleavable part. The polyhalogenated aromatic alcohol residue can 
easily be determined by EC-GC. The sensitivity of the EC method for this type of molecule is 
so high that only 2% of one bead surface should be loaded with it. The scheme of an encoded 
library synthesis is presented on Fig.3.4-6. To encode the library, a binary code is necessary: 
every reaction is coded by one or several tag molecules. In the presented example, two tags 
are used to code three reactions in both two cycles. E.g.: if after analysis, the T1, T2, and T4 
are detected, that means that on the beads, the Z was in the first and Y in the second position. 
Using the binary code, N tag molecules can encode 2N-1 reactions. [176]   
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Figure 3.4-6: Scheme of the preparation of an encoded split-and-mix library 
 
The “one-bead-screening“ method is an efficient way to test a large number of different 
molecules to find out the active sequences. In this method, all participants of the library are 
tested at the same time. The screening reaction is made with the library and a simple visible 
reaction taking place on the active beads. The typical size and shape dependent coloration of 
Ag-NPs [181-187] was anticipated to allow for an easy identification of active library 
members. Then, the coloured beads are removed and analysed. The sequence on a bead is 
determined by detecting the present tag molecules.   
3.4.2.2 Combinatorial experiments 
 
The synthesized tripeptide library (by Dr. Kirsten Belser), contains seven different linkers and 
seven different L- and D- amino acids in positions AA1 and AA2, hence the library 1 consisted 
maximally of 73 = 343 different peptides. In the three variable positions, the library 1 contains 
the amino acids D/L-Asp, D/L-His, D/L-Ser, L-Tyr (AAn), and a linker, which can be a linear 
spacer like Gly, ß-Ala, aminohexanoic acid (Ahx) or a turn inducing rigid motive like Pro-
Gly, Pro-Aib and trans-2-aminocyclohexane carboxylic acid (turnrac, Achc;) (Xn). 
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Figure 3.4-7: Encoded split-and-mix library 1 
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AAn: L-Asp, D-Asp, L-His, D-His, L-Ser, D-Ser, L-Tyr 
 Xn: no motif, Ahx, Pro-Aib, Gly, Pro-Gly, β-Ala, trans-2-aminocyclohexane carboxylic acid 
 
Regarding the choice of the peptides, which are present in the library 1, some principle 
considerations should be made. The histidine amino acid plays a key role in the mechanism of 
the silver resistance process of the cell, thus the presence of this aminoacid was necessary. 
The tyrosine is well known for its photo activity and reducting behaviour [189-191], which 
can be beneficial during the light reduction. The serine and aspartame can function as good 
oxygen donor complexing agents since silver ions; in absence of N donors are readily 
complexed with carboxyl or hydroxyl oxygen atoms. The sulphur containing amino acids 
were avoided because their silver complexation is expected to be so strong that no other 
complexing effect can be observed. The strong interaction between the sulphur containing 
group and the silver ions probably hinders the NP formation.  
The role of the linker is to predetermine the form of the amino acid chain. Thus, the spatial 
arrangement of the side chains AA1 and AA2 can either help or hinder the complexation of 
the metal ion. Indeed, the importance of turn-inducing linkers in peptides binding to metal 
ions other than Ag+ has been already observed [192] 
The library 1 is incubated with 0.05M AgNO3 so that the silver ion concentration is in large 
excess (around 10 times higher than the peptide receptor concentration on the solid support). 
After 15 min sonication with the silver nitrate solution, the beads are washed 5 times with 
nanopure water to wash out the non complexed, free silver ions. The wet beads are reduced 
either with light (8h with a 15W electrical lamp, from a distance of 10cm) or with 0.05M 
sodium ascorbate solution (chemical reduction). After the chemical reduction, the beads were 
again washed 5 times with nanopure water. The light microscopic images are made using wet 
samples. For the SEM measurements, the samples are dried under vacuum. 
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The images of the library 1 are shown in a Fig.3.4-8, (light reduced samples), and in Fig.3.4-
10 (chemically reduced samples).        
 
a,   b, 
Figure 3.4-8a,b: Library 1 after Ag+ incubation and light reduction (LR), light microscopic 
(a) and SEM images (b) 
 
The light reduction generates several red, dark red or spotted beads and many colourless or 
slightly coloured beads. Similar but lighter colours have been observed for the light reduced 
isonicitinic acid coupled T-gel (iso-TG) sample. The SEM image shows also differences 
between the beads. Some beads are covered with nanoparticles corresponding to the dark red 
coloured beads. No particles can be found on the colourless beads. The fact that coloured and 
colourless beads are present after the reduction means that some tripeptide sequences react 
well with silver ions and others do not interact with Ag+. The silver ions attached on the 
surface by the tripeptides are reduced by the light generating nanoparticles. The energy 
dispersive X-ray analysis (EDAX) of the solid particles confirms the presence of metallic 
silver. (Fig.3.4-9) 
 
Figure 3.4-9: EDAX spectrum of 
the Ag+ incubated and light 
reduced library 1,   
 
 
 
 
 
Indeed, on the EDAX spectrum the signal of the Pt, used as sprinkled metal, is observed as 
main peak. The C and O from the organic molecules and the Cl (since the library was 
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prepared using polychlorinated tag molecules to determine the tripeptide sequences present in 
one bead) can also be observed. 
 The colouration of the beads is more pronounced using chemical reduction. There are 
different coloured beads present after the reduction: dark red, red, orange and yellow beads 
are found next to the colourless beads. (Fig.3.4-10a) 
a, b, 
 
c, 
 
d, 
Figure 3.4-10a,b: Library 1 after Ag+ incubation and chemical reduction (CR), light 
microscopic (a) and SEM images (b,c,d) 
 
The SEM images show different sized AgNPs on the different beads. Since the colour of the 
AgNPs changes with their size, the different coloured beads have different sized NPs on the 
surface. This suggests that beads, containing certain tripeptide sequences, have a higher 
affinity to silver, resulting in more and larger AgNPs. The colour diversity of the beads 
suggests higher selectivity in the case of the chemical reduction method. 
To answer the question of the selectivity, namely if there are tripeptide sequences having 
higher affinity for silver ions, the coloured beads were analysed by EC-GC technique. 
Isolation of several of the coloured beads from both LR and CR assays, and analysis of the 
peptides on them, revealed the following main consensus sequences listed in Table 3.4-1 and 
3.4-2. 
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Table 3.4-1: AgNPs formation by reduction of Ag+ with light (light reduction, LR), most 
often found sequences after GC analysis 
 
Colour AA1 X1 (linker) AA2 
Red Ac-D/L-His Achc L-Tyr 
 Ac-D/L-Ser Achc L-Tyr 
 Ac-L-Tyr Achc D/L-Ser 
 
Analysing these sequences, which are active for light reduction, some general remarks can be 
made, namely the importance of the tyrosine amino acid is significant. The tyrosine, being a 
photoactive molecule, possibly helps the reduction of the silver ions to nanoparticles during 
LR. Histidine, being a good complexing agent for silver, and the serine seem to be also 
important. Their role is probably to attach the silver ions on the surface and coordinate them 
for the reduction. Since the two effects, the attachment of silver ions and the reduction, should 
take place near each other, the spatial arrangement of the tripeptide seems to be crucial. This 
can be the explanation why turn linker motifs have a higher occurrence in the GC results than 
the linear flexible linkers (see the detailed table of the GC results in the experimental part). 
The chemically reduced library 1 has a higher diversity in colour of the beads the same is true 
for the tripeptide sequences found after GC analysis. (Table  3.4-2).   
 
Table 3.4-2: AgNPs formation by reduction of Ag+ with sodium ascorbate (chemical 
reduction, CR), most often found sequences after GC analysis (“X”: random linker) 
 
Colour AA1 X1 (linker) AA2 
Dark red/red/ 
dark orange 
beads  
Ac-D/L-His X D/L-His 
Ac-D/L-His X D/L-Asp 
Ac-D/L-Asp X D/L-His 
 Ac-D/L-His X L-Tyr 
 Ac-L-Tyr X D/L-His 
 Ac-D/L-His X D/L-Ser 
 Ac-D/L-Ser X D/L-His 
yellow/light  Ac-D/L-Asp X D/L-Asp 
orange Ac-D/L-Ser X L-Tyr 
beads Ac-L-Tyr X D/L-Ser 
 Ac-D/L-Asp X D/L-Ser 
 Ac-D/L-Ser X D/L-Asp 
 
The occurrence of the histidine amino acid is very high, as well the aspartate and the serine. 
These amino acids have a high affinity towards the silver ions. This seems to be the 
determining factor for the colouration of the beads. Compared with the LR, the rigid turn-
inducing linkers and the tyrosine have lost their predominant important role during the 
reduction with sodium ascorbate. 
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3.4.3 Silver affinity and AgNP generation of tripeptides on solid 
support 
 
After the evaluation of the results of library 1, further investigations were done on some 
active tripeptide structures using SEM, EDAX and powder X-ray spectroscopy techniques to 
characterize the particles, their size and distribution, and to understand the formation of the 
nanoparticles. To determine the loading of silver on the different T-gel beads, the AAS 
technique was used.  
The synthesized tripeptide sequences are split into different groups. In the first group, 
tripeptides contain the sequences that were found to be positive after analysing the LR library 
1. The prepared positive sequences contain histidine, serine and tyrosine and a rigid turn-
inducing linker (Achc). Some negative control sequences were also synthesized; these are not 
present among the sequences found by GC analysis. In the second group, tripeptide sequences 
are present with amino acids found in a high occurrence after the GC analysis of the CR 
library 1. Those tripeptide sequences, found in the last group, were prepared for another 
purpose, for example as the model sequences or tripeptides for solution experiments.[2] All 
sequences were completely analyzed independently of which group they belong to and are 
attached on the beads. The tripeptides synthesized in TG are treated in a same way as the 
library 1. The beads are incubated in AgNO3 solution, then washed and reduced by light or 
sodium ascorbate. Then the samples were photographed, dried, and SEM measurements were 
done. The silver ion uptake of the beads was calculated by measuring the remaining silver ion 
concentration in the treating solution, using AAS. Some reduced T-gel beads were measured 
by powder X-ray to identify the nanoparticles on the surface Fig.3.4-11. These measurements 
could be made only on samples with the coverage high enough to detect the crystalline 
structure on the surface.  
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 Figure 3.4-11: Example of powder X-ray 
spectra of the AgNPs on the beads 
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3.4.3.1 Light reduction  
 
The results of the first group of the tripeptides are listed in Table 3.4-3, and some 
representative images are shown in Fig.3.4-12. The compositions of the sequences have been 
chosen accordingly to the GC analysis of the light reduced library 1 and the representative 
sequences were synthesized. Negative control sequences were also synthesized to compare 
the affinity for silver and the behaviour toward light reduction. 
Peptides-NHTG 
Light reduction Chemical reduction Uptake 
mMAg/
mM pept Color NP size (nm) Color NP size (nm) 
AcDHis-Achc-LTyr Red 300-500nm Dark red 100-200nm 0.67 
AcLHis-Achc-LTyr Red 300-500nm Dark red 100-200nm 0.60 
AcLSer-Achc-LTyr Orange >500nm cryst. Yellow ≤ 50nm 0.33 
AcDSer-Achc-LTyr Orange > 1 µm cryst. Yellow ≤ 50nm 0.35 
AcLTyr-Achc-DSer Orange > 1 µm cryst. Yellow ≤50nm 0.34 
AcDHis-proAib-
LTyr 
Colourless - Dark red 200-300nm 0.68 
AcLSer-proAib-LTyr Colourless >700nm rare Colourless Rare 100 isol.  0.18 
AcLSer-proAib-LSer Colourless > 1 µm cryst. Colourless - 0.23 
AcLTyr-LTyr Colourless 500-1000nm rare Colourless > 1 μm rare 0.23 
AcLTyr-LGly-LTyr Colourless >1 µm isol.cryst. Colourless - 0.31 
AcDAsp-ßAla-DAsp Colourless > 400nm aggr. Grey 250-1000nm  0.37 
Tripeptide sequences, positive and negative controls, for light reduction 
      
AcDHis-Gly-LTyr Grey 2-300nm Dark red cov. 
agg.+100nm  
0.80 
AcDHis-LTyr Grey 500nm cryst. Red 100-200nm 0.44 
AcDHis-LHis Red 1-200nm isol. Dark red 1-200nm aggr. 0.81 
Tripeptide sequences to test the spacial effect on the NP generation 
 
Table 3.4-3: The first 14 tripeptide sequences, synthesized as positive and negative controls 
for light reduction, and their complete analysis 
 
The results confirm a very high selectivity for a turn inducing linker and tyrosine. Fig.3.4-
12a,b,c show the optical microscope images of two active sequences: AcDHis-Achc-LTyr-TG 
and AcLSer-Achc-LTyr-TG and the negative control sequence AcDHis-LHis-TG. 
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a, AcDHis-Achc-LTyr-TG b, AcLSer-Achc-LTyr-TG c, AcLTyr-LGly-LTyr-TG 
 
Figure 3.4-12a,b,c: Optical microscopic images of the Ag+ incubated and light reduced (LR) 
different tripeptide containing beads 
 
The colour of the beads is darker in the case of the AcDHis-Achc-LTyr-NHTG than that other 
active sequence AcLSer-Achc-LTyr-NHTG. Silver uptake measurements were done to 
measure the affinity of the tripeptide sequences towards silver ions. The AcDHis-Achc-LTyr-
NHTG has a higher uptake, thus higher affinity to silver ions than the AcLSer-Achc-LTyr-
NHTG. Also, the first peptide shows darker coloured beads than the second one. (Darker 
colour means generally larger NPs.) The most active sequence AcDHis-Achc-LTyr-NHTG 
contains a good silver complexing molecule, His and a photoactive residue, Tyr. Their special 
spatial arrangement is controlled via the Achc turn inducing linker. This suggests that the 
collective presence of the three influencing factors namely: a good complexing amino acid, a 
photoactive residue and good spatial arrangement, results in Ag+ uptake and thus the AgNPs 
formation. If one of these conditions is missing, the tripeptide would not favour the AgNP 
formation by light, as for instance the negative control sequence AcLTyr-LGly-LTyr-NHTG. 
Although the AcLTyr-LGly-LTyr-NHTG has a photoactive residue, the affinity towards silver 
ions is not high enough and does not show colouration by this reducing method. The 
sequences presented in the Table 3.4-3 confirm that the tripeptide sequence should fulfil the 
three conditions described above simultaneously to generate AgNPs on the surface via light 
reduction. If the tripeptide doesn’t contain any photoactive residue as the AcDAsp-ßAla-
DAsp-NHTG or AcLSer-proAib-LSer-NHTG there is also no AgNPs formation on the 
surface. The sequences missing a good silver complexing group, AcLTyr-LTyr-NHTG and 
AcLTyr-LGly-LTyr-NHTG or having an unfavourable spatial arrangement, AcLSer-proAib-
LTyr-NHTG and AcDHis-proAib-LTyr-NHTG are also inactive for the light reduction. If all 
of the three conditions are fulfilled, the affinity of the tripeptide seems to be the colour 
determining factor. The darker the colour, the larger are the AgNPs, which are present. The 
uptake measurements determine the quantity of the silver ions remaining on the surface after 
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incubation in AgNO3 solution, and are thus representative for the silver affinity of the 
tripeptide. 
The uptake measurements show a significant affinity of the sequences containing histidine 
amino acid. The two histidine containing tripeptides have such a high affinity, uptake (0.81 
mM Ag/mM peptide) that the light reduction takes place even without any photoactive 
residue. The silver ions are probably attached so close to each other that the light initiates the 
autocatalytic photo reduction. The above described results demonstrate the weakness of this 
reducing method, namely that it is not possible to detect all of the sequences attaching silver 
ions.  
Before analysing the tripeptide sequences prepared to study the reduction with sodium 
ascorbate, Fig.3.4-13,14 presents an example comparing the two methods in case of the photo 
reducible tripeptide AcDHis-Achc-LTyr-NHTG. 
   
Figure 3.4-13: SEM images of the AcDHis-Achc-LTyr-TG, tripeptide after Ag+ incubation and 
light reduction (LR) 
 
   
Figure 3.4-14: SEM images of the AcDHis-Achc-LTyr-TG, tripeptide after Ag+ incubation and 
chemical reduction (CR) 
 
The SEM images show a big difference between the two samples. The most remarkable 
difference can be observed in the shape of the AgNPs. In the case of the light reduced sample, 
500nm size crystalline AgNPs can be observed in inhomogeneous distribution. This is in 
contrast to the light reduced sample, where the bigger aggregates of small AgNPs are 
covering homogenously the whole surface. This difference can be explained by the 
mechanism of the two reducing methods. The light reduction takes place during 8 hours, 
which is a long process allowing enough time for the crystallisation. 
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Since the samples are irradiated from the top of the sample, the reduction effect is 
inhomogeneous, thus the AgNPs formation will be strong on the irradiated side of the bead 
and weaker on the shaded side. The reduction achieved in this way is not complete. To prove 
this incompleteness of the reduction, further AAS measurements were carried out. The 
measurements show that the percentage of the unreduced silver ions can vary between 78% 
for AcLHis-Gly-LHis-NHTG and 25% for AcDHis-LHis-NHTG. The iso-TG has around 50% 
ionic silver after light reduction. The light reduced beads are not photostable since no fixation 
process for the AgNPs, as it is generally used in photography to remove unreduced silver 
ions, was done, thus the ionic/metal silver ratio can change with the time and the AgNPs 
formation continues further when exposed to light.  
3.4.3.2 Chemical reduction 
 
Comparing the SEM images of the two reduction methods of the tripeptide AcDHis-Achc-
LTyr-NHTG Fig.3.4-13,14, the main differences become visible. As opposed to the photo 
reduction, the chemical reduction takes place in some minutes in the solution of sodium 
ascorbate. Hence, the reducing effect is homogenous and fast, there is no time for a 
crystallisation process. Some small aggregates are formed covering the surface. As this 
tripeptide forms different AgNPs after chemical reduction from those of light reduction, the 
other peptides also react differently. Library 1 shows higher diversity in colour and this 
increases the diversity in AgNP size. To study the AgNPs generation of the tripeptides by 
chemical reduction, the following sequences, listed in Table 3.4-4, were synthesized.    
 
Peptides-NHTG 
Light reduction Chemical reduction Uptake 
mMAg/
mM pept Colour NP size (nm) Colour NP size (nm) 
AcLAsp-ProGly-
LAsp 
Colourless >1µm isol. D. grey 400-1000nm 
aggr. 
0.57 
AcLHis-Gly-LHis Red 500nm isol. D. red 100-200nm 0.71 
AcDHis-ProAib-
LAsp 
Colourless 1-300nm cryst. D. yellow <100nm aggr. 
0.44 
AcDHis-Gly-DAsp Colourless >500nm isol. D.orange 1-200nm  aggr. 0.58 
AcLHis-ProGly-
DAsp 
Colourless 2-300nm cryst. Orange 2-500nm aggr. 
0.64 
AcLAsp-βAla-DHis Colourless 2-400nm  D. yellow 1-200nm cov. 0.59 
AcLSer-βAla-LHis Red-grey 1-200nm isol. Red 1-200nm cov. 0.70 
AcLAsp-Achc-LTyr L.rosa - Grey ~400nm aggr. 0.37 
Tripeptide sequences for chemical reduction 
 
Table 3.4-4: Second 8 tripeptide sequences, synthesized as positive controls for chemical 
reduction, and their complete analysis 
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To analyse the results, the tripeptides of the first group (Table 3.4-2) were also used. The first 
important observation should be made regarding the colour of the beads. The synthesized 
sequences show the same diversity in colour as in library 1. In Fig.3.4-15, three peptides are 
shown comparing their colours, their SEM images, AgNP size and distribution.  
 
Figure 3.4-15a,b,c: Optical microscopic and SEM images of the three tripeptide sequences  
a: AcDHis-ProAib-LAsp-TG, b: AcLSer-βAla-LHis-TG and c: AcDHis-LHis-TG after 
incubation in Ag+ and chemical reduction 
   
   
   
a, AcDHis-ProAib-LAsp-TG, 
CR 
b, AcLSer-βAla-LHis-TG, CR c, AcDHis-LHis-TG, CR 
 
The AgNPs present on the surface of the different coloured beads show a big difference in 
their size and diversity. The light yellow, coloured beads of AcDHis-ProAib-LAsp-NHTG 
have aggregates of maximum 100nm on the surface. The red beads of the AcLSer-βAla-LHis-
NHTG have larger aggregates and higher coverage on the surface, but the coverage does not 
reach the level of that of the AcDHis-LHis-NHTG peptide. There, the complete coverage can 
be observed by the dark beads of the AcDHis-LHis-NHTG, and the size of the AgNPs is 
difficult to determine. Ca. ~50nm sized grains stick together, covering the whole surface. This 
is a good example for the fact that the colour of the beads is determined by the size and the 
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distribution of the AgNPs. The other important observation concerns the relationship between 
the colour of the beads after the chemical reduction and the silver affinity of the peptides.  
 
Table 3.4-5: Summary of the colour of the TG beads, 20 different tripeptide sequences, after 
CR and their Ag+ uptake  
 
Peptide-NHTG Colour after CR Uptake NPs on the surface 
AcLSer-proAib-LTyr Colourless 0.18 Rare 100 isol.  
AcLSer-proAib-LSer Colourless 0.23 - 
AcLTyr-LTyr Colourless 0.23 > 1 μm rare 
AcLSer-Ahx-LTyr Yellow 0.26 <50nm cov 
AcLSer-Achc-LTyr Yellow 0.33 ≤ 50nm 
AcDSer-Achc-LTyr Yellow 0.35 ≤ 50nm 
AcLTyr-Achc-DSer Yellow 0.34 ≤50nm 
AcDHis-ProAib-LAsp D. yellow 0.44 <100nm aggr. 
AcDHis-Gly-DAsp D.orange 0.58 1-200nm  aggr. 
AcLHis-Ahx-LAsp  D.orange 0.55 1-300nm aggr. 
AcLHis-ProGly-LAsp D.orange 0.47 50-200nm cryst.. 
AcDHis-LTyr Red 0.44 100-200nm 
AcDHis-Achc-LTyr Dark red 0.67 100-200nm 
AcLHis-Achc-LTyr Dark red 0.60 100-200nm 
AcDHis-proAib-LTyr Dark red 0.68 200-300nm 
AcLHis-Gly-LHis Dark red 0.71 100-200nm 
AcDHis-Gly-LTyr Dark red 0.80 cov. agg.+100nm  
AcDHis-LHis Dark red 0.81 1-200nm aggr. 
AcLAsp-Achc-LTyr Grey 0.37 ~400nm aggr. 
AcDAsp-ßAla-DAsp Grey 0.37 250-1000nm  
   
Table 3.4-5 shows, that contrary to the light reduction method, the reduction with sodium 
ascorbate detects silver ions attached on the surface, independently on the conformation of the 
peptide or the presence of a photoactive residue. Therefore, this method is more sensitive on 
silver ions but much less specific for the tripeptide sequences than the photo reduction 
method. The colour of the beads has a direct relationship with the silver affinity of the 
peptides. The higher the uptake means darker colour of the beads. The uptake for the 
colourless, yellow, orange and dark red beads are around 0.20, 0.30, 0.50 and 0.70 mM 
Ag/mM peptide, respectively. The size of the aggregates of NPs on the surface is increasing 
in the same way. Interestingly, in the histidine containing tripeptides, the grain size of the 
AgNPs is more or less the same, but the size of the aggregates and coverage is increasing with 
the uptake and the colour gets darker. If the sequence does not contain any histidine, the size 
of the AgNPs and thus the colour of the beads is different: e.g. for AcLAsp-Achc-LTyr-TG 
and AcDAsp-ßAla-DAsp-TG sequences. Although the uptake of these sequences is not so 
high, around 0.40 mMAg/mM peptide, the dark colour is present, but in a different tone: not 
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yellow-orange but grey, and the size of the AgNPs is also larger than in the case of the 
histidine containing peptides. The other peptides, containing different amino acids than 
histidine, are the serine containing peptides. As the affinity towards silver ions of these 
peptides is weaker, the uptake is low and the AgNPs size is also small, thus the colour of 
these beads is light.  
3.4.3.3 Other complementary experiments with the solid phase tripeptide 
sequences 
The previously made observations are confirmed by the last group of the tripeptide sequences 
on T-gel listed in Table 3.4-6. The colour of the beads after chemical reduction depends on 
the uptake, and only the two histidine containing tripeptides show some colour after light 
reduction.  
Table 3.4-6: Other complementary tripeptide and model sequences and their analysis 
Peptides-TG 
Light reduction Chemical reduction Uptake 
mMAg/
mM pept Colour NP size (nm) Colour NP size (nm) 
AcLHis-Ahx-LAsp  Colourless No cryst. mater. D.orange 1-300nm aggr. 0.55 
AcLHis-ProGly-
LAsp 
Colourless No cryst. mater. D.orange 50-200nm 
cryst.. 0.47 
AcLHis-Ahx-LHis L.red >500 aggr. D.red 50-100nm cov. 0.38 
AcLHis-ProGly-LHis Red 50-100nm cov. D.red >100 aggr.cov. 0.64 
AcLSer-Ahx-LTyr Colourless >1 µm isol.cryst. Yellow <50nm cov 0.26 
AcLSer-ProGly-LTyr Colourless >100nm isol. Yellow <30nm cov 0.19 
Tripeptide sequences prepared by C.P* for solution experiments  
      
Isonicotinic acid  Red spot 2-700nm cryst. Grey 1-200nm aggr. 0.46 
Ac-TGel Colourless > 1 μm cryst. Colourless > 1 μm  0.29 
Model sequences 
 
Regarding the conformation of the rigid turn-inducing motif, all possible diastereoisomers of 
peptides AcDHis-Achc-LTyr-NHTG, AcDSer-Achc-LTyr-NHTG and Ac-LTyr-Achc-DSer-
NHTG were re-synthesized and examined. The performed experiments, LR, CR, silver uptake 
measurements and SEM, of these sequences show essentially the same results, demonstrating 
that the absolute configuration of the amino acids is of minor importance for their activity. 
The same is true for the configuration of the amino acids. During the GC analysis of the 
library 1, independently of the reduction method, any linker was found suggesting that the 
relative orientation of the two amino acids towards each other is not crucial for their activity. 
In both assays, no pronounced selectivity for L- or D-configured amino acids was observed. 
Cysteine containing tripeptide was also synthesized, to test a sulphur containing amino acid 
sequence with silver treatment and both reduction methods. The measured uptake was not as 
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high as by histidine containing tripeptides (0.36 mMAg/mMpetide). The SEM measurements 
did not show any AgNPs on the surface of the light reduced beads (colourless beads), and just 
some very small AgNPs (less than 30nm) after reduction with sodium ascorbate. The cysteine 
attaches the silver probably so strongly that it hinders the AgNP formation and blocks the 
silver ion movement to build up larger aggregates.     
3.4.4 Complementary experiments in solution 
 
Besides the tests on solid phase peptides, some other experiments were done in solution. The 
TEM and UV studies [194] show the AgNPs formation also in solution phase.    
NMR studies were done on AcDHis-racAchc-LTyr-NH2 tripeptide to determine which groups 
are involved in the NP generation and which are the silver binding sites of the peptide. For 
this purpose, the NMR spectra of 2.2mM peptide in D2O/H2O with different equivalents of 
Ag+ (AgNO3 solution) in H2O, were measured. As the racemic mixture of the Achc molecule 
was used, both diastereomers can be found in the sample solution. Using different equivalents 
of Ag+, the proton signal of the binding sites will be shifted with the increase of the silver 
concentration. In Fig.3.4-16,17 and Table 3.4-7, the most important signal and their shifts are 
presented. 
Figure 3.4-16: Schema of the conformation of the AcDHis-racAchc-LTyr-NH2 tripeptide 
  
 
Figure 3.4-17: Chemical shifts of the 1H signals without Ag+ and 700 eq. concentration Ag+  
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Table 3.4-7: Shift of some 1H signals in function of the Ag+ concentration 
 Eqv. Ag+ Hε-TyrSS Hε-TyrRR NH-turnRR Hδ-TyrSS NHε-HisRR 
Ref.signal 
[ppm] 0 6.80 6.68 8.02 7.10 8.54 
 
 
Shift 
[Hz] 
4.91 2.83 2.43 1.41 2.43 2.94 
24.6 4.99 4.86 7.17 5.38 18.2 
98.0 13.7 12.3 20.9 14.3 48.6 
250.8 31.2 28.7 35.5 32.0 77.6 
490.6 59.0 56.6 52.1 59.8 99.9 
702.4 70.9 69.4 57.2 71.2 108.3 
 
The results show a significant shift of the ε proton of the imidazole side chain, the proton of 
the peptide bond between the Achc linker, and the histidine and the different protons of the 
tyrosine side chain. This latter suppose the interaction between the silver ion and the aromatic 
ring of the tyrosine, having a contact between the π system and the Ag+. The shift of the 
histidine imidazol proton confirms the previous observation, that the main binding site is the 
histidine with its two N donor atoms. Different studies were done to describe the complexing 
behaviour of histidine towards silver ions [195] Generally, the silver tends to prefer 
coordination with N donor atoms compared to O atoms. In the histidine molecule, there are 3 
nitrogen atoms (1 amine and 2 imidazole). From the imidazol N-atoms only one is able to 
coordinate silver at a time so it means one possible coordination site, thus two N sites are 
available, one imidazole and one on the amino N-atom. There are two carboxylic oxygen 
atoms that could be available sites and interact with the metal. Depending on the pH, it gives 
many possibilities to form complexes resulting in different structures. Nomiya et al. [195] 
prepared a histidine silver polymer [Ag – His]n from Ag2O under basic conditions where the 
crystal structure formed a 1-D chain consisting of a 2-coordinated silver(I) atom linking with 
the N-amino atom  in one His - ligand and the N-imidazole atom in a different His - ligand, in 
which the carboxylic oxygen atoms do not participate in the coordination to the silver(I) 
centre. This type of structure formation is confirmed by the works of Mirolo [196]. Under 
basic condition silver histidine complex from AgNO3 was prepared, it contains silver 
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atom coordinating with one histidine by the amino group and to another histidine by its 
imidazole nitrogen, which is similar structure as the polymer prepared with Ag2O by Nomiya. 
In the silver histidine complex prepared under neutral conditions from AgNO3 [Ag 
(LHistidine)(NO3)2].2H2O, the silver is attached to two imidazol nitrogen atoms from two 
different histidine molecules. If the silver complex is prepared in acidic solution, the silver 
forms a network with histidine {[Ag(LHistidine)(NO3)2].2H2O}n through complexation with 
the only available atoms, the carboxylic oxygen donors. The pH of the solution during the 
crystallisation has thus a big impact as it determines the possible coordination sites for the 
silver.  
As for NMR measurements, the experiments were carried out at neutral pH, thus the binding 
of the silver by the imodazol N of the histidine is confirmed by the previous results. Using the 
NMR measurements, the binding constant of the peptide to Ag+ was calculated. The 
determined very weak complexation constant of 2.13M is probably due to the TFA salt, which 
was used during the measurement. To determine the binding constant of the free peptide, 
further investigations should be done.   
Other solution experiments were done by Conelious Pfumbidzai: analyze if the identified 
peptides are also able to induce the formation of Ag-NPs in solution phase. Experiments were 
done with Ac-L-His-Ahx-L-Asp-NH2 and Ac-L-His-ProGly-L-Asp-NH2 peptides. Upon 
mixing of aqueous solutions of these peptides with AgNO3 (0.1 equiv.) followed by addition 
of sodium ascorbate (0.12 equiv.) the solutions turned yellow and orange respectively (Figure 
3.4-18). These colours are indicative of solutions containing Ag-NPs. This is supported by the 
absorption maximum at 408 nm observed in the UV-Vis spectra of the Ag-NPs derived from 
these peptides, which is typical for Ag-NPs. 
Figure 3.4-18: AgNPs formation by tripeptide in 
aqueous solution 
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Ac-LHis-Ahx-LAsp-NH2(left) and 
Ac-LHis-ProGly-LAsp-NH2(right) 
and UV-Vis spectra of Ag-NPs in 
solution with Ac-LHis-Ahx-LAsp-
NH2 (blue) and Ac-LHis-ProGly-
LAsp-NH2(red) after  5 hours 
 
3.4.5 Conclusions 
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The developed two reduction methods, light reduction and chemical reduction with sodium 
ascorbate, are suitable to detect silver ions attached on the surface of the solid-phase bound 
peptides. Both methods operate with nanoparticle generation. The size and distribution of the 
AgNPs depend on which tripeptide sequences are used. Both reduction methods have their 
advantages and disadvantages:  
The light reduction method is suitable to detect higher uptakes and light sensitive structures, 
such as Tyr containing sequences. The spatial conformation of these sequences is also 
important; if the turn linker keeps the complexing site, e.g. His, close to the photoactive site, 
Tyr, of the peptide, the photo reduction is more pronounced, and thus the AgNP formation is 
more developed. The reduction of the silver ions through light is slow, allowing enough time 
for crystallisation, which results in larger, well designed structures. The silver ion reduction to 
Ag0 is not complete and part of the Ag+ remains in ionic form attached to the surface.  
The reduction with sodium ascorbate results in a complete reduction of the ions to NPs. The 
colour of the beads depends of the size of the NP and their aggregates. Since the size and 
distribution of the AgNPs depends directly on the quantity of the silver ions present on the 
surface before reduction, the colour of the beads is a good indicator of the silver affinity to the 
tripeptide sequences. Different tripeptide sequences attach the silver in different quantity, the 
AgNP size and distribution depend on the tripeptide sequences. That means: using defined 
tripeptide sequences, different sized AgNPs can be generated.  
The control of the AgNPs by tripeptides points out a further biological utilisation. Generally, 
the AgNPs in medicine should be size controlled, and attaching these AgNPs on the surface of 
the material can foster an antimicrobial effect to the surface.  
Regarding the affinity of the different amino acids to silver, the histidine is the most 
significant although both serine and aspartate have an affinity to the Ag+. The tripeptides 
containing no histidine can show quite high uptake and also light reducible characteristics. 
This means that the histidine is not the only powerful Ag-binding amino acid (after the 
sulphur containing amino acids). The amino acids serine and aspartate can also play a role, 
probably much less significant than the histidine, in the different biological processes in the 
context of silver. 
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4 Conclusions  
 
This thesis reports on novel antimicrobial silver containing coatings for implant materials. 
Several materials were successfully coated with silver coordination polymers and their 
antimicrobial activity was positively tested. In Table 4-1, a short summary of the results is 
presented:  
 
Substrate Active compound on the surface Loading mg Ag/m2 Antimicrobial effect 
Au(111) model surface Silver coordination polymer 424 ++ 
Titanium rough disks Silver coordination polymer 403 ++ 
Titanium smooth disks Silver coordination polymer 429 ++ 
Steel rough disks Silver coordination polymer 201 + 
Steel polished disks Silver coordination polymer 224 + 
Isonicotinate grafted polymer 
(crystallisation) 
Silver coordination polymer 80 + 
Isonicotinate grafted polymer 
(dip coating) 
Silver coordination polymer 263 ++ 
AcDHis-Achc-LTyr-N- 
peptide grafted polymer 
Silver coordination polymer 84 + 
Isonicotinate grafted polymer AgNPs and/or Ag ions 390 AgNPs -/ Ag ions + 
AcDHis-Achc-LTyr-N- 
peptide grafted polymer 
AgNPs and/or Ag ions 568 AgNPs -/ Ag ions ++ 
Table 4-1: Short summary of the different coatings on various substrates  
 
After preliminary tests, one of the previously described silver coordination networks of 
ethanediyl bis(isonicotinate) ligand (Adl7) has been chosen as surface coating. Different 
substrates were coated following the principle to attach the coating to the surface with 
covalent bonds. For this purpose, a disulfide molecule (bis 2-((4-pyridinylcarbonyl)oxy)ethyl 
disulfide) for the gold surface, isonicotinic acid molecule for some titanium samples and 
surface grafted isonicotinate or tripeptide (AcDHis-Achc-LTyr-N-) for polymer surfaces were 
used. Other surfaces (steel and some titanium substrates) were coated via electrostatic 
interaction between the surface and the coating. After the attachment of the anchor molecule, 
Surface treatment and analysis 
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the silver coordination polymer was built up on a surface using in-situ crystallisation or the 
alternating dip coating method. The coated surface shows a nanostructure of the silver 
compound. This nanostructure, with individual peaks from 10-100nm, is very homogenous 
for the coating attached with covalent bonds, and existing, but less homogenous for 
electrostatically attached coatings. There is a group of middle sized structures (1-50µm 
intervals) and another group of macro sized (up to 100µm), well designed crystals that are 
present on the surface. The crystallisation conditions, namely the crystallization time and the 
concentration of the treating solution determine the quantity of silver compound grafted on 
the surface according to the surface loading. Fig.4-1 shows the example of the gold surface 
treatment by in-situ crystallisation:   
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Figure 4-1: Ag loading on gold plate in function of the treating solution concentration and the 
crystallisation time  
 
The longer the treating time and/or higher the concentration of the crystallization solution, the 
higher is the loading of the surface. Higher surface loading results in higher silver ion 
concentration in the solution above the coating. Fig.4-2 shows the example of the different 
substrates having varying loading on the surface and respectively their silver release in 
Müller-Hinton biological medium. Choosing the appropriate crystallisation conditions, as the 
crystallisation time and concentration, the loading of the substrate can be determined and the 
silver release can be controlled. 
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Figure 4-2: Silver loading on the surface and relating silver concentration in the solution 
above the coated sample 
 
The silver ion concentration released by the material determines the effect of the coating: it is 
either inactive or active against the bacteria or eventually toxic for the living organism. The 
surface treatment method was optimized on each substrates and the best treatment conditions 
for each substrate and/or application are listed in Table 4-2. 
  
Substrate  Application Pre-treatment Treatment 
Au(111) model 
surface  
in vitro 
microbiological 
assays 
5mM disulfide in 
CH2Cl2/EtOH for 5 
days 
In-situ crystallization from 
1mM [Ag(L1)NO3] in 
EtOH/THF for 3 hours 
Titanium rough (TiR) 
and smooth (TiS) 
disks 
in vitro 
microbiological 
assays 
- In-situ crystallization from 
2mM [Ag(L1)NO3] in 
EtOH/THF for 3 days 
Steel polished (StPol) 
and rough  (StR) 
disks and cylinders 
in vitro 
microbiological 
assays 
- In-situ crystallization from 
2mM [Ag(L1)NO3] in 
EtOH/THF for 3 days 
Titanium rough (TiR) 
cages 
in vivo 
microbiological 
assays 
- In-situ crystallization from 
1mM [Ag(L1)NO3] in 
EtOH/THF for 3 days 
Gold alloy dental 
implant material 
Flow chamber 
experiment 
- In-situ crystallization from 
2mM [Ag(L1)NO3] in 
EtOH/THF for 14 days 
Titanium dental 
implant material 
Flow chamber 
experiment 
5mM isonicotinic 
acid in CH2Cl2/EtOH 
for 7 days 
In-situ crystallization from 
2mM [Ag(L1)NO3] in 
EtOH/THF for 14 days 
 
Table 4-2: Summary of the different substrates + application and their treatments  
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Isonicotinate and peptide grafted polymers have been used to generate silver nanoparticles 
(AgNPs) on the surface. This was made for two purposes:  
Nanoparticles generation 
- to build up an antimicrobial coating from nanoparticles  
- to study the molecular mechanism of the Ag+.  
For this goal, a combinatorial chemistry method was used. For the identification of peptides 
able to attach silver ions and induce the formation of AgNPs, a split-and-mix library was 
used. The different reducing methods serve to detect the attached silver on the surface as 
AgNP formation results in a colour change of the sample. The library and different peptide 
sequences on solid support were incubated in AgNO3 aq. solution and then two reducing 
methods were used: light and chemical reduction to generate AgNPs from the surface attached 
silver ions. The light reducing method was efficient on sequences fulfilling three conditions:  
- they should contain a good silver complexing agent (as His or Ser),  
- a photosensitive molecule and  
- the spatial conformation of the sequences to allow the reduction of the ions.  
AcD/LHis-Achc-LTyr-N- and AcD/LSer-Achc-LTyr-N- peptide sequences meet these 
conditions, having a red and yellow colour, respectively, after reduction. The distribution of 
the light generated AgNPs is neither homogenous nor is the reduction complete, however the 
AgNPs have well developed crystalline structures. This is issued from the characteristics of 
the illumination, which is inhomogeneous and slow enough to give time for crystallisation. 
The reduction with sodium ascorbate (chemical reduction) takes only few minutes in solution, 
which is a homogenous and fast reaction way, thus a complete reduction and poorly 
crystallized particles were generated. By this method, the photo sensibility of the sequence is 
not a requirement for the reduction to take place. The AgNPs generation depends on the 
concentration of the attached silver on the surface. Thus, this is a direct method to determine 
the silver affinity of the different tripeptide sequences. Here, all of the sequences having 
higher silver uptake than 0.25 mM Ag/ mM peptide show colouration. The colour of the 
surface due to the AgNPs becomes darker from yellow/grey to dark red/black with silver 
uptakes from 0.25 to 0.80 mM Ag/mM peptide, respectively. The different sizes of AgNPs 
result in this variety of the colours. This is more accentuated for the chemically reduced 
samples since there are no restrictive conditions for the AgNP generation. Generally, different 
peptides allow for the formation of AgNPs with different sizes using either light or a chemical 
reducing agent (sodium ascorbate). Regarding the molecular mechanism of the Ag+, some 
main observations can be made: the key role of the His amino acid is confirmed. All of the 
histidine containing sequences showed affinity towards silver ions. Both, the serine and the 
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aspartame amino acid, attached the silver ions, due to their carboxyl containing side chains, 
which is a good complexing group for the silver ions. Although these amino acids have lower 
affinity towards silver than histidine, they could also play a role in the silver transport on a 
cellular level. 
 
Different in vitro microbiological assays have been done to test the antimicrobial properties of 
the developed coating. Isothermal microcalorimetric measurements determine the bacterial 
multiplication heat. This method was used to measure the activity of the free compound and 
the treated polymer surfaces against S.epidermidis. The antimicrobial activity of the silver 
polymer network coating on polymer surface depends on the loading of the surface and does 
not depend on the quality of the anchor molecule. Regarding the nanoparticle loaded surfaces, 
if only AgNPs are present on the surface (chemical reduced samples), no antimicrobial 
activity is observed. If the reduction is not complete and some silver ions remain on the 
surface (light reduced samples), the coated surface has antimicrobial properties. To achieve 
biologically active silver containing coatings, a release of oxidized form silver (Ag(I)) from 
the surface is thus necessary. The coated implant materials and gold plates were tested with 
the classical plating method in agar. Several bacterial strains were used, such as the gram 
positive S.epidermidis and S.aureus, the two principal responsible strains for the biofilm 
formation and infection of the implants, and the gram negative strain E.Coli. All of the coated 
implant materials were tested positively against the different bacterial strains. Coated titanium 
cages were used for in vivo assays. The after implantation, with S.epidermidis infected coated 
cages did not show any bacterial activity on the surface after one week. Some complementary 
microbiological assays were done on coated titanium and gold dental implant materials in a 
flow chamber, where the treated and untreated substrates were exposed to S.sanguinis (normal 
habitant of the oral flora, causing among others cavities) in sterilized saliva. The tests showed 
a dramatically decreased bacterial number on the coated substrates. The untreated samples 
showed ca.80% more living bacteria on the surface comparing to the silver treated samples.  
Microbiological assays 
All these microbiological experiments confirm the general antimicrobial efficiency of the 
developed silver coordination network coatings on implant materials. 
Regarding the silver action mechanism inside of the cells, it seems that silver acts in several 
levels of the cells, probably disturbs the TCA cycle, hence the respiratory chain, but also acts 
at the level of DNA. To prove these theories, further investigations are required.  
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Following this study, further investigation should be done to improve the mechanical stability 
of these coatings. Since the silver coordination networks have a large diversity, other 
compounds, could be tried to tune the three important characteristics of the coating: structure, 
stability and solubility. Copper is also known for its antimicrobial activity [198] and ability to 
form coordination networks, hence, its ability to build up antimicrobial coatings should be 
studied. Further investigations could be done to work on the coating of different polymer 
surfaces. Regarding the biological assays, cell viability tests with fibroblasts are currently 
under investigation. Other trials with osteoblast cells should be done because the 
osseointegration of the implant is a crucial step towards healing.    
Outlook 
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5 Experimental part  
 
Abbreviations 
 
Ac  acetyl 
Ac2O  aceticacid anhydrid 
Achc  trans-2-Aminocyclohexan Carbonacid 
AcN  acetonitril 
Ahx  aminohexanacid 
Aib  α-Methylalanin 
β-Ala  β-Alanin 
Asc  ascorbate (Vitamin C) 
Asp  aspartate 
Aq.  aquoeus 
BE  binding energy (eV) 
Bead  Tenta-gel bead 
BHI  brain-heart-infusion serum/medium 
CR  chemically reduced 
Cys  cystein 
Disulfide bis 2-((4-pyridinylcarbonyl)oxy)ethyl disulfide 
DMAP N,N-Dimethylaminopyridin 
DMF  N,N-Dimethylformamide 
DMSO dimethylsulfoxid 
EC-GC electroncapture Gaschromatography 
EDAX  energydispersiv Röntgenanalysis 
ESI  Electron Spray Ionisation 
eq  equivalent 
EtOH  ethanol 
EtOAc  ethylacetat 
Et3N  eriethylamin 
Et2O  diethylether 
Fmoc  9-Fluorenylmethoxycarbonyl 
GC  gaschromatography 
Gly  glycin 
h  hour(s) 
HCTU O-(1H-6-chlorobenzotriazol-1-yl)1,1,3,3-tetramethyluronium 
hexafluorophosphat 
His  histidin 
HPLC  High Pressure Liquid Chromatography 
ica isogenic biofilm negative bacterial strains 
IMC Isothermal Microcalorimetry 
iso-TG  isonicotinic acid coupled tenta-gel beads 
u. v.  under vacuum 
J  coupling constant in Hertz 
kcal  kilocalorie 
LR  light reduction 
MeOH  methanol 
MHA  Müller-Hinton agar 
MHB  Müller-Hinton medium 
MHz  megahertz 
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min  minute(s) 
MRSA  methicilin-resistant Staphylococcus Aureus 
MRSE  methicilin-resistant Staphylococcus epidermidis  
MS  mass spectrometry 
m/z  mass/charge 
nm  nanometer 
NMR  Nuclear Magnetic Resonance 
NP  nanoparticle 
ppb  parts per billion 
ppm  parts per million 
quant.  quantitative 
rac  racemic 
RT  room temperature 
SAM  self assembled monolayer 
SEM  Scanning Electron Microscopy  
SM  synthetic medium 
StR  rough steel restorative implant material 
StPol  polished steel restorative implant material 
TFA  2,2,2- trifluoraceticacid 
TG, T-Gel  TentaGel-Resin    
THF  tetrahydrofuran 
TiR  rough titanium restorative implant material 
TiS  smooth titanium restorative implant material 
TRIS HCl tris(hydroxymethyl)amiomethan hydrochlorid 
turn  structure determinative Element 
Tyr  tyrosin 
UV-Vis ultraviolet-visible 
W  watt  
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5.1 
 
Equipments and materials 
5.1.1 Analytical  equipments 
 
1H-NMR Bruker Avance 400 (400 MHz), Bruker 500 DRX (500 MHz) 
Chemical shifts (δ) are given in ppm and refer to Tetramethylsilan as internal Standard (δTMS 
= 0.00 ppm) or the solvent signal of CDCl3 (δ = 7.26 ppm), d6-DMSO (δ = 2.50 ppm) or 
CD3OD (δ = 3.31 ppm). All spectra of 1D or 2D experiments were analysed (COSY, NOESY, 
TOCSY) and the coupling constants (J) are given in Hertz (Hz). The signals are indicated as 
follows: s = singlet, brs = broad singlet, d = doublet, brd = broad doublet, t = triplet, brt = 
broad triplet, q = quartet, quin = quintet, m = multiplet, ψ = pseudo. All the deutered solvents 
were purchased from Cambridge Isotope Laboratories. 
13C-NMR Bruker Avance 400 (101.1 MHz), Brucker 500 DRX (125.6 MHz) 
Chemical shifts (δ) are given in ppm and refer to the solvent signal of CDCl3 (δ = 77.1 ppm), 
d6-DMSO (δ = 39.5 ppm) er CD3OD (δ = 49.3 ppm). All spectra are 1H-coupled and assigned 
by 1D or 2D Experiments (DEPT, HMBC, HMQC). Quarternary C-Atoms are indicated as 
Cq. 
Mass spectroscopy Bruker Esquire 3000 plus, Finnigan MAT LCQ (octapol) 
The samples are 0.01 mg/mL or 0.1 mg/mL solutions in MeOH, CH2Cl2 or H2O and directly 
injected. The ion generation is made by electron spray ionisation (ESI). The values are given 
in atom mass per charge (m/z). 
Atomic Absorption Spectroscopy (AAS)  Shimadzu AA-6300 
For all silver measurements, a combined Au/Ag lamp was used. The measurements were 
carried without any background correction; a simple standard method was used for the silver 
concentration determination. The standard concentrations are varied from 0.1 ppm to 8 ppm. 
All of the solutions contain HNO3 to keep the silver ions in solution, the concentration of the 
acid depending on the sample. In all of the measurements, appropriate blank solutions are 
measured.     
Scanning Electron Microscopy (SEM) Philips ESEM XL 30 FEG and  Hitachi S– 4800  
All of the measurements were made in the Zentrum für Mikroskopie in Pharmazentrum, Basel 
by Gianni Morson, Marcel Düggelin, Daniel Mathys or Eva Bieler and in the Department für 
Geowissenschaften in Fribourg. The T-Gel samples were sputtered with 5 nm Pt or Au and 
measured at 5 kV. The images were measured in two different modes namely: contrast or 
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back-scattering modus depending on the sample. Some  EDAX spectra were taken with the 
same device.  
Powder diffractometer STOE STADI P automatic Diffractometer 
Powder diffraction for all samples was measured on a STOE STADI P automated 
diffractometer, with CuK source, graphite monochromator, by using quartz sample holders; 
for the pure reagents, 10-25 mg of substance were used. The program PowderCell 2.2[23d] 
was used for calculation of X-ray powder patterns based on the single crystal structure 
determinations. Experimental and calculated patterns were then compared.  
XPS Leybold EA 10N  
Equipped with an Mg Kα (1253.6eV) X-ray source and with an experimental resolution of 
0.8eV. The energy position of each spectrum was calibrated with reference to the 4f7/2 level of 
a clean gold sample (84.9eV). Mathematical analysis of the XPS data was done using the 
software UNIFIT. XPS measurements were carried out at the Physics department of Basel by 
Dr. Teresa de los Arcos. For the T-Gel measurements, we used a Si(110) surface, for the 
others the previously mentioned substrates.  
AFM PycoLE System 
Tapping mode AFM was performed, molecular imaging, with silicon nitride cantilevers, k ¼ 
42 N/m, at a force set point 3.8 V and a scan rate of 1 line 1/s. Different positions on the 
sample were monitored. All experiments were performed on dry sample at room temperature. 
Crystallography STOE IPDS-II diffractometer 
The measurement was done on a STOE IPDS-II diffractometer with monochromated graphite 
Mo Kα radiation, λ = 0.71073 Å, equipped with an Oxford Cryosystems open flow cryostat 
[199]. The structure was solved with the SIR 2004 program [200] and refined by full-matrix 
least-square on F2 with SHELX-97 [201]. The non-H atoms were refined anisotropically and 
the hydrogen atoms were simulated and refined. The different representations of the 
compound were drawn with the Diamond program using a Pov Ray representation. 
Microscope (reflexion) Leitz Aristomet, Leica optic (Dept. of Physics of Univ. Basle)  
Microscope (transmission) Olympus Microscope SXZ12,  
Microscope-Camera Olympus Camedia C-3000 Zoom 
Peptide Synthesizer Syro I MultiTech GmbH 
Isothermic Microcalorimetry       TAM III-48, Waters-TA Instruments, New Castle DE, 
USA, 48 parallel Channels. The measurements were carried out in the group of Prof. A.U. 
Daniels, LOB, University of Basel by Dr. Ueli von Ah and Dr. Olivier Braissant 
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5.1.2 Solvents and chemicals 
 
All of the used chemicals and solvents were purchased in the highest quality. The solvents 
used for the chromatography were previously distilled. The water (nanopure water) used for 
all of the experiments and measurements, was filtered through a Barnstead Ultrapure Water 
System. TentaGel-NH2-Resin was bought from RAPP Polymere GmbH Tübingen 
(Deutschland) and the Rink-Amid-Polystyrolresine from Novabiochem (Schweiz). The 
protected amino acids were purchased from Bachem AG (Schweiz) and Novabiochem 
(Schweiz). Coupling reagents, isonicotinic acid, AgNO3 and other chemicals (acids, NH3 etc.) 
were bought from Fluka, Acros or Bachem AG. 1000 ppm silver standard solution was 
purchased from Fluka and Acros, the Au(111) plates from Arrandee.   
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5.2 
 
Synthesis and chemical characterisation  
5.2.1 Ligand  
Isonicotinic acid (15 g, 0.122 mol) is stirred in SOCl2 (40 mL) in the presence of DMF (0.6 
mL) at 60°C for 12h. Excess thionyl chloride is removed in vacuo. Dried ethylene glycol (3.4 
mL, 0.061 mol) is added. After the evolution of hydrogen chloride ends, the mixture is heated 
at 150°C for a few hours. The mixture is dissolved in water, and NH4OH is added. After 
filtration, recrystallization in ethyl acetate gives white crystals of L. 
Yield 5,4 g (35%). Analysis calculated for C14H12N2O4: C 61.76, H 4.44, N 10.29; found: C 
61.12, H 4.52, N10.11%. 1H NMR (300MHz, CDCl3, 293 K):󲐀(ppm) 8.73 (4 H, m, H-pyr), 
7.82 (4H, m, H-pyr), 4.69 (4H, s, H-ethyl). 
5.2.2 Bis 2-((4-pyridinylcarbonyl)oxy)ethyl disulfide 
Synthesis: DCC (4.13 g, 20.02 mmol) was added to a concentrated solution of isonicotinic 
acid 2.24 g, 18.20 mmol), 2-hydroxyethyl disulfide (1.404 g, 9.10 mmol), and DMAP (0.22 g, 
1.82 mmol) in 20 mL of dichloromethane at 0 °C. After 1 h, the solution was allowed to warm 
to room temperature, and stirring was continued for 4 day. After removal of the precipitated 
dicyclohexylurea (DCU) by filtration, the product was recovered by extraction with CH2Cl2. 
After the CH2Cl2 extract was washed twice with water, it was dried with magnesium sulfate 
and then evaporated on the rotavap. The bis 2-((4-pyridinylcarbonyl)oxy)ethyl disulfide was 
obtained by evaporation under reduced pressure and recrystallization with ethanol. The 
product was dissolved in methylene chloride and chromatographed on silica gel with ethyl 
acetate. Yield: 0.56g (17%) M: 364.0558 (C16H16N2O4S2);  1H NMR (300MHz, CDCl3, 293 
K):󲐀(ppm) 8.80 (d, 4H), 7.87 (d, 4H), 4.68 (t, 4H), 3.13 (t, 4H) 
Elementary analysis calculated for (C16H16N2O4S2): C 52.73, H 4.43, N 7.69 and O 17.56, 
found: C 53.03 / 52.97 H 4.40 / 4.45 and N 7.54 / 7.58 %.   
 
The single crystal X-ray measurements: Crystals of the disulfide were measured at the 
University of Basle and Fribourg by Laurent Mirolo. Diffractometer is a STOE IPDS-II 
diffractometer with monochromated graphite Mo Kα radiation,  λ=0.71073 Å, equipped with 
an Oxford Cryosystems open flow cryostat [199] with an absorption correction by analytical 
integration [200] The structure was solved with direct methods and refined by full-matrix 
least-square on F2 with the SHELX-99 package [201]. 
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Table 5-1: 
A - Crystal data and structure refinement for disulfide.  
Empirical formula   C16 H16 N2 O4 S2  
Formula weight 364.43  
Temperature 200(2) K  
Wavelength 0.71073 Å  
Crystal system Monoclinic  
Space group P2(1)/c  
Unit cell dimensions a = 18.3640(4) Å  α = 90 ° 
 b = 10.9400(4) Å β = 99.887(4) ° 
 c = 8.5540(9) Å γ = 90 ° 
Volume 1692.99(19) Å3  
Z 4  
Density (calculated) 1.430 Mg/m3  
Absorption coefficient 0.337 mm-1  
F(000) 760  
Crystal size 0.23 x 0.19 x 0.11 mm3  
Theta range for data collection 2.18 to 26.75 ° 
Index ranges -23<=h<=22, 0<=k<=13, 0<=l<=10 
Reflections collected 13192  
Independent reflections 3580 / 3580 [R(int) = 0.0000] 
Completeness to theta = 26.75° 99.4 %  
Absorption correction None  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3580 / 0 / 217  
Goodness-of-fit on F2 0.918  
Final R indices [I>2sigma(I)] R1 = 0.0411, wR2 = 0.0868 
R indices (all data) R1 = 0.0643, wR2 = 0.0935 
Largest diff. peak and hole 0.256 and -0.355 e.Å-3 
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Table 5-2.  Atomic coordinates (x104) and equivalent isotropic displacement parameters (Å2x 
103) for disulfide. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y y U(eq) 
C(1) 3543(1) -170(2) -688(3) 45(1) 
C(2) 4072(1) 290(2) 507(2) 36(1) 
C(3) 4017(1) 1499(2) 933(2) 34(1) 
C(4) 3426(1) 2182(2) 166(3) 48(1) 
C(5) 2926(1) 1627(2) -1003(3) 57(1) 
C(6) 4585(1) 2105(2) 2146(2) 35(1) 
C(7) 5639(1) 1779(2) 4125(3) 38(1) 
C(8) 6043(1) 691(2) 4909(3) 41(1) 
C(9) 8075(1) 724(2) 4850(3) 43(1) 
C(10) 8223(1) -345(2) 5957(3) 45(1) 
C(11) 8682(1) -692(2) 8666(3) 38(1) 
C(12) 9528(1) -250(2) 12939(3) 47(1) 
C(13) 9205(1) -808(2) 11548(3) 44(1) 
C(14) 9022(1) -105(2) 10192(2) 35(1) 
C(15) 9167(1) 1140(2) 10307(3) 40(1) 
C(16) 9483(1) 1609(2) 11765(3) 48(1) 
N(1) 2976(1) 470(2) -1447(3) 54(1) 
N(2) 9671(1) 944(2) 13066(2) 49(1) 
O(1) 4630(1) 3190(2) 2365(2) 53(1) 
O(2) 5051(1) 1293(1) 2936(2) 41(1) 
O(3) 8510(1) -1755(2) 8539(2) 58(1) 
O(4) 8596(1) 105(1) 7472(2) 41(1) 
S(1) 6761(1) 1124(1) 6549(1) 42(1) 
S(2) 7541(1) 1966(1) 5520(1) 44(1) 
     
 
Table 5-3.  . Bond lengths [Å] and angles [°] for disulfide 
    
C(1)-N(1) 1.328(3) N(1)-C(1)-C(2) 124.3(2) 
C(1)-C(2) 1.379(3) C(3)-C(2)-C(1) 118.09(19) 
C(2)-C(3) 1.380(3) C(2)-C(3)-C(4) 118.59(19) 
C(3)-C(4) 1.387(3) C(2)-C(3)-C(6) 122.31(18) 
C(3)-C(6) 1.494(3) C(4)-C(3)-C(6) 119.06(19) 
C(4)-C(5) 1.378(3) C(5)-C(4)-C(3) 118.4(2) 
C(5)-N(1) 1.329(3) N(1)-C(5)-C(4) 123.8(2) 
C(6)-O(1) 1.202(3) O(1)-C(6)-O(2) 123.90(19) 
C(6)-O(2) 1.334(2) O(1)-C(6)-C(3) 124.59(19) 
C(7)-O(2) 1.451(2) O(2)-C(6)-C(3) 111.49(17) 
C(7)-C(8) 1.499(3) O(2)-C(7)-C(8) 105.96(17) 
C(8)-S(1) 1.815(2) C(7)-C(8)-S(1) 112.15(15) 
C(9)-C(10) 1.500(3) C(10)-C(9)-S(2) 115.56(16) 
C(9)-S(2) 1.825(2) O(4)-C(10)-C(9) 107.91(18) 
C(10)-O(4) 1.444(2) O(3)-C(11)-O(4) 124.6(2) 
C(11)-O(3) 1.205(3) O(3)-C(11)-C(14) 124.0(2) 
C(11)-O(4) 1.332(3) O(4)-C(11)-C(14) 111.43(18) 
C(11)-C(14) 1.493(3) N(2)-C(12)-C(13) 123.6(2) 
C(12)-N(2) 1.334(3) C(12)-C(13)-C(14) 118.9(2) 
C(12)-C(13) 1.378(3) C(13)-C(14)-C(15) 118.1(2) 
C(13)-C(14) 1.384(3) C(13)-C(14)-C(11) 119.9(2) 
C(14)-C(15) 1.388(3) C(15)-C(14)-C(11) 122.09(19) 
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C(15)-C(16) 1.380(3) C(16)-C(15)-C(14) 118.3(2) 
C(16)-N(2) 1.325(3) N(2)-C(16)-C(15) 124.3(2) 
S(1)-S(2) 2.0277(8) C(1)-N(1)-C(5) 116.7(2) 
  C(16)-N(2)-C(12) 116.7(2) 
  C(6)-O(2)-C(7) 116.52(16) 
  C(11)-O(4)-C(10) 116.15(17) 
  C(8)-S(1)-S(2) 104.88(8) 
    C(9)-S(2)-S(1) 104.78(8) 
 
Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+1,-z+2   #2 -x+1,-
y+1,-z+1   #3 -x,-y+1,-z+1 
 
Table 5-4. Anisotropic displacement parameters (Å2 x 103) for disulfid The anisotropic 
displacement factor exponent takes the form:  -2 π2 [ h2 a*2 U11 + ... + 2 h k a* b* U12 ]  
 
  U11 U22 U33 U23 U13 U12 
C(1) 51(1) 34(1) 46(1) -4(1) -1(1) -1(1) 
C(2) 38(1) 33(1) 38(1) 2(1) 5(1) 2(1) 
C(3) 33(1) 35(1) 33(1) 0(1) 4(1) 0(1) 
C(4) 48(1) 35(1) 55(1) -5(1) -5(1) 9(1) 
C(5) 48(1) 51(2) 63(2) -7(1) -15(1) 10(1) 
C(6) 33(1) 34(1) 37(1) 1(1) 7(1) 0(1) 
C(7) 32(1) 37(1) 42(1) -4(1) 1(1) -4(1) 
C(8) 34(1) 38(1) 48(1) 5(1) -1(1) -7(1) 
C(9) 35(1) 56(1) 38(1) -6(1) 1(1) 0(1) 
C(10) 42(1) 45(1) 43(1) -12(1) -5(1) 3(1) 
C(11) 34(1) 34(1) 45(1) -3(1) 1(1) 2(1) 
C(12) 48(1) 53(2) 40(1) 3(1) 3(1) 10(1) 
C(13) 45(1) 37(1) 48(1) 3(1) 5(1) 3(1) 
C(14) 27(1) 36(1) 41(1) -1(1) 5(1) 3(1) 
C(15) 42(1) 33(1) 44(1) 1(1) 5(1) 0(1) 
C(16) 52(1) 41(1) 50(1) -8(1) 5(1) -6(1) 
N(1) 52(1) 47(1) 53(1) -6(1) -13(1) 1(1) 
N(2) 48(1) 54(1) 44(1) -9(1) 0(1) 2(1) 
O(1) 52(1) 33(1) 66(1) -9(1) -9(1) 2(1) 
O(2) 36(1) 33(1) 49(1) 0(1) -8(1) -3(1) 
O(3) 74(1) 36(1) 59(1) -3(1) -6(1) -9(1) 
O(4) 41(1) 39(1) 39(1) -3(1) -5(1) -2(1) 
S(1) 34(1) 56(1) 35(1) 3(1) 3(1) -2(1) 
S(2) 33(1) 41(1) 57(1) 3(1) 4(1) -4(1) 
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Table 5-5.  Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2 x 103) 
for disulfide.  
  x y z U(eq) 
H(1) 3586 -981 -983 54 
H(2) 4455 -200 1012 43 
H(4) 3369 2996 434 57 
H(5) 2529 2088 -1511 68 
H(7A) 5436 2266 4895 45 
H(7B) 5969 2287 3632 45 
H(8A) 6264 242 4131 49 
H(8B) 5694 153 5297 49 
H(9A) 7813 431 3837 52 
H(9B) 8545 1050 4673 52 
H(10A) 7762 -737 6076 54 
H(10B) 8531 -940 5538 54 
H(12) 9654 -734 13839 57 
H(13) 9111 -1644 11520 52 
H(15) 9055 1646 9425 48 
H(16) 9569 2447 11839 57 
     
 
5.2.3 Ag coordination networks 
Synthesis of Adl7: Small crystals are obtained at room temperature, in the dark, after 1-2 days 
in a closed vessel from a mixture of 25ml 4mM AgNO3 in THF/EtOH 1/1 solution and 25ml 
4mM L THF/EtOH 1/1 solution. After 5 days, the crystals are filtered and washed with EtOH. 
Yield: 30 mg (68%). The crystallisation takes place also in different concentrations, starting at 
0.2mM complex concentration the crystal formation is reached. Depending on the 
concentration of the starting solution, the size of the crystals can be influenced.  
Synthesis of Adl3: Small crystals are obtained at room temperature from AcN/EtOH 1 to 1. 
The Adl7 crystals are completely dissolved in AcN/EtOH 1 to 1. After slow evaporation in 
the dark, Adl3 precipitates on a bottom of the recipient.   
Powder X-ray measurements: Since, only the crystalline structures are differing and only the 
powder X-ray spectra can serve as reliable information and identification of the compound. 
This technique is used routinely to identify the compounds. Some mg of the compound are 
put into the sample holder, and with continuously rotation, the sample is measured between 3 
to 80º theta. The time and the taken points of the measurement depend on the desired 
resolution. The spectra are then compared to the simulated powder spectra of the compounds 
obtained from the single crystal data. 
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Figure 5-1: Powder X-ray spectra of synthesized Adl3 and from the single crystal data 
simulated powder X-ray spectra of Adl3  
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Figure 5-2: Powder X-ray spectra of synthesized Adl7 and from the single crystal data 
simulated powder X-ray spectra of Adl7  
 
Dissolution studies: For the dissolution studies, the coordination polymer compounds were 
synthesized in a previously described way. AgCl was prepared freshly by precipitation of a 
mixture of molar equivalents of concentrated NaCl and AgNO3 aq. (nanopure water) 
solutions. The precipitate was dried and used for further experiments. 4-5mg of compound are 
weighed into small (5ml) vessels. 2ml of the medium are added on top, then the vessel is 
closed and shaken (5 sec sonication) and stored in the dark. The solution is removed and 
filtered on a 0.40µm disposable filter (Millipore, Millex GS, 0.40µm). To 0.5 ml of the 
filtrate, 0.5 ml 10%HNO3 solution is added and diluted to 10ml with water for the silver 
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determination by AAS. The precipitation was washed 3 times with EtOH, then dried in 
vacuum, and a powder spectrum is taken. 
Two biological media for microbiological assays are used for the dissolution tests. The 
Müller-Hinton medium was proposed by MUELLER and HINTON (1941) for testing the 
sensitivity of clinically important pathogens towards antibiotics or sulfonamides and is 
composed of beef infusion, casamino acids, and starch. (Typical Composition (g/litre): Meat 
infusion 2.0; casein hydrolysate 17.5; starch 1.5.) This medium mixed with agar is used for 
further microbiological assays. The synthetic medium is an artificial medium, used for 
bacterial growth inhibition tests of S.aureus; the exact composition is shown in Table 5-6. 
Table 5-6: The composition of the synthetic medium 
Synthetic Medium for S.aureus Newman 
Solution 1 
products g/L  (2x) Solution 2 products M 
Solution 3 
products 
% 
(w/v) 
Na2HPO4 3.54 citrate 1 glucose 20 
KH2PO4 2.72 (tri Na)   
Solution 6   
vitamins 
mM 
(1000x) 
MgSO4.7H2O 0.4 
Solution 5   amino 
acids g/100 mL (50x) cyanocobalamine 0.036 
NH4Cl 1 alanine 0.8 p-aminobenzoate 0.29 
NaCl 1 valine 0.8 biotin 0.04 
Solution 4   leucine 0.8 nicotinic acid 0.81 
products g/L (25x) isoleucine 0.8 
Ca-D-pantotheic 
ac. 0.21 
MOPS 
209.26 
pH 7.0 aspartate 0.8 
pyridoxamine 
hydrochloride 0.62 
Solution 7  trace 
elements 
mM 
(1000x) glutamate 0.8 
thiaminium 
dichloride 0.29 
ZnCl2 0.51 serine 0.8 riboflavin 0.26 
MnCl2 0.5 threonine 0.8 
Solution 8  
product mM 
H3BO3 0.097 cysteine 0.8 FeCl2 0.5 
CoCl2 1.46 arginine 0.8 in 2N HCl   
CuCl2 0.015 lysine 0.8 Solution 9    
NiCl2 0.1 proline 0.8 product  
NaMoO4 0.148 phenylalanine 0.8 NaOH 2N  
  tryptophane 0.8   
  histidine 0.8   
  glycine 8   
 
Light sensibility tests: The test based on the preliminary assay is described in [202] The Adl3 
and Adl7 are prepared as described previously. The other compounds were synthesized 
according to [93] Adl8 and Adl10 and [207] J11. 0.01 M solutions in CH3CN are prepared 
and filter paper (ø:3cm) was impregnated with the different solutions. The filter papers are 
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first dried in the dark and are then illuminated with a 15W electric lamp from a distance of 10 
cm. The colour change of the different filter papers is compared after 5h illumination.   
5.2.4 Peptide synthesis 
5.2.4.1 General procedures of the peptide synthesis 
Synthetic steps follow the same procedure according to the sections below. Peptides 
containing ACHC group and the isonicotinic acid coupled T-Gel are prepared manually, the 
others were prepared by the automatic peptide synthesizer.   
 
5.2.4.1.1 Manual peptide synthesis on solid support 
 
For the synthesis 200 mg TentaGel Resin (0.09 mmol, 1.0 eq) was used.  
Synthesis on TentaGel Resin 
A, Fmoc-aminoacid is coupled with an amino-functionalised TentaGel-Resin with HCTU. 
CH2Cl2 suspension of the T-Gel resin are mixed with an aminoacid (1.5–3 eq) solution and 
HCTU (3.0 eq) in 1 mL DMF in a Merryfield vessel and is shaken for 2 min. Then iPr2NEt 
(3.0–6.0 eq) is added and the mixture is shaken for 2h. After removing all the reactant, the 
resin is washed 3 times with CH2Cl2 and the degree of coupling is controlled with a Kaiser 
[204] or TNBS-Test [205]. 
B, After the aminoacid coupling, the Fmoc protecting group is removed: The resin is mixed 
with 20 % (v/v) piperidin in DMF and shaken for 2 min. Then, the piperidin solution is 
removed. The same solution is once more given to the resin and shaken again for 10 min. 
Finally, the resin is washed three times with DMF and five times with CH2Cl2, and the 
completeness of coupling is controlled with a Kaiser [204] or TNBS-Test [205]. 
C, After the deprotection, the free amines are acetylated: The resin is suspended in 5 ml 
CH2Cl2. The suspension is mixed with NEt3 (100 eq) and shaken for 2 min, than Ac2O (50 eq) 
is given to the mixture and shaken again for 1 h. After the removal of all the reactants the 
resin was 3 times washed with CH2Cl2 and the completeness of acetylation is controlled with 
a Kaiser [204] or TNBS-Test [205]. 
D, The side chain protecting groups of the T-Gel resin are cleaved: The resin is mixed with a 
mixture of 95 % TFA, 2.5 % TIS und 2.5 % H2O and shaken for 2 h. Than, the resin is 
washed three times with CH2Cl2, five times with 10 % Et3N in CH2Cl2 and ten times with 
CH2Cl2. 
For the synthesis, 200 mg Rink-amid resin (0.14 mmol, 1.0 eq) were used. 
Synthesis on Rink Amid Resin 
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A, Fmoc-aminoacid is coupled on an amino-functionalised Rink-amid resin with  HCTU. 
CH2Cl2 suspension of the Rink-amid resin are mixed with an aminoacid (1.5–3 eq) solution 
and HCTU (3.0 eq) in 1 mL DMF in a Merryfield vessel and is shaken for 2 min. Then 
iPr2NEt (3.0–6.0 eq) is added and the mixture is shaken for 2h. After removing all the 
reactants, the resin is washed 3 times with CH2Cl2 and the degree of coupling is controlled 
with a Kaiser [204] or TNBS-Test [205]. 
B, After the aminoacid coupling, the Fmoc protecting group is removed: The resin is mixed 
with 20 % (v/v) piperidin in DMF and shaken for 2 min. Then, the piperidin solution is 
removed. The same solution is once more given to the resin and shaken again for 10 min. 
Finally, the resin is washed three times with DMF and five times with CH2Cl2, and the level 
of the deprotection is controlled with a Kaiser [204] or TNBS-Test [205]. 
C, After the deprotection, the free amines are acetylated: The resin is suspended in 5 ml 
CH2Cl2.  The suspension is mixed with NEt3 (100 eq) and shaken for 2 min, then Ac2O (50 
eq) is given to the mixture and shaken again for 1 h. After the removal of all reactants, the 
resin was washed 3 times with CH2Cl2 and the degree of acetylation is controlled with a 
Kaiser [204] or TNBS-Test [205]. 
E, End up cleavage of the side chain protecting groups and the synthesized peptide from the 
Rink-Resin: The resin is mixed with a mixture of 95 % TFA, 2.5 % TIS und 2.5 % H2O and 
shaken for 2 h. Then, the resin is washed three times with CH2Cl2.  After that the solvent is 
removed and the oily product is washed several times with Et2O and precipitated. The white 
precipitation is dried.  
 
5.2.4.1.2 Peptide synthesis on solid support with automatic synthesizer 
The description of the automatic way of the synthesis concerns both resins (TentaGel and 
Rink Amid resin).   
A, Fmoc-Aminoacid coupling: The aminoacid (4 eq) and HCTU (4 eq) are dissolved in DMF 
(ca. 5 mL / g aminoacid) and mixed with an iPr2NEt (12 eq) in N-Methylpyrolidon (3 M) 
solution. The mixture is shaken for 1.5 h, then the reagent is removed from the resin and the 
resin is washed with DMF.  
B, Fmoc-Cleavage: The resin is mixed with 40 % (v/v) piperidin in DMF and shaken for 2 
min. After the solution is removed from the resin, it is shaken for 10 min with 20 % (v/v) 
piperidin in DMF. Then, the resin was washed five times with DMF.  
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C, Acetylation of the free amins: After the last deprotection the resin is suspended with 2 ml 
CH2Cl2 and first mixed with NEt3 (100 eq) then with Ac2O (50 eq) and the mixture is shaken 
for 1 h. All reagents are removed and the resin is washed five times with CH2Cl2.  
In the case of the synthesis on Rink amid resin, the last step is followed by the cleavage of the 
side chain protecting groups and the peptide from the resin. (step E)    
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5.2.4.2 Peptide synthesis for Nanoparticle generation 
 
The following Table 5-7 shows the quantity of the different amino acids and coupling 
reagents for the synthesized peptides. For the automatic synthesis 4.0 eq for the manual 3.0 eq 
of the substances is used.  
Table 5-7:  Quantity of the different amino acids and coupling reagents for the synthesized 
peptides  
 
TentaGel 
Substance Eq n 
[mmol] 
m 
[mg] 
V 
[mL] 
Fmoc-D/L-His(Trt)-OH 3.0 4.0 
0.26 
0.34 
159.9 
213.3 
 
Fmoc-trans-2-Aminocyclohexane acid rac 3.0 0.26 100.0  
Fmoc-trans-(R,R)-Aminocyclohexane acid 3.0 0.26 100.0  
Fmoc-trans-(S,S)-Aminocyclohexane acid 3.0 0.26 100.0  
Fmoc-L-Tyr(tBu)-OH 3.0 4.0 
0.26 
0.34 
120.0 
158.3 
 
Fmoc-D/L-Ser(tBu)-OH 3.0 4.0 
0.26 
0.34 
99.9 
131.9 
 
Fmoc-L-Pro-OH 4.0 0.34 116.1  
Fmoc-Aib-OH 4.0 0.34 111.9  
Fmoc-Gly-OH 4.0 0.34 102.3  
Fmoc-D/L-Asp(OtBu)-OH 3.0 4.0 
0.26 
0.34 
111.0 
141.6 
 
Fmoc-β-Ala-OH 3.0 4.0 
0.26 
0.34 
80.0 
107.1 
 
Fmoc-Ahx-OH 4.0 0.34 121.6  
Fmoc-L-Phe-OH 3.0 0.26 110.0  
Fmoc-L-Cys-OH 4.0 0.34 201.5  
Fmoc-L-Ala-OH 4.0 0.34 107.1  
Isonicotinicacid 3.0 0.34 31.8  
HCTU 3.0 4.0 
0.26 
0.34 
107.0 
142.3 
 
iPr2NEt 
6.0 
12.0 
0.52 
1.03 
 0.09 
0.18 
NEt3 100 8.6  1.20 
Ac2O 50 4.3  0.41 
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Rink 
Substance Eq n 
[mmol] 
m 
[mg] 
V 
[mL] 
Fmoc-D/L-His(Trt)-OH 3.0 4.0 
0.43 
0.57 
264.0 
353.2 
 
Fmoc-trans-2-Aminocyclohexane acid rac 3.0 0.43 155.5  
Fmoc-trans-(R,R)-Aminocyclohexane acid 4.0 0.43 155.5  
Fmoc-trans-(S,S)-Aminocyclohexane acid 4.0 0.43 155.5  
Fmoc-L-Tyr(tBu)-OH 3.0 4.0 
0.43 
0.57 
196.0 
261.9 
 
Fmoc-D/L-Ser(tBu)-OH 3.0 4.0 
0.43 
0.57 
163.0 
218.6 
 
Fmoc-L-Pro-OH 4.0 0.57 192.3  
Fmoc-Aib-OH 4.0 0.57 185.5  
Fmoc-Gly-OH 4.0 0.57 168.9  
Fmoc-D/L-Asp(OtBu)-OH 3.0 4.0 
0.43 
0.57 
175.0 
233.7 
 
Fmoc-β-Ala-OH 3.0 
4.0 
0.43 
0.57 
133.0 
176.8 
 
Fmoc-Ahx-OH 4.0 0.57 200.7  
Fmoc-L-Phe-OH 3.0 0.43 170.0  
Fmoc-L-Cys-OH 4.0 0.57 337.2  
Fmoc-L-Ala-OH 4.0 0.57 176.8  
HCTU 3.0 4.0 
0.43 
0.57 
176.0 
235.8 
 
iPr2NEt 
6.0 
12.0 
0.43 
1.70 
 0.15 
0.29 
NEt3 100 14.2  2.0 
Ac2O 50 7.1  0.67 
 
Isonicotinic acid TentaGel 
 
Synthesis on TentaGel: Isonicotinic acid is coupled on amino funcionalised TentaGel-Resin 
with HCTU:  
CH2Cl2 suspension of the T-Gel resin is mixed with isonicotinic acid (1.5–3 eq) solution and 
HCTU (3.0 eq) in 1 mL DMF in a Merryfield vessel and is shaken for 2 min. Then iPr2NEt 
(3.0–6.0 eq) is added and the mixture is shaken for 2h. After removing all of the reactants, the 
resin is washed 3 times with CH2Cl2 and dried. 
The following table (Table 5-8) shows the characteristics of the synthesised peptides:   
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Table 5-8: Characterisation of the synthesised tripeptide sequences 
Peptide  Structure MW (g/mol) Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-
His-rac-
ACHC-
L-Tyr-
NH-
TG/H  
92a/b 
 
 
C24H32N6O5 
484.24  
 
79.0 1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
8.76 (s, 1H, CHImi), 7.3 (s, 
1H, CHImi), 7.2 (s, 2H, 
CHImi), 7.05 (d, J = 8.6 
Hz, 2H, ArHTyr), 7.03 (d, J 
= 8.3 Hz, 2H, ArHTyr), 
6.68 (d, J = 8.3 Hz, 2H, 
ArHTyr), 6.62 (d, J = 8.6 
Hz, 2H, ArHTyr), 4.66 (dd, 
J = 8.1 Hz, 6.1Hz, 1H, 
CHα His) 4.55 (dd, J = 8.8 
Hz, 5.6 Hz, 2H, CHα His, 
CHα Tyr), 4.49 (dd, J = 9.8 
Hz, 4.8 Hz, 1H, CHα Tyr), 
3.99 (dt, J = 11.2 Hz, 4.3 
Hz, 1H, CHβ ACHC), 3.85 
(dt, J = 11.6 Hz, 4.8 Hz, 
1H, CHβ ACHC), 3.19 (dd, J 
= 15.4 Hz, 6.1 Hz, 1H, 
CH2β His), 3.06 (m, 3H, 
CH2β His), 2.96 (dd, J = 
15.2 Hz, 7.8 Hz, 1H, CH2β 
Tyr), 2.78 (m, 2H, CH2β 
Tyr), 2.69 (dd, J = 15.1 Hz, 
6.1 Hz, 1H, CH2β Tyr), 
2.26 (m, 2H, CHα ACHC), 
1.99 (s, 3H, CH3 Ac), 1.96 
(s, 3H, CH3 Ac), 1.88 (m, 
3H, CH2 ACHC), 1.71 (m, 
5H, CH2 ACHC), 1.33 (m, 
8H, CH2 ACHC); 
13C-NMR (100.6 MHz, 
CD3OD, 25°C): δ (ppm) 
= 
177.1/176.2/173.4/171.1
/170.9/168.5/ 165.7 
(CO), 157.4 (CAr-OH), 
134.8 (CHImi), 134.7 
(CHImi), 131.3 (CqImi), 
131.4 (CHAr Tyr), 131.2 
(CHAr Tyr), 130.5 (CqImi), 
129.6 (CqTyr), 128.9 
(CqTyr), 118.7 (CHImi), 
118.6 (CHImi), 116.2 
(CHAr Tyr), 55.5 (CHα 
Tyr), 53.7 (CHα Tyr), 53.1 
(CHα His), 51.9 (CHα 
His), 50.9 (CHα ACHC), 
50.5 (CHβ ACHC), 38.5 
(CH2β Tyr), 38.2 (CH2β 
Tyr), 33.5 (CH2 ACHC), 
31.3 (CH2 ACHC), 30.5 
(CH2 ACHC), 28.7 (CH2β 
His), 28.2 (CH2β His), 
26.0 (CH2 ACHC), 26.0 
(CH2 ACHC), 25.9 (CH2 
ACHC), 25.8 (CH2 ACHC), 
22.7 (CH3 Ac), 22.5 
(CH3 Ac); 
calculated
: 484.24; 
found: 
485.2 
[M+H]+. 
Ac-L-
His-rac-
ACHC-
L-Tyr-
NH-
TG/H 
 93a/ b 
 
 
C24H32N6O54
84.24  
 
53.0   
 
77% 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
8.76 (s, 1H, CHImi), 7.30 
(s, 1H, CHImi), 7.08 (dd, J 
= 8.3 Hz, 4.8 Hz, 4H, 
ArHTyr), 6.70 (dd, J = 8.3 
Hz, 4.5 Hz, 4H, ArHTyr), 
4.60 (m, 2H, CHα His) 4.55 
(dd, J = 9.3 Hz, 5.3 Hz, 
1H, CHα Tyr), 4.45 (dd, J = 
8.1 Hz, 6.6 Hz, 1H, CHα 
Tyr), 3.95 (dt, J = 11.3 Hz, 
3.5 Hz, 1H, CHβ ACHC), 
3.82 (dt, J = 11.6 Hz, 4.3 
Hz, 1H, CHβ ACHC), 3.14 
(dd, J = 15.2 Hz, 6.3 Hz, 
1H, CH2β His), 2.99 (m, 
4H, CH2β His, CH2β Tyr), 
2.81 (m, 2H, CH2β Tyr), 
2.32 (m, 1H, CHα ACHC), 
2.23 (m, 1H, CHα ACHC), 
1.96 (s, 3H, CH3 Ac), 1.88 
(s, 3H, CH3 Ac), 1.72 (m, 
6H, CH2 ACHC), 1.29 (m, 
8H, CH2 ACHC); 
13C-NMR (100.6 MHz, 
DMSO, 25°C): δ (ppm) 
= 
173.5/173.4/172.9/172.6
/169.2/169.1/ 
168.9/168.7 (CO), 155.6 
(CAr-OH), 133.7 
(CHImi), 133.5 (CHImi), 
132.7 (CqImi), 129.9 
(CHAr Tyr), 129.8 (CHAr 
Tyr), 129.1 (CqImi), 127.9 
(CqTyr), 127.8 (CqTyr), 
116.7 (CHImi), 114.7 
(CHAr Tyr), 54.8 (CHα 
Tyr), 54.2 (CHα Tyr), 53.6 
(CHα His), 51.9 (CHα 
His), 48.8 (CHα ACHC), 
48.5 (CH β ACHC), 36.9 
(CH2β Tyr), 36.6 (CH2β 
Tyr), 32.2 (CH2 ACHC), 
32.1 (CH2 ACHC), 30.6 
(CH2 ACHC), 29.4, (CH2 
ACHC), 28.7 (CH2β His), 
28.0 (CH2β His), 27.9 
(CH2 ACHC), 27.7 (CH2 
ACHC), 24.3 (CH2 ACHC), 
22.4 (CH3 Ac), 22.3 
(CH3 Ac); 
calculated
: 484.24;  
found: 
485.2 
[M+H]+. 
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Peptide  Structure MW (g/mol) Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-
Ser-rac-
ACHC-
L-Tyr-
NH-
TG/H 
 94a/b 
  
C21H30N4O6434.49  
 
38.0  
 
(62%) 
1H-NMR (400.0 
MHz, d6-DMSO, 25 
°C): δ (ppm) = 7.05 
(d, J = 7.1 Hz, 4H, 
ArHTyr), 6.67 (dd, J = 
8.6 Hz, 2.5 Hz, 4H, 
ArHTyr), 4.39 (s, 2H, 
CHα Tyr) 4.35 (dd, J = 
9.1 Hz, 5.1 Hz, 1H, 
CHα Ser), 4.24 (m, 
3H, CHα Ser, CHβ 
ACHC, CHβ ACHC), 3.51 
(m, 4H, CH2β Ser), 
2.92 (ddd, J = 13.3 
Hz, 7.1 Hz, 5.3 Hz, 
2H, CH2β Tyr), 2.71 
(m, 2H, CH2β Tyr), 
2.26 (dt, J = 11.1 Hz, 
3.6 Hz, 1H, CHα 
ACHC), 2.17 (dt, J = 
12.1 Hz, 3.6 Hz, 1H, 
CHα ACHC), 1.97 (s, 
3H, CH3 Ac), 1.89 (s, 
3H, CH3 Ac), 1.80 (m, 
2H, CH2 ACHC), 1.61 
(m, 6H, CH2 ACHC), 
1.20 (m, 8H, CH2 
ACHC); 
13C-NMR (100.6 MHz, 
d6-DMSO, 25°C): δ 
(ppm) = 
174.4/173.9/173.8/173.
7/170.8/170.6/ 
169.8/169.5 (CO), 
155.9 (CAr-OH), 130.6 
(CHAr Tyr), 130.4 (CHAr 
Tyr), 128.3 (CqTyr), 
115.2 (CHAr Tyr), 62.2 
(CH2β Ser), 62.0 (CH2β 
Ser), 55.7 (CHα Ser), 55.1 
(CHα Ser), 54.8 (CHα 
Tyr), 54.1 (CHα Tyr), 
50.1 (CHα ACHC), 49.8 
(CHα ACHC), 49.3 (CHβ 
ACHC), 48.6 (CHβ ACHC), 
37.0 (CH2β Tyr), 36.9 
(CH2β Tyr), 32.7 (CH2 
ACHC), 32.5 (CH2 ACHC), 
29.3 (CH2 ACHC), 24.8 
(CH2 ACHC), 24.7 (CH2 
ACHC), 23.0 (CH3 Ac), 
22.8 (CH3 Ac); 
 
calculated: 
434.49; 
found: 
457.2 
[M+Na]+. 
Ac-L-
Ser-rac-
ACHC-
L-Tyr-
NH-
TG/H  
95a/b 
  
C21H30N4O6 
 
434.49  
 
38.0  
 
(62%) 
1H-NMR (400.0 
MHz, D2O, 25°C): δ 
(ppm) = 7.12 (dd, J = 
8.3 Hz, 3.8 Hz, 4H, 
ArHTyr), 6.80 (dd, J = 
8.1 Hz, 6.1 Hz, 4H, 
ArHTyr), 4.57 (dd, J = 
8.8 Hz, 5.6 Hz, 1H, 
CHα Tyr) 4.45 (t, J = 
7.6 Hz, 1H, CHα Tyr), 
4.29 (m, 2H, CHα 
Ser), 3.88 (m, 1H, 
CHβ ACHC), 3.71 (m, 
5H, CHβ ACHC, CH2β 
Ser), 2.85 (m, 2H, 
CH2β Tyr), 2.28 (m, 
2H, CHα ACHC), 2.03 
(s, 3H, CH3 Ac), 1.98 
(s, 3H, CH3 Ac), 1.85 
(m, 2H, CH2 ACHC), 
1.74 (m, 5H, CH2 
ACHC), 1.29 (m, 9H, 
CH2 ACHC); 
 
13C-NMR (100.6 MHz, 
d6-DMSO, 25°C): δ 
(ppm) = 
173.3/172.8/172.7/169.
7/169.2/169.1/ 
169.0/168.9 (CO), 
155.6 (CAr-OH), 155.5 
(CAr-OH), 129.97 (CHAr 
Tyr), 129.93 (CHAr Tyr), 
127.9 (CqTyr), 127.8 
(CqTyr), 114.7 (CHAr 
Tyr), 114.6 (CHAr Tyr), 
64.8 (CH2β Ser), 61.8 
(CHα Ser), 54.8 (CHα 
Tyr), 49.1 (CHβ ACHC), 
48.8 (CHβ ACHC), 36.9 
(CH2β Tyr), 36.9 (CH2β 
Tyr), 36.9 (CH2β Tyr), 
33.6 (CH2 ACHC), 32.6 
(CH2 ACHC), 32.5 (CH2 
ACHC), 28.5 (CH2 ACHC), 
28.5 (CH2 ACHC), 24.32 
(CH2 ACHC), 24.31 (CH2 
ACHC), 22.5 (CH3 Ac), 
22.4 (CH3 Ac); 
calculated: 
434.49; 
found: 
457.9 
[M+Na]+. 
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Peptide  Structure MW 
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-L-
Tyr-rac-
ACHC-
D-Ser-
NH-
TG/H  
96a/b 
 
 
C21H30N4O
5 
 
434.49  
 
51.2  
 
(83%) 
1H-NMR (400.0 MHz, 
d6-DMSO, 25°C): δ 
(ppm) = 7.04 (dd, J = 
8.6 Hz, 6.3 Hz, 4H, 
ArHTyr), 6.68 (dd, J = 
8.6 Hz, 2.2 Hz, 4H, 
ArHTyr), 4.30 (s, 3H, 
CHα Tyr, CHα Ser), 4.14 
(m, 1H, CHα Ser), 3.66 
(m, 2H, CHβ ACHC), 
3.60 (m, 4H, CH2β Ser), 
2.87 (dd, J = 13.6 Hz, 
5.8 Hz, 1H, CH2β Tyr), 
2.78 (dd, J = 14.1 Hz, 
3.5 Hz 1H, CH2β Tyr), 
2.51 (m, 2H, CH2β Tyr), 
2.30 (m, 2H, CHα 
ACHC), 1.79 (2 s, 9H, 
CH3 Ac, CH3 Ac, CH2 
ACHC) 1.67 (m, 5H, 
CH2 ACHC), 1.41 (m, 
2H, CH2 ACHC), 1.20 
(m, 6H, CH2 ACHC); 
 
13C-NMR (100.6 MHz, 
d6-DMSO, 25°C): δ 
(ppm) = 
174.9/174.9/173.8/173.6/
171.8/171.4 (CO), 155.9 
(CAr-OH), 130.9 (CHAr 
Tyr), 128.9 (CqTyr), 115.7 
(CHAr Tyr), 62.2 (CH2β 
Ser), 62.1 (CH2β Ser), 55.7 
(CHα Ser), 55.1 (CHα Ser), 
54.8 (CHα Tyr), 54.5 
(CHα Tyr), 50.0 (CHα 
ACHC), 49.9 (CHα ACHC), 
49.9 (CHβ ACHC), 49.6 
(CHβ ACHC), 37.8 (CH2β 
Tyr), 37.6 (CH2β Tyr), 33.0 
(CH2 ACHC), 29.7 (CH2 
ACHC), 27.5 (CH2 ACHC), 
25.1 (CH2 ACHC), 24.9 
(CH2 ACHC), 24.4 (CH2 
ACHC), 24.1 (CH2 ACHC), 
23.9 (CH2 ACHC), 23.1 
(CH3 Ac), 22.9 (CH3 Ac); 
calculated: 
434.49; 
found: 
457.2 
[M+Na]+ 
(100), 
435.74 
[M+H]+ 
(50). 
Ac-D-
His-
ProAib-
L-Tyr-
NH-
TG/H 
97a/b 
 
 
C26H35N7O
6 
 
541.60  
 
76.1 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ 
(ppm) = 8.56 (s, 1H, 
CHImi), 7.28 (s, 1H, 
CHImi), 7.06 (d, J = 8.1 
Hz, 2H, ArHTyr), 6.70 
(d, J = 8.3 Hz, 2H, 
ArHTyr), 4.80 (t, J = 
6.7 Hz, 1H, CHα Pro), 
4.41 (dd, J = 9.6 Hz, 
4.8 Hz, 1H, CHα His), 
4.24 (t, J = 6.8 Hz, 1H, 
CHα Tyr), 3.49 (m, 2H, 
CH2δ Pro), 3.18 (dd, J = 
14.1 Hz, 4.5 Hz, 2H, 
CH2β His), 2.95 (m, 2H, 
CH2β Tyr), 2.17 (m, 1H, 
CH2β Pro), 1.99 (m, 1H, 
CH2β Pro), 1.91 (m, 5H, 
CH3 Ac, CH2γ Pro), 1.38 
(s, CH3 Aib), 1.27 (s, 
CH3 Aib); 
 
13C-NMR (100.6 MHz, 
CD3OD, 25°C): δ (ppm) 
= 
176.8/174.6/173.2/171.6 
(CO), 157.3 (CAr-OH), 
135.3 (CHImi), 131.8 
(CqImi), 131.3 (CqTyr), 
129.8 (CHAr), 118.6 
(CHImi), 116.2 (CHAr Tyr), 
62.9 (CHα Tyr), 58.2 
(CHα Pro), 56.6 (CHα His), 
52.8 (CqAib), 37.2 (CH2β 
Tyr), 30.3 (CH2δ Pro), 28.1 
(CH2β His), 26.2 (CH2β 
Pro), 25.9 (CH2γ Pro), 24.9 
(CH3 Aib), 24.6 (CH3 Aib), 
22.5 (CH3 Ac); 
calculated: 
541.60; 
found: 
542.2 
[M+H]+. 
Ac-L-
Ser-
ProAib-
L-Tyr-
NH-
TG/H  
98a/b 
 
 
C23H33N5O
7 
491.24  
 
77.1  
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ 
(ppm) = 7.10 (d, J = 
6.8 Hz, 2H, ArHTyr), 
6.70 (d, J = 6.3 Hz, 
2H, ArHTyr), 4.77 (t, J 
= 6.3 Hz, 1H, CHα 
Pro), 4.42 (m, 1H, CHα 
Ser), 4.24 (t, J = 6.1 Hz, 
1H, CHα Tyr), 3.85 (m, 
2H, CH2β Ser) 3.72 (t, J 
= 8.1 Hz, 1H, CH2δ 
Pro), 3.48 (m, 1H, CH2δ 
Pro), 3.25 (d, J = 14.1 
Hz, 1H, CH2β Tyr), 
2.93 (t, J = 12.0 Hz, 
1H, CH2β Tyr), 2.24 (m, 
1H, CH2β Pro), 1.99 (s, 
5H, CH3 Ac, CH2γ Pro), 
1.88 (m, 1H, CH2β Pro), 
1.35 (s, CH3 Aib), 1.17 
(s, CH3 Aib); 
13C-NMR (100.6 MHz, 
CD3OD, 25°C): δ (ppm) 
= 
176.9/176.8/174.5/173.4/
172.7 (CO), 157.3 (CAr-
OH), 131.3 (CqTyr), 
129.9 (CHAr), 116.2 
(CHAr Tyr), 63.0 (CH2β 
Ser), 62.8 (CHα Ser), 58.0 
(CHα Pro), 56.5 (CHα Tyr), 
54.5 (CqAib), 36.9 (CH2β 
Tyr), 30.4 (CH2δ Pro), 26.3 
(CH2β Pro), 25.9 (CH2γ 
Pro), 24.5 (CH3 Aib), 22.3 
(CH3 Ac); 
 
calculated: 
491.24; 
found: 
514.2 
[M+Na]+. 
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Peptide  Structure MW 
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-L-
Ser-
ProAib-
L-Ser-
NH-
TG/H 
99a/b 
  
C17H29N5O7 
 
415.21  
 
63.1 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
4.78 (t, J = 6.4 Hz, 1H, 
CHα Pro), 4.35 (t, J = 7.0 
Hz, 1H, CHα Ser), 4.29 (t, J 
= 4.0 Hz, 1H, CHα Ser), 
3.83 (m, 6H, CH2β Ser, 
CH2β Ser, CH2δ Pro), 2.29 
(m, 1H, CH2β Pro), 2.10 (m, 
2H, CH2β Pro, CH2γ Pro), 
2.00 (brs, 4H, CH3 Ac, 
CH2γ Pro), 1.48 (s, CH3 Aib), 
1.44 (s, CH3 Aib); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
176.9/175.3/174.7/1
73.4/172.6 (CO), 
63.1 (CH2β Ser), 62.9 
(CH2β Ser), 62.8 
(CHα Ser), 58.2 (CHα 
Ser), 57.7 (CHα Pro), 
54.6 (CqAib), 30.4 
(CH2δ Pro), 26.2 
(CH2β Pro), 26.0 
(CH2γ Pro), 25.1 
(CH3 Aib), 22.3 (CH3 
Ac); 
Calculated 
415.21; 
found: 
438.9 
[M+Na]+. 
Ac-L-
Tyr-L-
Tyr-NH-
TG/H 
100a/b 
 
 
C20H23N3O5 
 
385.16  
 
61.0  
 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
7.00 (dd, J = 11.3 Hz, 8.6 
Hz, 4 H, ArHTyr), 6.67 (dd, 
J = 8.3 Hz, 2.2 Hz, 4 H, 
ArHTyr), 4.48 (m, 2H, CHα 
Tyr), 3.03 (dd, J = 14.1 Hz, 
5.8 Hz, 1H, CH2β Tyr), 2.92 
(dd, J = 13.8 Hz, 6.0 Hz, 
1H, CH2β Tyr), 2.79 (dd, J = 
14.1 Hz, 8.6 Hz, 1H, CH2β 
Tyr), 2.70 (dd, J = 14.1 Hz, 
8.8 Hz, 1H, CH2β Tyr), 1.88 
(s, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
175.9/173.5/173.3 
(CO), 157.4 (CAr-
OH), 157.3 (CAr-
OH), 
131.5/131.3/129.1/1
29.0/116.2 (CHAr 
Tyr), 56.6/55.8 (CHα 
Tyr) 38.0/37.8 (CH2β 
Tyr), 22.4 (CH3 Ac). 
 
calculated: 
385.16; 
found: 
408.2 
[M+Na]+. 
Ac-L-
Tyr-Gly-
L-Tyr-
NH-
TG/H 
101a/b 
 
 
C22H26N4O6 
442.19  
 
53.0  
 (84%). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
7.08 (dd, J = 8.3 Hz, 3.8 
Hz, 4 H, ArHTyr), 6.75 (dd, 
J = 8.6 Hz, 2.2 Hz, 4 H, 
ArHTyr), 4.50 (dd, J = 8.6 
Hz, 5.1 Hz, 1H, CHα Tyr), 
4.43 (dd, J = 8.6 Hz, 6.6 
Hz, 1H, CHα Tyr), 3.89 (d, J 
= 16.9 Hz, 1H, CH2 Gly), 
3.66 (d, J = 16.9 Hz, 1H, 
CH2 Gly), 3.03 (m, 2H, 
CH2β Tyr), 2.83 (dd, J = 
13.8 Hz, 6.0 Hz, 2H, CH2β 
Tyr), 1.93 (s, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
176.5/174.9/174.3/1
71.6 (CO), 156.4 
(CAr-OH), 156.3 
(CAr-OH), 
131.4/131.3/129.3/1
29.1/116.3 (CHAr 
Tyr), 56.9/56.1 (CHα 
Tyr) 43.4 (CH2 Gly), 
37.6/37.4 (CH2β Tyr), 
22.6 (CH3 Ac); 
 
calculated: 
442.19; 
found: 
465.2 
[M+Na]+. 
Ac-D-
Asp-β-
Ala-D-
Asp-NH-
TG/H 
102a/b 
 
 
C13H20N4O8 
360.32  
 
61.1  
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
4.73 (dd, J = 7.8 Hz, 5.6 
Hz, 1H, CHα Asp), 4.66 (dd, 
J = 7.1 Hz, 5.8 Hz, 1H, 
CHα Asp), 3.50 (m, 1H, CH2 
β-Ala), 3.40 (m, 1H, CH2 β-
Ala), 2.78 (m, 4H, CH2β 
Asp), 2.43 (m, 1H, CH2 β-Ala), 
1.99 (s, 3H, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
174.1/174.1/173.3 
(CO), 51.4 (CHα 
Asp), 51.1 (CHα Asp), 
37.1 (CH2β Asp), 36.8 
(CH2 β-Ala), 36.6 
(CH2 β-Ala), 22.7 
(CH3 Ac); 
calculated: 
360.32; 
found: 
383.1 
[M+Na]+. 
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Peptide  Structure MW (g/mol) Yield  (mg) 1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-L-
Tyr-Pro-
Gly-L-
Tyr-Pro-
Gly-L-
Ser-NH-
TG/H 
103a/b 
 
 
C37H48N8O1 
780.34  
 
112.0 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 7.07 (m, 4H, ArHTyr), 
6.72 (m, 4H, ArHTyr), 
4.80 (m, 2H, CHα Pro), 
4.36 (m, 3H, CHα Tyr, 
CHα Tyr, CHα Ser), 3.84 
(m, 8H, CH2 Gly, CH2 Gly, 
CH2δ Pro, CH2δ Pro), 3.41 
(m, 2H, CH2β Ser), 3.03 
(m, 4H, CH2β Tyr, CH2β 
Tyr), 2.19 (m, 2H, CH2β 
Pro), 2.03 (m, 6H, CH2β 
Pro, CH2γ Pro), 1.87 (s, 3H, 
CH3 Ac); 
 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
177.3/175.1/174.8/1
73.0/172.9/172.8/ 
171.9/171.5 (CO), 
131.8 (CHAr), 131.6 
(CHAr), 128.9 
(CqAr), 128.8 (CqAr), 
116.6 (CHAr), 116.3 
(CHAr), 63.3 (CH2β 
Ser), 62.8 (CHα Pro), 
62.4 (CHα Pro), 57.2 
(CHα Ser), 54.7 
(CHα Tyr), 54.3 
(CHα Tyr), 44.1 (CH2 
Gly), 43.4 (CH2 Gly), 
37.5 (CH2β Tyr), 37.2 
(CH2β Tyr), 30.3 
(CH2δ Pro), 26.3 
(CH2β Pro), 26.2 
(CH2γ Pro), 22.3 
(CH3 Ac); 
calculated: 
780.34; 
found: 
781.3 
[M+H]+ 
(100), 
803.2 
[M+Na]+ 
(73). 
Ac-L-
His-L-
His-Pro-
Gly-D-
His-NH-
TG/H 
104a/b 
 
 
C27H36N12O6 
624.29  
 
88.0  
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.80 (s, 3H, CHImi), 
7.40 (s, 1H, CHImi), 7.32 
(s, 1H, CHImi), 7.21 (s, 
1H, CHImi), 4.89 (m, 1H, 
CHα Pro), 4.70 (dd, J = 
9.1 Hz, 4.8 Hz, 1H, CHα 
His), 4.66 (dd, J = 8.3 Hz, 
5.8 Hz, 1H, CHα His), 
4.38(t, J = 7.1 Hz, 1H, 
CHα His), 3.9 (d, J = 17.1 
Hz, 1H, CH2 Gly), 3.78 
(d, J = 17.1 Hz, 2H, CH2 
Gly, CH2δ Pro), 3.60 (m, 
1H, CH2δ Pro), 3.30-3.13 
(m, 6H, CH2β His), 2.28 
(m, 1H, CH2β Pro), 2.09 
(m, 1H, CH2β Pro), 1.97 
(m, 2H, CH2γ Pro), 1.94 
(s, 3H, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 25°C): 
δ (ppm) = 
175.5/174.5/173.6/172
.1/171.7/170.9 (CO), 
135.14/135.12/135.01 
(CqImi), 
131.3/131.1/130.3 
(CHImi), 
118.6/118.5/118.4 
(CHImi), 62.6 (CHα 
Pro), 53.6 (CHα His), 
53.3 (CHα His), 51.9 
(CHα His), 43.8 (CH2 
Gly), 30.5 (CH2δ Pro), 
28.0 (CH2β His), 27.7 
(CH2β His), 27.4 (CH2β 
His), 26.3 (CH2β Pro), 
26.1 (CH2γ Pro), 22.5 
(CH3 Ac); 
calculated
: 624.29; 
found: 
625.2 
[M+H]+. 
Ac-L-
Ser-Ahx-
L-Asp-
Ahx-D-
His-NH-
TG/H 
105a/b 
 
 
C27H44N8O9 
 
624.32  
 
113.0  
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.83 (s, 1H, CHImi), 
7.34 (s, 1H, CHImi), 4.75 
(dd, J = 8.8 Hz, 5.3 Hz, 
1H, CHα His), 4.67 (t, J = 
7.6 Hz, 1H, CHα Asp), 
4.37 (t, J = 5.3 Hz, 1H, 
CHα Ser), 3.76 (d, J = 5.0 
Hz, 1H, CH2β Ser), 3.19 
(m, 5H, NHCH2 Ahx, 
NHCH2 Ahx, CH2β Asp), 
3.05 (dd, J = 15.4 Hz, 
9.1 Hz, 1H, CH2β Asp), 
2.85 (dd, J = 16.6 Hz, 
5.8 Hz, 1H, CH2β His), 
2.69 (dd, J = 16.4 Hz, 
7.8 Hz, 1H, CH2β His), 
2.23 (m, 4H, CH2CO 
Ahx), 2.02 (s, 3H, CH3 Ac), 
1.62 (m, 2H, CH2 Ahx), 
1.50 (m, 6H, CH2 Ahx), 
1.34 (m, 2H, CH2 Ahx), 
1.23 (m, 2H, CH2 Ahx); 
13C-NMR (100.6 
MHz, CD3OD, 25°C): 
δ (ppm) = 
176.2/176.1/174.8/173
.6/169.0 (CO), 135.0 
(CqImi), 131.5 (CHImi), 
118.5 (CHImi), 63.1 
(CH2β Ser), 57.1 (CHα 
Ser), 52.9 (CHα His), 
51.8 (CHα Asp), 43.8 
(CH2 Gly), 40.3 
(NHCH2 Ahx), 36.7 
(CH2β Asp), 36.6 
(CH2CO Ahx), 29.9 
(CH2β His), 28.4/28.1 
(CH2β Ahx), 27.6/27.5 
(CH2 Ahx), 26.6/26.5 
(CH2 Ahx), 22.7 (CH3 
Ac); 
 
calculated
: 624.32; 
found: 
625.2 
[M+H]+. 
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Peptide  Structure MW (g/mol) Yield  (mg) 1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-
His-
(R,R)-
ACHC-
L-Tyr-
NH-
TG/H 
106a/b 
 
 
C24H32N6O54
84.24  
 
49.6  
 
(72%). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.74 (s, 1H, CHImi), 7.2 
(s, 1H, CHImi), 7.03 (d, J 
= 8.3 Hz, 2H, ArHTyr), 
6.62 (d, J = 8.3 Hz, 2H, 
ArHTyr), 4.55 (t, J = 5.8 
Hz, 1H, CHα His), 4.49 
(dd, J = 9.8 Hz, 5.0 Hz, 
1H, CHα Tyr), 3.99 (dt, J 
= 11.4 Hz, 4.3 Hz, 1H, 
CHβ ACHC), 3.09 (dd, J = 
15.1 Hz, 5.6 Hz, 1H, 
CH2β His), 3.03 (dd, J = 
14.1 Hz, 5.1 Hz, 1H, 
CH2β His), 2.75 (ddd, J = 
13.9 Hz, 9.8 Hz, 6.3 Hz, 
2H, CH2β Tyr), 2.24 (dt, J 
= 11.6 Hz, 3.0 Hz, 1H, 
CHα ACHC), 1.96 (s, 3H, 
CH3 Ac), 1.88 (m, 2H, 
CH2 ACHC), 1.75 (m, 2H, 
CH2 ACHC), 1.33 (m, 4H, 
CH2 ACHC); 
13C-NMR (100.6 
MHz, CD3OD, 25°C): 
δ (ppm) = 
177.1/175.7/173.1/170
.9/167.8 (CO), 157.4 
(CAr-OH), 134.7 
(CHImi), 131.3 (CHAr 
Tyr), 130.5 (Cq Imi), 
129.6 (CqTyr), 118.7 
(CHImi), 116.2 (CHAr 
Tyr), 53.1 (CHα Tyr), 
51.9 (CHα His), 51.1 
(CHα ACHC), 50.5 
(CHβ ACHC), 38.2 
(CH2β Tyr), 33.5 (CH2 
ACHC), 31.3 (CH2 
ACHC), 28.7 (CH2β His), 
26.08 (CH2 ACHC), 
26.02 (CH2 ACHC), 22.5 
(CH3 Ac); 
 
calculated
: 484.24; 
found: 
485.3 
[M+H]+. 
 
For the NMR Titration this Peptid was alone and also with 
AgNO3 in D2O measured  
1H-NMR (600 MHz, D2O, 25°C): δ 
(ppm) = 8.54 (d, J = 1.3 Hz, 1H, CHImi), 
8.23 (d, J = 7.5 Hz, 1H, NHTyr), 8.12 (d, 
J = 7.9 Hz, 1H, NHHis), 8.01 (d, J = 9.7 
Hz, 1H, NHACHC), 7.48 (s, 1H, NH2 Amid), 
7.08 (s, 2H, ArHTyr), 7.07 (s, 1H, NH2 
Amid), 7.04 (s, 1H, CHImi), 6.68 (d, J = 8.8 
Hz, 2H, ArHTyr), 4.43 (dq, J = 7.9 Hz, 
5.6 Hz, 1H, CHα His), 4.35 (ddd, J = 10.1 
Hz, 7.6 Hz, 5.1 Hz, 1H, CHα Tyr), 3.86 
(m, 1H, CHβ ACHC), 2.99 (dd, J = 14.7 
Hz, 5.1 Hz, 1H, CH2β Tyr), 2.86 (dd, J = 
16.2 Hz, 5.3 Hz, 1H, CH2β His), 2.79 (dd, 
J = 14.7 Hz, 10.1 Hz, 1H, CH2β Tyr), 
2.66 (dd, J = 16.2 Hz, 7.9 Hz, 1H, CH2β 
His), 2.31 (dt, J = 8.7 Hz, 3.7 Hz, 1H, 
CHα ACHC), 1.92 (s, 3H, CH3 Ac), 1.83 
(m, 1H, CH2ζ ACHC), 1.80 (m, 1H, CH2γ 
ACHC), 1.73 (m, 1H, CH2δ ACHC), 1.69 (m, 
2H, CH2ε ACHC), 1.35 (m, 1H, CH2ζ 
ACHC), 1.28 (m, 1H, CH2δ ACHC), 1.24 (m, 
1H, CH2ε ACHC), 1.22 (m, 1H, CH2γ 
ACHC); 
13C-NMR (150 MHz, 
D2O, 25°C): δ (ppm) = 
177.4 (COTyr), 176.4 
(COAmid), 174.1 
(COAc), 171.2 
(COACHC), 154.7 (CAr-
OH), 134.4 (CHImi), 
130.6 (CHAr Tyr), 129.7 
(CqImi), 128.8 (CqTyr), 
117.4 (CHImi), 115.6 
(CHAr Tyr), 55.9 (CHα 
Tyr), 52.7 (CHα His), 
50.1 (CHα ACHC), 49.8 
(CHβ ACHC), 36.5 
(CH2β Tyr), 31.9 (CH2γ 
ACHC), 29.7 (CH2ζ 
ACHC), 27.8 (CH2β His), 
24.4 (CH2δ ACHC, CH2ε 
ACHC), 21.9 (CH3 Ac); 
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Peptide  Structure MW 
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-
His-
(S,S)-
ACHC-
L-Tyr-
NH-
TG/H 
107a/b 
 
  
C24H32N6O
5 
 
484.24  
 
49.6  
 
(72%) 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
8.71 (s, 1H, CHImi), 7.3 (s, 
1H, CHImi), 7.05 (d, J = 
8.1 Hz, 2H, ArHTyr), 6.62 
(d, J = 8.3 Hz, 2H, 
ArHTyr), 4.66 (t, J = 6.6 
Hz, 1H, CHα His), 4.55 
(dd, J = 8.6 Hz, 6.1 Hz, 
1H, CHα Tyr), 3.85 (m, 
1H, CHβ ACHC), 3.19 (dd, 
J = 14.9 Hz, 5.3 Hz, 1H, 
CH2β His), 3.04 (dd, J = 
14.1 Hz, 5.8 Hz, 1H, 
CH2β Tyr), 2.96 (dd, J = 
14.9 Hz, 7.8 Hz, 1H, 
CH2β His), 2.80 (dd, J = 
13.9 Hz, 9.1 Hz, 1H, 
CH2β Tyr), 2.26 (m, 1H, 
CHα ACHC), 1.99 (s, 3H, 
CH3 Ac), 1.88 (m, 1H, CH2 
ACHC), 1.68 (m, 3H, CH2 
ACHC), 1.30 (m, 4H, CH2 
ACHC); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
177.1/176.2/173.5/
171.2/ (CO), 157.5 
(CAr-OH), 134.8 
(CHImi), 131.5 
(CqImi), 131.3 
(CHAr Tyr), 128.9 
(CqTyr), 118.6 
(CHImi), 116.2 
(CHAr Tyr), 55.5 
(CHα Tyr), 53.7 
(CHα His), 51.6 
(CHα ACHC), 50.9 
(CHβ ACHC), 38.5 
(CH2β Tyr), 33.2 
(CH2 ACHC), 30.5 
(CH2 ACHC), 28.3 
(CH2β His), 25.9 
(CH2 ACHC), 25.8 
(CH2 ACHC), 22.8 
(CH3 Ac); 
 
calculated
: 484.24; 
found: 
485.2 
[M+H]+. 
With the help of the NMR Titration in D2O we could the signals of the SS 
diastereomers from the mixed diastereomers distinguish as showed:  
1H-NMR (600 MHz, D2O, 
25°C): δ (ppm) = 8.56 (s, 
1H, CHImi), 8.24 (m, 1H, 
NHTyr), 8.07 (d, J = 8.1 
Hz, 1H, NHHis), 7.97 (d, J 
= 9.7 Hz, 1H, NHACHC), 
7.60 (s, 1H, NH2 Amid), 
7.22 (s, 1H, CHImi), 7.10 
(s, 2H, ArHTyr), 6.98 (s, 
1H, NH2 Amid), 6.80 (d, J = 
8.8 Hz, 2H, ArHTyr), 4.57 
(m, 1H, CHα Tyr), 4.48 (m, 
1H, CHα Tyr), 3.75 (m, 
1H, CHβ ACHC), 3.08 (m, 
1H, CH2β Tyr), 3.06 (m, 
1H, CH2β His), 2.96 (m, 
1H, CH2β His), 2.82 (m, 
1H, CH2β Tyr), 2.24 (m, 
1H, CHα ACHC), 1.93 (s, 
3H, CH3 Ac), 1.73 (m, 1H, 
CH2ε ACHC), 1.68 (m, 2H, 
CH2γ ACHC, CH2δ ACHC), 
1.53 (m, 1H, CH2ζ ACHC), 
1.24 (m, 1H, CH2δ ACHC), 
1.18 (m, 1H, CH2ζ ACHC), 
1.13 (m, 1H, CH2ε ACHC), 
1.09 (m, 1H, CH2γ ACHC). 
13C-NMR (150 
MHz, D2O, 25°C): 
δ (ppm) = 176.5 
(COTyr), 176.1 
(COAmid), 174.1 
(COAc), 171.2 
(COACHC), 154.6 
(CAr-OH), 134.4 
(CHImi), 130.9 
(CHAr Tyr), 130.0 
(CqImi), 128.6 
(CqTyr), 117.5 
(CHImi), 115.6 
(CHAr Tyr), 54.3 
(CHα Tyr), 53.5 
(CHα His), 49.9 
(CHβ ACHC), 49.8 
(CHα ACHC), 37.1 
(CH2β Tyr), 31.7 
(CH2γ ACHC), 29.4 
(CH2ζ ACHC), 27.8 
(CH2β His), 24.4 
(CH2δ ACHC, CH2ε 
ACHC), 21.9 (CH3 
Ac); 
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Peptide  Structure MW 
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-Ser-
(R,R)-
ACHC-L-
Tyr-NH-
TG/H 
108a/b 
 
 
C21H30N4O6 
 
434.49  
 
42.7   
 
(69%) 
1H-NMR (400.0 MHz, d6-
DMSO, 25°C): δ (ppm) = 
9.10 (s, 1H, OH), 7.78 (d, J = 
8.1 Hz, 1H, NH), 7.70 (d, J = 
8.8 Hz, 1H, NH), 7.67 (d, J = 
7.8 Hz, 1H, NH), 7.10 (s, 1H, 
NH), 6.97 (d, J = 8.3 Hz, 2H, 
ArHTyr), 6.62 (d, J = 8.1 Hz, 
2H, ArHTyr), 4.61 (m, 1H, 
CHα Tyr) 4.24 (m, 2H, CHα 
Ser, CHβ ACHC), 3.76 (m, 1H, 
CH2β Ser), 3.45 (m, 1H, CH2β 
Ser), 2.81 (m, 1H, CH2β Tyr), 
2.68 (m, 1H, CH2β Tyr), 2.20 
(m, 1H, CHα ACHC), 1.86 (s, 
3H, CH3 Ac), 1.78 (m, 1H, 
CH2 ACHC), 1.62 (m, 3H, CH2 
ACHC), 1.20 (m, 4H, CH2 
ACHC); 
13C-NMR (100.6 
MHz, d6-DMSO, 
25°C): δ (ppm) = 
172.9/172.8/169.5/
169.1 (CO), 155.5 
(CAr-OH), 129.9 
(CHAr Tyr), 127.9 
(CqTyr), 114.7 
(CHAr Tyr), 62.2 
(CH2β Ser), 55.2 
(CHα Ser), 54.8 
(CHα Tyr), 49.5 
(CHα ACHC), 48.8 
(CHβ ACHC), 36.8 
(CH2β Tyr), 32.3 
(CH2 ACHC), 31.5 
(CH2 ACHC), 28.7 
(CH2 ACHC), 24.4 
(CH2 ACHC), 22.3 
(CH3 Ac); 
 
calculated
: 434.49;  
found: 
457.2 
[M+Na]+. 
Ac-D-Ser-
(S,S)-
ACHC-L-
Tyr-NH-
TG/H 
109a/b 
 
 
C21H30N4O6 
 
434.49  
 
37.6  
 
(61%). 
1H-NMR (400.0 MHz, d6-
DMSO, 25°C): δ (ppm) = 
9.10 (s, 1H, OH), 7.78 (d, J = 
8.6 Hz, 1H, NH), 7.70 (d, J = 
8.1 Hz, 1H, NH), 7.67 (d, J = 
7.8 Hz, 1H, NH), 7.10 (s, 1H, 
NH), 6.98 (d, J = 8.3 Hz, 2H, 
ArHTyr), 6.63 (d, J = 8.1 Hz, 
2H, ArHTyr), 4.61 (m, 1H, 
CHα Tyr) 4.32 (m, 1H, CHα 
Ser), 4.24 (m, 1H, CHβ ACHC), 
3.56 (m, 1H, CH2β Ser), 3.45 
(m, 1H, CH2β Ser), 2.88 (dd, J 
= 13.9 Hz, 4.8 Hz, 1H, CH2β 
Tyr), 2.65 (dd, J = 13.6 Hz, 8.8 
Hz, 1H, CH2β Tyr), 2.26 (m, 
1H, CHα ACHC), 1.88 (s, 3H, 
CH3 Ac), 1.82 (m, 1H, CH2 
ACHC), 1.58 (m, 2H, CH2 
ACHC), 1.20 (m, 4H, CH2 
ACHC); 
13C-NMR (100.6 
MHz, d6-DMSO, 
25°C): δ (ppm) = 
173.4/173.1/169.3/
169.1 (CO), 155.6 
(CAr-OH), 129.8 
(CHAr Tyr), 127.6 
(CqTyr), 114.7 
(CHAr Tyr), 61.8 
(CH2β Ser), 54.5 
(CHα Ser), 53.6 
(CHα Tyr), 49.5 
(CHα ACHC), 47.8 
(CHβ ACHC), 36.6 
(CH2β Tyr), 32.0 
(CH2 ACHC), 30.5 
(CH2 ACHC), 28.5 
(CH2 ACHC), 24.1 
(CH2 ACHC), 22.7 
(CH3 Ac); 
 
calculated
: 434.49; 
found: 
457.2  
[M+Na]+. 
Ac-L-Tyr-
(R,R)-
ACHC-D-
Ser-NH-
TG/H 
110a/b 
 
 
C21H30N4O5 
 
434.49  
 
46.7  
 
(75%). 
1H-NMR (400.0 MHz, d6-
DMSO, 25°C): δ (ppm) = 
7.90 (d, J = 8.8 Hz, 1H, NH), 
7.60 (d, J = 8.1 Hz, 1H, NH), 
7.52 (d, J = 7.8 Hz, 1H, NH), 
7.22 (s, 1H, NH), 6.96 (d, J = 
8.3 Hz, 2H, ArHTyr), 6.62 (d, J 
= 8.3 Hz, 2H, ArHTyr), 4.30 
(m, 1H, CHα Tyr), 4.14 (m, 
1H, CHα Ser), 3.70 (m, 1H, 
CHβ ACHC), 3.60 (dd, J = 10.8 
Hz, 5.1 Hz, 1H, CH2β Ser), 
3.55 (dd, J = 10.8 Hz, 4.8 Hz, 
1H, CH2β Ser), 2.87 (dt, J = 8.6 
Hz, 5.3 Hz, 1H, CH2β Tyr), 
2.54 (m, 1H, CH2β Tyr), 2.29 
(m, 1H, CHα ACHC), 1.77 (s, 
5H, CH3 Ac, CH2 ACHC) 1.62 
(m, 2H, CH2 ACHC), 1.41 (m, 
1H, CH2 ACHC), 1.15 (m, 3H, 
CH2 ACHC); 
 
13C-NMR (100.6 
MHz, d6-DMSO, 
25°C): δ (ppm) = 
172.8/172.3/170.0/
168.9 (CO), 155.5 
(CAr-OH), 129.9 
(CHAr Tyr), 127.9 
(CqTyr), 114.7 
(CHAr Tyr), 61.5 
(CH2β Ser), 55.7 
(CHα Ser), 54.8 
(CHα Ser), 53.9 
(CHα Tyr), 49.1 
(CHα ACHC), 48.5 
(CHβ ACHC), 37.3 
(CH2β Tyr), 31.8 
(CH2 ACHC), 29.3 
(CH2 ACHC), 28.7 
(CH2 ACHC), 24.3 
(CH2 ACHC), 22.5 
(CH3 Ac); 
 
calculated
: 434.49; 
found: 
457.2 
[M+Na]+. 
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Peptide  Structure MW  
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-L-
Tyr-
(S,S)-
ACHC-
D-Ser-
NH-
TG/H 
111a/b 
 
 
C21H30N4O5 
 
434.49  
 
42.6 mg 
(69%). 
1H-NMR (400.0 MHz, 
d6-DMSO, 25°C): δ 
(ppm) = 7.89 (dd, J = 
8.6 Hz, 5.1 Hz, 1H, 
NH), 7.76 (dd, J = 12.1 
Hz, 8.6 Hz, 1H, NH), 
7.48 (d, J = 8.1 Hz, 1H, 
NH), 7.24 (s, 1H, NH), 
6.99 (t, J = 8.1 Hz, 2H, 
ArHTyr), 6.60 (d, J = 8.3 
Hz, 2H, ArHTyr), 4.30 
(m, 1H, CHα Tyr), 4.17 
(m, 1H, CHα Ser), 3.72 
(m, 1H, CHβ ACHC), 3.60 
(dd, J = 10.6 Hz, 5.1 Hz, 
1H, CH2β Ser), 3.46 (dd, 
J = 10.6 Hz, 5.6 Hz, 1H, 
CH2β Ser), 2.71 (m, 1H, 
CH2β Tyr), 2.51 (m, 1H, 
CH2β Tyr), 2.29 (m, 1H, 
CHα ACHC), 1.81 (m, 2H, 
CH2 ACHC), 1.72 (s, 3H, 
CH3 Ac), 1.64 (m, 2H, 
CH2 ACHC), 1.43 (m, 1H, 
CH2 ACHC), 1.20 (m, 3H, 
CH2 ACHC); 
 
13C-NMR (100.6 
MHz, d6-DMSO, 
25°C): δ (ppm) = 
173.4/172.8/172.0 
(CO), 155.5 (CAr-
OH), 129.9 (CHAr 
Tyr), 128.0 (CqTyr), 
114.6 (CHAr Tyr), 
64.8 (CH2β Ser), 
55.2 (CHα Ser), 
54.2 (CHα Ser), 
54.1 (CHα Tyr), 
49.2 (CHα ACHC), 
47.9 (CHβ ACHC), 
36.8 (CH2β Tyr), 
33.2 (CH2 ACHC), 
28.7 (CH2 ACHC), 
27.4 (CH2 ACHC), 
24.3 (CH2 ACHC), 
22.3 (CH3 Ac); 
 
berechnet: 
434.49; 
gefunden: 
457.2 
[M+Na]+. 
Ac-L-
His-Gly-
L-His-
NH-
TG/H 
112a/b 
 
 
C16H22N8O4 
 
390.40  
 
55.0 
(quant.) 
 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.81 (s, 2H, CHImi), 
7.37 (d, J = 10.8 Hz, 2H, 
CHImi), 4.72 (dd, J = 8.5 
Hz, 4.7 Hz, 1H, CHα 
His), 4.61 (t, J = 6.9 Hz, 
1H, CHα His), 3.89 (q, J 
= 16.7 Hz, 2H, CH2 Gly), 
3.31 (m, 2H, CH2β His), 
3.14 (dq, J = 15.4 Hz, 
8.5 Hz, 2H, CH2β His), 
1.98 (s, 3H, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
174.4/173.8/171.8 
(CO), 135.0/134.9 
(CqImi), 
131.1/131.0 
(CHImi), 
118.6/118.5 
(CHImi), 53.9 
(CHα His), 53.4 
(CHα His), 43.7 
(CH2 Gly), 27.9 
(CH2β His), 27.7 
(CH2β His), 22.6 
(CH3 Ac); 
calculated
: 390.40; 
found: 
391.3 
[M+H]+. 
Ac-D-
His-Pro-
Aib-L-
Asp-NH-
TG/H 
113a/b 
 
 
C21H31N7O7 
 
493.51  
 
70.0  
 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.80 (s, 1H, CHImi), 
7.39 (s, 1H, CHImi), 4.67 
(m, 2H, CHα Asp, CHα 
His), 4.28 (t, J = 7.3 Hz, 
1H, CHα Pro), 3.72 (m, 
1H, CH2δ Pro), 3.62 (m, 
1H, CH2δ Pro), 3.21 (dd, 
J = 15.1 Hz, 5.6 Hz, 1H, 
CH2β His), 3.06 (dd, J = 
15.4 Hz, 8.2 Hz, 1H, 
CH2β His), 2.95 (dd, J = 
16.7 Hz, 5.6 Hz, 1H, 
CH2β Asp), 2.81 (dd, J = 
16.7 Hz, 7.6 Hz, 1H, 
CH2β Asp), 2.26 (m, 1H, 
CH2β Pro), 2.10 (m, 1H, 
CH2β Pro), 1.97 (m, 5H, 
CH3 Ac, CH2γ Pro), 1.48 
(s, CH3 Aib), 1.45 (s, CH3 
Aib); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
176.8/175.8/174.7/
174.6/173.1/170.9 
(CO), 134.9 
(CHImi), 131.1 
(CqImi), 118.8 
(CHImi), 62.9 
(CHα Pro), 58.2 
(CHα His), 57.9 
(CHα Asp), 51.9 
(Cq Aib), 36.4 
(CH2β Asp), 30.6 
(CH2δ Pro), 27.8 
(CH2β His), 26.2 
(CH2β Pro), 25.6 
(CH2γ Pro), 25.6 
(CH3 Aib), 25.4 
(CH3 Aib), 22.4 
(CH3 Ac); 
 
calculated
: 493.51; 
found: 
494.2 
[M+H]+. 
 
5 Experimental part   
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Peptide  Structure MW 
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-
His-Gly-
D-Asp-
NH-
TG/H 
114a/b 
 
 
C14H20N6O
6 
 
368.35  
 
63.7  
 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
8.78 (s, 1H, CHImi), 7.38 (s, 
1H, CHImi), 4.76 (dd, J = 7.3 
Hz, 5.6 Hz, 1H, CHα His), 
4.70 (t, J = 6.1 Hz, 1H, CHα 
Asp), 3.92 (s, 2H, CH2 Gly), 
3.24  (dd, J = 16.6 Hz, 5.8 
Hz, 1H, CH2β His), 3.15 (dd, J 
= 14.9 Hz, 6.6 Hz, 1H, CH2β 
His), 2.87 (dd, J = 16.9 Hz, 5.3 
Hz, 2H, CH2β His, CH2β Asp), 
2.76 (dd, J = 16.9 Hz, 7.6 Hz, 
1H, CH2β Asp), 1.98 (s, 3H, 
CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
174.0/173.6/172.9
/171.8 (CO), 
135.1 (CHImi), 
130.8 (CqImi), 
118.8 (CHImi), 
53.7 (CHα His), 
51.2 (CHα Asp), 
43.6 (CH2 Gly), 
36.7 (CH2β Asp), 
28.0 (CH2β His), 
22.6 (CH3 Ac); 
 
calculated: 
368.35; 
found: 
369.1 
[M+H]+. 
Ac-L-
His-Pro-
Gly-D-
Asp-NH-
TG/H 
115a/b 
 
 
C19H27N7O
7:  
 
465.46  
 
67.2  
 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
8.79 (s, 1H, CHImi), 7.43 (s, 
1H, CHImi), 4.97 (t, J = 6.8 
Hz, 1H, CHα His), 4.80 (dd, J 
= 8.3 Hz, 5.6 Hz, 1H, CHα 
Asp), 4.35 (t, J = 7.1 Hz, 1H, 
CHα Pro), 4.05 (d, J = 16.6 
Hz, 1H, CH2 Gly), 3.83 (m, 
1H, CH2δ Pro), 3.77 (d, J = 
16.6 Hz, 1H, CH2 Gly), 3.50 
(m, 1H, CH2δ Pro), 3.20 (dd, J 
= 15.1 Hz, 6.8 Hz, 1H, CH2β 
His), 3.07 (dd, J = 15.1 Hz, 6.8 
Hz, 1H, CH2β His), 2.94 (dd, J 
= 16.9 Hz, 5.3 Hz, 1H, CH2β 
Asp), 2.83 (dd, J = 16.7 Hz, 
8.3 Hz, 1H, CH2β Asp), 2.25 
(m, 1H, CH2β Pro), 2.08 (m, 
1H, CH2β Pro), 1.97 (m, 5H, 
CH3 Ac, CH2γ Pro); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
175.7/174.1/173.1
/171.6/170.9 
(CO), 135.2 
(CHImi), 130.4 
(CqImi), 119.1 
(CHImi), 62.4 
(CHα Pro), 51.7 
(CHα His), 51.1 
(CHα Asp), 43.9 
(CH2 Gly), 36.7 
(CH2β Asp), 30.7 
(CH2δ Pro), 27.6 
(CH2β His), 26.3 
(CH2β Pro), 25.0 
(CH2γ Pro), 22.3 
(CH3 Ac); 
 
calculated: 
465.46; 
found: 
466.2 
[M+H]+. 
Ac-L-
Asp-β-
Ala-D-
His-NH-
TG/H 
116a/b 
 
 
C15H22N6O
6 
 
382.37  
 
54.0  
 
(quant.). 
 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
8.81 (s, 1H, CHImi), 7.34 (s, 
1H, CHImi), 4.71 (dd, J = 8.1 
Hz, 5.8 Hz, 1H, CHα His), 
4.61 (dd, J = 7.8 Hz, 6.3 Hz, 
1H, CHα Asp), 3.44 (m, 2H, 
CH2 β-Ala), 3.28 (dd, J = 15.4 
Hz, 5.6 Hz, 2H, CH2β Asp), 
3.07 (dd, J = 15.4 Hz, 8.1 Hz, 
2H, CH2β Asp), 2.80 (dd, J = 
16.6 Hz, 5.6 Hz, 2H, CH2β 
His), 2.68 (dd, J = 16.9 Hz, 7.8 
Hz, 2H, CH2β His), 2.41 (dt, J 
= 6.8 Hz, 2.2 Hz, 2H, CH2 β-
Ala), 1.99 (s, 3H, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
174.0/173.9/173.5
/173.3 (CO), 
134.9 (CqImi), 
131.4 (CHImi), 
118.5 (CHImi), 
53.2 (CHα His), 
51.6 (CHα Asp), 
36.9 (CH2 β-Ala), 
36.5 (CH2 β-Ala), 
28.0 (CH2β Ser), 
22.6 (CH3 Ac); 
 
calculated: 
382.37; 
found: 
383.2 
[M+H]+. 
 
5 Experimental part   
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Peptide  Structure MW 
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-
His-rac-
ACHC-
L-Phe-
NH-
TG/H 
117a/b 
 
  
C24H32N6O4 
 
468.55  
 
50.4  
 
(76%t) 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.75 (s, 1H, CHImi), 
7.21 (m, 7H, CHImi, 
ArHPhe), 4.63 (m, 2H, 
CHα His) 4.52 (m, 2H, 
CHα Phe), 3.97 (dt, J = 
11.1 Hz, 3.8 Hz, 1H, 
CHβ ACHC), 3.83 (dt, J = 
11.6 Hz, 3.8 Hz, 1H, 
CHβ ACHC), 3.19 (m, 4H, 
CH2β His), 2.96 (m, 3H, 
CH2β Tyr), 2.70 (dd, J = 
15.4 Hz, 6.3 Hz, 1H, 
CH2β Tyr), 2.26 (m, 2H, 
CHα ACHC), 1.99 (s, 3H, 
CH3 Ac), 1.95 (s, 3H, CH3 
Ac), 1.87 (m, 2H, CH2 
ACHC), 1.77 (m, 5H, CH2 
ACHC), 1.58 (m, 1H, CH2 
ACHC), 1.30 (m, 8H, CH2 
ACHC); 
 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
171.0 (CO), 138.8 
(CqPhe), 138.3 
(CqPhe), 134.8 
(CqImi), 130.3 
(CHImi), 129.5 (CHAr 
Phe), 127.9 (CHAr Phe), 
123.4 (CHAr Phe), 
118.8 (CHImi), 55.2 
(CHα Phe), 55.0 (CHα 
Phe), 53.1 (CHα His), 
52.9 (CHα His), 50.9 
(CHα ACHC), 50.5 
(CHβ ACHC), 38.9 
(CH2β Phe), 38.3 
(CH2β Phe), 33.5 
(CH2 ACHC), 33.1 
(CH2 ACHC), 31.2 
(CH2 ACHC), 30.5 
(CH2 ACHC), 28.7 
(CH2β His), 28.2 
(CH2β His), 26.0 (CH2 
ACHC), 25.9 (CH2 
ACHC), 22.8 (CH3 Ac), 
22.5 (CH3 Ac); 
calculated: 
468.55; 
found: 
469.3 
[M+H]+. 
Ac-D-
His-
Gly-L-
Tyr-
NH-
TG/H 
118a/b 
  
C19H24N6O5 
 
416.43  
 
63.7  
 
(quant.). 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.78 (s, 1H, CHImi), 
7.36 (s, 1H, CHImi), 7.07 
(d, J = 8.1 Hz, 2H, 
ArHTyr), 6.69 (d, J = 7.8 
Hz, 2H, ArHTyr), 4.63 (t, J 
= 6.3 Hz, 1H, CHα His), 
4.53 (dd, J = 9.6 Hz, 5.1 
Hz, 1H, CHα Tyr), 3.90 (d, 
J = 16.6 Hz, 2H, CH2 Gly), 
3.74 (d, J = 16.6 Hz, 2H, 
CH2 Gly), 3.24 (dd, J = 
14.9 Hz, 6.1 Hz, 1H, 
CH2β His), 3.11 (dd, J = 
15.4 Hz, 6.6 Hz, 2H, 
CH2β His, CH2β Tyr), 2.81 
(dd, J = 14.2 Hz, 9.6 Hz, 
1H, CH2β Tyr), 1.98 (s, 
3H, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
178.3/173.5/171.9 
(CO), 153.9 (CHAr-
OH), 135.0 (CHImi), 
131.3 (CqImi), 131.0 
(CqTyr), 130.8 (CHAr 
Tyr), 118.8 (CHImi), 
116.3 (CHAr Tyr), 56.4 
(CHα Tyr), 53.7 (CHα 
His), 45.6 (CH2 Gly), 
38.7 (CH2β Tyr), 28.0 
(CH2β His), 22.6 (CH3 
Ac); 
calculated: 
416.43; 
found: 
417.2 
[M+H]+. 
Ac-D-
His-L-
Tyr-
NH-
TG/H 
119a/b 
 
 
C17H21N5O4 
 
359.35  
 
50.0  
 
(quant.). 
 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) 
= 8.71 (s, 1H, CHImi), 
7.05 (d, J = 8.6 Hz, 3H, 
ArHTyr, CH Imi), 6.68 (d, J 
= 8.6 Hz, 2H, ArHTyr), 
4.60 (t, J = 6.3 Hz, 1H, 
CHα His), 4.54 (dd, J = 9.6 
Hz, 4.8 Hz, 1H, CHα Tyr), 
3.10 (m, 2H, CH2β His), 
2.89 (dd, J = 15.6 Hz, 7.3 
Hz, 2H, CH2β Tyr), 2.76 
(dd, J = 14.1 Hz, 9.8 Hz, 
2H, CH2β Tyr), 1.94 (s, 
3H, CH3 Ac); 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
173.5/171.9 (CO), 
157.4 (CHAr-OH), 
134.8 (CHImi), 131.3 
(CqImi), 129.3 
(CqTyr), 128.3 (CHAr 
Tyr), 118.3 (CHImi), 
116.3 (CHAr Tyr), 56.0 
(CHα Tyr), 53.7 (CHα 
His), 38.7 (CH2β Tyr), 
28.1 (CH2β His), 22.5 
(CH3 Ac); 
calculated: 
359.35; 
found: 
360.2 
[M+H]+. 
 
5 Experimental part   
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Peptide  Structure MW  
(g/mol) 
Yield  
(mg) 
1H-NMR 13C-NMR ESI-MS 
(m/z) 
Ac-D-
His-L-
His-NH-
TG/H 
120a/b 
 
C14H19N7O3 
 
333.35  
 
50.0  
 
(quan
t.). 
 
1H-NMR (400.0 MHz, 
CD3OD, 25°C): δ (ppm) = 
8.80 (s, 2H, CHImi), 7.34 
(d, J = 5.1 Hz, 2H, CHImi), 
4.70 (dd, J = 8.8 Hz, 5.4 
Hz, 1H, CHα His), 4.59 (dd, 
J = 8.5 Hz, 5.4 Hz, 1H, 
CHα His), 3.25 (m, 2H, 
CH2β His), 3.10 (dq, J = 8.8 
Hz, 6.3 Hz, 2H, CH2β His), 
1.96 (s, 3H, CH3 Ac); 
 
13C-NMR (100.6 
MHz, CD3OD, 
25°C): δ (ppm) = 
174.4/173.9/172.5 
(CO), 135.1/135.0 
(CqImi), 131.3/131.2 
(CHImi), 118.4/118.3 
(CHImi), 54.0 (CHα 
His), 53.4 (CHα His), 
27.9 (CH2β His), 27.5 
(CH2β His), 22.5 
(CH3 Ac); 
calculated: 
333.35; 
found: 
334.2 
[M+H]+. 
Ac-L-
Cys-Gly-
L-Ala-
NH-
TG/H 
121a/b 
 
 
C10H18N4O4S 
 
290.34  
 
40.0  
 
(quan
t.). 
 
1H-NMR (400.0 MHz, d6-
DMSO, 25°C): δ (ppm) = 
4.32 (dd, J = 7.3 Hz, 5.6 
Hz, 1H, CHα Cys), 4.17 (q, 
J = 7.2 Hz, 1H, CHα Ala), 
3.71 (d, J = 4.1 Hz, 2H, 
CH2 Gly), 2.77 (dd, J = 13.6 
Hz, 5.4 Hz, 1H, CH2β Cys), 
2.66 (dd, J = 13.6 Hz, 7.6 
Hz, 1H, CH2β Cys), 1.88 (s, 
3H, CH3 Ac), 1.20 (2s, 3H, 
CH3 Ala); 
13C-NMR (100.6 
MHz, d6-DMSO, 
25°C): δ (ppm) = 
174.0/170.3/169.7/1
68.1 (CO), 55.2 
(CHα Cys), 47.7 
(CHα Ala), 41.9 (CH2 
Gly), 25.7 (CH2β Cys), 
22.4 (CH3 Ac), 18.1 
(CH3 Ala); 
 
calculated: 
290.34; 
found: 
313.3 
[M+Na]+. 
Ac-L-
Asp-rac-
ACHC-
L-Tyr-
NH-
TG/H 
122a/b 
 
 
C22H30N4O 
 
462.50  
 
47.3  
 
(76%) 
1H-NMR (400.0 MHz, d6-
DMSO, 25°C): δ (ppm) = 
6.97 (d, J = 6.3 Hz, 4H, 
ArHTyr), 6.61 (d, J = 7.9 
Hz, 4H, ArHTyr), 4.50 (t, J 
= 6.6 Hz, 1H, CHα Tyr), 
4.44 (dd, J = 9.5 Hz, 3.8 
Hz, 1H, CHα Tyr), 4.32 (dd, 
J = 8.5 Hz, 4.7 Hz, 1H, 
CHα Asp), 4.26 (t, J = 7.2 
Hz, 1H, CHα Asp), 3.72 (dt, 
J = 11.0 Hz, 3.8 Hz, 1H, 
CHβ ACHC), 3.55 (dt, J = 
11.0 Hz, 3.8 Hz, 1H, CHβ 
ACHC), 2.92 (dd, J = 13.8 
Hz, 4.7 Hz, 1H, CH2β Tyr), 
2.77 (dd, J = 13.2 hz, 7.6 
Hz, 1H, CH2β Tyr), 2.64 (m, 
4H, CH2β Tyr, CH2β Asp), 
2.36 (m, 2H, CH2β Asp), 
2.20 (m, 2H, CHα ACHC), 
1.75 (brs, 7H, CH2 ACHC, 
CH3 Ac), 1.55 (m, 6H, CH2 
ACHC), 1.37 (m, 1H, CH2 
ACHC), 1.13 (m, 8H, CH2 
ACHC); 
13C-NMR (100.6 
MHz, d6-DMSO, 
25°C): δ (ppm) = 
172.6/172.5/171.6/1
71.5/169.6/169.0 
(CO), 155.5 (CAr-
OH), 130.0 (CHAr 
Tyr), 129.9 (CHAr Tyr), 
128.0 (CqTyr), 127.9 
(CqTyr), 114.8 (CHAr 
Tyr), 114.6 (CHAr Tyr), 
54.1 (CHα Tyr), 54.0 
(CHα Tyr), 53.5 
(CHα Asp), 53.4 
(CHα Asp), 49.4 
(CHα ACHC), 48.9 
(CHβ ACHC), 36.9 
(CH2β Tyr), 36.7 
(CH2β Tyr), 36.6 
(CH2β Asp), 36.3 
(CH2β Asp), 32.1 
(CH2 ACHC), 32.0 
(CH2 ACHC), 28.9 
(CH2 ACHC), 28.6 
(CH2 ACHC), 24.4 
(CH2 ACHC), 24.3 
(CH2 ACHC), 24.3 
(CH2 ACHC), 24.2 
(CH2 ACHC), 22.4 
(CH3 Ac), 22.3 (CH3 
Ac); 
calculated: 
462.50; 
found: 
575.7 
[M+TFA 
 
 
 
5 Experimental part   
Novel silver containing antimicrobial coatings for implant materials: new applications of Ag(I) coordination networks 180 
5.3 
5.3.1 Au(111) plates 
Coatings 
The substrate: The base material borosilicate glass: Borosilicate Glass thickness 0.7 +/- 0.1 
mm. The special glass substrate is well suited for the flame annealing procedure that is used 
to obtain Au(111) terraces. As adhesive layer, a thin, Chromium layer is applied to the glass 
surface: Chromium layer 2.5 +/- 1.5 nm. This layer guarantees optimal adhesion to the glass 
as well as to the subsequently deposited gold layer. A final gold layer is presented on top of 
the thin Chromium layer: Gold layer 250 +/- 50 nm, size 11x11 mm (surface:121mm2) 
Before the experiment, a flame annealing is necessary to obtain the Au(111) terraces. The 
flame annealing is made with a Bunsen burner. Caution: if the applied flame is too hot, the 
chromium layer can diffuse on a surface. As the flame annealing removes all impurities, there 
is no need for further cleaning. 
5.3.1.1 In situ crystallisation 
General sample preparation: The plates are treated one by one in a separate closed glass 
vessel (15ml). The flame annealed plates are immediately immersed after cooling down into a 
disulfide solution for pre-treatment. 0.182g bis 2-((4-pyridinylcarbonyl)oxy)ethyl disulfide 
(M: 364 g/mol) is dissolved in 100ml CH2Cl2/EtOH 1/1 solvent (5mM solution). 10 ml of this 
solution is used for 1 plate. The time of pre-treatment is 5 days. Then, the plate is removed 
and washed with EtOH and immediately put into the Ag(L1)NO3 (=Adl7) solution. The 
concentration and the treating time of the complex solution vary. In general, equal 
concentration of AgNO3 and L1 solution are prepared separately. Then, 5 ml of each solution 
is measured into the glass vessel over the gold plate, closed and placed in the dark for the 
determined treating time (from 3h to 14 days). Finally, the plates are removed, washed with 
EtOH, placed in a light protected desiccator and dried under vacuum over P2O5. The prepared 
samples are kept in the dark, in a closed, clean container, to avoid the light reduction of the 
product and the contamination of the surface. The concentrations and the treating times are 
changed depending on the aim of the experience. 
Example of 5pcs 2mM/3days samples: 91mg bis 2-((4-pyridinylcarbonyl)oxy)ethyl disulfide 
(M: 364 g/mol) are dissolved in 50ml CH2Cl2/EtOH 1/1 solvent (5mM solution). The flame 
annealed plates are placed one by one in a 15ml glass vessel and 10 ml of disulfide solution is 
measured. The vessels are closed and kept immobile for 5 days. Then the plates are removed, 
washed with EtOH and placed in a clean 15ml glass vessel. 16.67mg AgNO3 is dissolved in 
25ml EtOH/THF 1/1 solvent (4mM solution) and 26.6mg L1 is dissolved in 25ml EtOH/THF 
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1/1 solvent (4mM solution). 5 ml of each solution are measured into the glass vessel over the 
gold plate, mixed briefly, closed and placed in the dark for 3 days. Then the plates are 
removed from the solution, washed with EtOH and dried in a desiccator under vacuum over 
P2O5. 
Samples for AFM measurements: 1st sample (Fig.3.2-8): the pre-treatment was carried out as 
described in a general sample preparation. The gold plate was fixed vertically and immersed 
by half into the solution (1mM for the Adl7 compound), in a closed vessel and kept in dark. 
The solution was continuously stirred for 5 days to avoid big crystal formation. After 5 days, 
the plate was removed and washed with EtOH and dried under vacuum. For the second 
measurements (Fig.3.2-9-12) the samples were prepared in a general way, using 0.5mM/3h, 
0.25mM /7days treating conditions.   
Samples for XPS measurements: the following samples were prepared: sample2: 0,25mM/3h; 
sample3: 1mM/3d; sample 4: 2mM/3h. The last two samples were used in the dissolution test 
described later. sample5: 1mM/3d, 24h incubation in MHB for 24h; sample6: 1mM/3d, 24h 
incubation in SM. 
Powder X-ray spectra: The sample is prepared in a general way. After the disulfide pre-
treatment, the plate is treated with a 2mM Adl7 solution for 14days. These conditions are 
identical to the ones used for the dental implant materials. 
Samples for dissolution studies and Silver determination on a surface by AAS: 
In order to study how the loading of the surface changes with the concentration and the 
treating time, total screening was made changing the treating time from 3h to 7days and the 
concentration of the complex solution from 0.5mM to 2mM. The prepared samples are listed 
in Table 5-9. After the pre-treatment, the plates, one by one, were put into the 10ml solution 
and removed after the defined time, then washed and dried as previously described. One plate 
of each condition was kept for the SEM measurements. The others were used to determine the 
loading and to incubate them in different biological media. For the dissolution experiment the 
prepared coated substrates were put into a crystallisation plate (Combo plate, USA) each hole 
has a determined 2ml volume), one plate in every hole, then 2ml of synthetic medium or 
Müller-Hinton medium was layered on each plate, then closed. The plates were kept 
immobile in the dark for 24h. After this 24h incubation time, the substrates were removed, 
washed with EtOH dried and kept for the further experiments. From each substrate, the 
solution was removed filtered through 0.40 µm Millipore disposable filter. AAS measurement 
was carried out to determine the silver concentration of the media after the incubation.  
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 Table 5-9: Samples prepared for the test to study the time and concentration dependency of 
the loading and their dissolution in different media 
 
 Sample 
Starting 
conc  Treating incubated Ag ng  Ag ng  sum. ng Ag in sol 
 name 
Ad7 
(mM) 
 time 
(h) 
in 
medium on a surf. 
in the 
sol. surf+sol (ppm) 
I/1a 0.5 3 no 0.432 - 0.432   
I/1b 0.5 3 MHB 0.437 0.000 0.437 0.000 
I/1c 0.5 3 SM 0.336 0.000 0.336 0.000 
I/2a 0.5 24 no 0.985 - 0.985   
I/2b 0.5 24 MHB 0.884 0.000 0.884 0.000 
I/2c 0.5 24 SM 0.730 0.000 0.730 0.000 
I/3a 0.5 72 no 2.754 - 2.754   
I/3b 0.5 72 MHB 1.764 0.000 1.764 0.000 
I/3c 0.5 72 SM 1.687 0.000 1.687 0.000 
I/4a 0.5 168 no 3.778 - 3.778   
I/4b 0.5 168 MHB 3.345 0.000 3.345 0.000 
I/4c 0.5 168 SM 2.663 1.139 3.802 0.5697 
II/1a 1 3 no 2.176   2.176   
II/1b 1 3 MHB 0.364 0.000 0.364 0.000 
II/1c 1 3 SM 0.412 0.000 0.412 0.000 
II/2a 1 24 no 16.800 - 16.800   
II/2b 1 24 MHB 1.070 0.000 1.070 0.000 
II/2c 1 24 SM 0.812 2.058 2.870 1.029132 
II/3a 1 72 no 17.090 - 17.090   
II/3b 1 72 MHB 1.895 1.767 3.662 0.8835 
II/3c 1 72 SM 9.682 2.125 11.807 1.062745 
II/4a 1 168 no 37.400 - 37.400   
II/4b 1 168 MHB 3.588 2.282 5.870 1.1412 
II/4c 1 168 SM 2.195 2.114 4.309 1.057143 
III/1a 2 3 no 55.800   55.800   
III/1b 2 3 MHB 11.068 9.408 20.476 4.704202 
III/1c 2 3 SM 19.138 3.627 22.764 1.813445 
III/2a 2 24 no 135.150   135.150   
III/2b 2 24 MHB 64.000 6.182 70.182 3.090756 
III/2c 2 24 SM 30.675 3.492 34.167 1.746218 
III/3a 2 72 no 211.475   211.475   
III/3b 2 72 MHB 80.100 8.691 88.791 4.345658 
III/3c 2 72 SM 39.275 6.316 45.591 3.157983 
III/4a 2 168 no 234.175   234.175   
III/4b 2 168 MHB 80.575 6.047 86.622 3.023529 
III/4c 2 168 SM 68.325 2.551 70.876 1.27563 
 
For the AAS measurements, the external standard method is used. The following standard 
solutions are prepared: Stock solution 20ppm concentration: 1ml 1000ppm Fluka standard 
solution is diluted to 50ml with nanopure water. (Table 5-10) 
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Table 5-10: Standard solutions for the loading and dissolution experiments 
 Conc. (ppm) Stock solution (ml) 10% HNO3 added (ml) Solution volume (ml) 
Blank 0 0 0,5 50 
Standard1 0,1 0,5 1,0 100 
Standard2 0,2 0,5 0,5 50 
Standard3 0,4 1,0 0,5 50 
Standard4 0,8 2,0 0,5 50 
Standard5 1,6 4,0 0,5 50 
 
Figure 5-1: One example of the standard line 
   
 
 conc.real Abs 
stand1 0.1 0.0230 
stand2 0.2 0.0457 
stand3 0.40 0.0882 
stand4 0.80 0.1722 
stand5 1.60 0.3358 
   
 
The silver concentration of the sample solution should be in the region determined by the 
standard solutions. Therefore, the dilution might change sample-by-sample keeping the 
concentration in this region. 
AAS samples: 
Ag concentration of the mediums after the incubation: to 1ml of filtered solution, 0,5ml 10% 
HNO3 is added and diluted to 10 ml with water.  
Ag loading on a surface I-II series:  The Au plates were sonicated for 2 min with 1ml 20% 
HNO3 then the whole amount of solution is filled up to 10ml with nanopure water. 
Ag loading on a surface III series:  The Au plates were sonicated for 2 min with 1ml 20% 
HNO3 then the whole amount of solution was filled up to 25ml with nanopure water. 
The complete removal of the coating from the surface was controlled by SEM.  
After the measurements, the results are given in ppm. (The ppm for diluted aqueous solution 
can be converted to mg/l without making errors. Then the results, given in mg/l for Ag are 
calculated to mols.)  
The detailed parameters of the machine are found later in the Chapter 5.4.1. 
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5.3.1.2 Layer-by–layer method 
The alternating dip coating method is used. 20ml 2mM AgNO3 solution and 20ml 2mM L1 
solution in THF/EtOH were prepared in separate vessels. The pre-treated Au(111) plate was 
immersed into the AgNO3 solution first for 1min, then removed and washed with EtOH and 
immersed into the ligand solution for 1min, then removed and washed with EtOH, and put 
into the silver solution. The cycle AgNO3-washing-L1-washing was repeated 15 times. After 
the last washing, the gold plate is dried and kept under vacuum until further experiments. 
 
5.3.2 Ti and Au dental implant materials 
 
General sample preparation: 
The numbered gold and titanium implant material plates (13x13mm sizes, suitable for the 
flow-chamber experiment) have been polished in the Institut für Präventivzahnmedizin und 
Orale Mikrobiologie. The plates are polished in average after every 3rd measurement. Since 
the substrates are used several times, a cleaning process is used to remove all the organic and 
inorganic contaminations from the surface. 30 ml freshly prepared piranha solution (21ml 
ccH2SO4+9 ml ccH2O2) is used for 6-8 samples. After the acid removal, the surface is cleaned 
for 10 min in sonicator once with EtOH and three times with distillated water, then dried 
under vacuum, over P2O5. For the treatment, one plate is placed in 10 ml solution, to keep the 
surface solution ratios similar as in the case of the gold plates. The pre-treatment time is 7 
days. After the pre-treatment, the samples are washed one by one abundantly with EtOH and 
directly after are treated with the compound solution. The concentration of the (AgNO3+L1) 
solution is 2mM and treating time 14 days generally. In the Table 5-11, the different 
treatment methods are presented. 
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Table 5-11: Different treatment methods in order to optimize the surface coating for the 
dental implant materials 
 
After the cleaning procedure, one gold plate is immersed into the mixture of 5ml 4mM 
AgNO3 in EtOH/THF 1/1 solution and 5ml 4mM L1 in EtOH/THF 1/1 solution in a 15ml 
glass vessel. The closed vessel is kept in the dark for 14 days, then the plate is removed, 
washed with EtOH and dried under vacuum over P2O5. The ready plates are kept in the dark in 
a closed container until use. 
After the cleaning procedure, one titanium plate is immerged in 10 ml 5mM isonicotinic acid 
solution in EtOH/CH2Cl2. After 5 days, the plate is removed and washed with EtOH. The pre-
treated plate is put into a mixture of 5ml 4mM AgNO3 in EtOH/THF 1/1 solution and 5ml 
4mM L1 in EtOH/THF 1/1 solution in a 15ml glass vessel. The closed vessel is kept in the 
dark for 14 days, then the plate removed and washed with EtOH and dried under vacuum over 
P2O5. The ready plate is kept in the dark in a closed container until use. The plates were 
photographed under the microscope. 
Silver determination by AAS 
To determine the silver loading on a surface, the crystalline compound was removed from the 
surface with 2 ml 20% HNO3 aq solution. The acidic solution was filled up to 25ml with 
nanopure water, then this solution is diluted 20 times (1ml to 20ml with nanopure water). The 
prepared solution was measured by AAS. The methods and standards are described in Chapter 
5.3.1.1. 
To determine the silver concentration of the flow chamber liquid, the following conditions 
have been chosen: a flow chamber experiment with 4 samples in the chamber, 2 gold 
substrates (one treated with Ag, the other not (reference Au)) and two titanium ones (a treated 
with Ag, the other not (reference Ti)),. The treated surface was 2 times (14x14=)196 mm2. 
The chamber contained exactly 16.8 ml of suspension: Saliva/Buffer/Bacteries. 8 ml of this 
No. Substrate Name Chem. Treatment Notes 
1 Au Complete 
treatment 
Disulfide+AgNO3+Lig  
(1 mM) 
Spotted small cryst and 
inhomogeneous surface 
2 Au Crystals AgNO3+Lig (2 mM) Big crystals  
3 Au Crystals AgNO3+Lig (2 mM) Bigger cryst then 2 but less 
dense 
4 Au Heated 
crystals 
AgNO3+Lig (2 mM)→  
50 min in 200 °C 
Big crystals+small crystals  
2 Ti Less conc. 
Crystals  
AgNO3+Lig (1 mM) Inhomogeneous surface 
(similar then Au1)  
3 Ti Complete 
treatment 
II 
Isonicotinic acid+AgNO3+Lig 
(1 mM) 
Small spots, probably cryst, 
homogeneous surface 
4 Ti Crystals AgNO3+Lig (2 mM) Big crystals+small crystals 
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suspension was received in 4 Eppendorf tubes (contained 2ml of each). One part of the 
suspension, 4 ml, was measured without any filtration and dilution. A second part, 4 ml, of 
solution was measured after filtration, through a sterile filter: MILLEX GS 0.22μm form 
Millipore (used by the dental lab generally). For the measurements the following standard 
solutions were used: 
a., Standards 
AgNO3 stock solution: 100 ppm (5ml Standard certified solution AgNO3 from FLUKA 1000 
ppm to 50 ml Nanopure water), the 10% HNO3 solution is prepared from 66% fuming HNO3 
and diluted 7.6 ml cc acid was diluted to 50ml with nanopure water. 
 
Table 5-12: Standards for the silver concentration determination in the flow chamber liquid  
Standard  ml of AgNO3 ml of True value Abs Real conc. 
No stock sol. 10% HNO3 (ppm)   (ppm) 
Blank 0 1       
stand1 1 1 1 0.1296 0.8648 
stand2 2 1 2 0.2538 2.0185 
stand3 4 1 4 0.4868 4.1829 
stand4 6 1 6 0.688 6.0519 
stand5 8 1 8 0.885 7.8819 
 
All the standard solutions are filled up to 100 ml with nanopure water. 
b., Samples & Results 
The samples are measured concentrated, without dilution. The measurement of the 1st  
sample, without filtration gives an absorption 0.1618, which means 1.5 ppm concentration. 
During the measurement, the change of the abs. was high, meaning that the error of the 
measurement is higher than usual for this method. This variation comes probably from the 
inhomogeneity of the samples. The measurement of the 2nd sample, with filtration gives an 
absorption 0.030, which means 0.17 ppm concentration. The filtered sample was 
homogeneous and the variation of the absorbance was much lower. The flow-chamber 
contained exactly 16.8 ml of suspension, this amount of suspension contained 0.025 mg Ag, 
and from this amount, only 0.003 mg Ag was in the bacterial free solution. The loading of the 
gold and titanium dental implant substrates are determined in a same way described by the 
gold plates for the III series. 
5.3.3 Titanium and steel implant materials  
General sample preparation: 
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The samples are cleaned. First, the samples are sonicated for 10 min once in EtOH and three 
times in distilled water, then dried under vacuum, over P2O5. For the treatment, 5 disks or 
cylinders from the same material are treated together in 10 ml solution, to keep the surface/ 
solution ratios similar as in the case of the gold plates. The pre-treatment time varies between 
3 days and 8 days. After the pre-treatment, the samples are washed one by one abundantly 
with EtOH and treated directly with the Adl7 solution. The concentration of the (AgNO3+L1) 
solution varies between 0.5mM and 2mM depending on the experiment.   
Samples with different treating methods: 
To test the microbiological activity, samples were prepared with different treating methods 
(Table 5-13).  
 
Table 5-13: Different treatment methods in order to optimize the coating on various 
substrates, 1a : Steel rough cylinder; 1b : Steel smooth cylinder; 2a : Steel rough disks; 2b : 
Steel smooth disks; 3a : Ti rough cylinder; 4a : Ti rough disks; 4b : Ti smooth disks; 5 : Gold 
plate 
No. Method description 1a 1b 2a 2b 3a 4a 4b 5 
0 Cleaning x x x x x x x x 
1 Isonic. acid 5mM, 3 days+ Ladl/AgNO3 cryst, 
 2 mM, 10 days 
x x x x x x x  
2 Isonic. acid 5mM, ~8 days+ Ladl/AgNO3 
cryst, 1 mM, 20 days 
x x x x x x x  
3 Disulfide 5mM, ~8 days+ Ladl/AgNO3 cryst, 
1 mM, 20 days 
       x 
4 Ladl/AgNO3 cryst, 2 mM, 14 days x x x x x x x x 
5 Pyridine-4-boronic acid, ~8 days+ 
Ladl/AgNO3 cryst, 1 mM, 20 days 
x x x x x x x  
 
Based on the microbiological results new sets of samples were prepared, this time only for 
one treating method with 2mM complex concentration, with a large timescale window from 
3h to 10days of treatment, to optimize the treating time  
 
Table 5-14: Time dependence measurements for the method 4: Ladl/AgNO3 (Adl7) in-situ 
crystallization, 2 mM, 14 days 
No. Treating time 1a 1b 2a 2b 3a 4a 4b 
0 Cleaning x x x x x x x 
1 3 hours x x x x x x x 
2 7 hours x x x x x x x 
3 1 days x x x x x x x 
4 5 days x x x x x x x 
5 10 days x x x x x x x 
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5 samples per treating time, all of the materials were prepared and tested. For the dissolution 
tests and the silver determination on surface, new samples were prepared, listed in Table 5-
15. 
Table 5-15: Samples prepared for the 
dissolution tests of the restorative 
implant materials 
 
 
 
 
 
 
The loading is removed with 1ml 20% HNO3 solution with 2min sonication. The whole 
amount of solution washed out in a 10ml vessel and filled up with nanopure water and the 
silver concentration of this solution is determined by AAS. The previously described (in the 
chapter 5.3.1.1) silver standards are used and the sample solutions are further diluted on 
demand. The primary results are used for further calculations. The dissolution tests were 
carried out as previously described. One ml of the medium was removed after a 24h 
incubation and the silver concentration was determined.  
5.3.4 Coating on T-Gel resin  
 
The isonicotinic acid coupled and the His-ACHC-Tyr-TG T-gel resin were used to build up 
the coating on a surface. 37.4mg isonicotinic acid and 40.3mg tripeptide coupled resin were 
used for the in-situ crystallisation. The resins were immersed in 10ml 0.2mM complex 
solution (10ml 0.4mM AgNO3 and 10mm 0.4mM L1 solution in THF/EtOH were prepared 
and 5ml of each solutions were mixed in a 15 ml glass vessel) and kept closed in the dark for 
14 days. Then the resins were washed 3 times with EtOH, dried and kept in the dark and cold 
for the further experiments. For the layer-by-layer experiments, 30mg isonicotinic acid 
coupled T-gel were used. 10ml 2mM AgNO3 solution and 10ml 2mM L solution in 
THF/EtOH were prepared in separate vessels. The resin was transferred into a syringe closed 
with a PE filter, then the AgNO3 solution was layered onto. The syringe was shaken and the 
solution flows slowly through. Then the resin was washed with EtOH three times and the L 
solution layered upon the resin. After the solution has flown through, the resin was washed 
three times with EtOH and AgNO3 solution layered upon. This cycle AgNO3-washing-L was 
repeated twelve times and after the last washing, the resin was dried and kept in the dark and 
Sample Treatment Dissolution 
MHB SM 
TiR 1mM/3days x x 
 2mM/3days x x 
TiS 1mM/3days x x 
 2mM/3days x x 
StR 1mM/3days - - 
 2mM/3days - - 
StPol 1mM/3days - - 
 2mM/3days - - 
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cold for further experiments. The SEM measurements were carried out without any other 
treatment. 
The silver loadings of the resins are determined by AAS. The standard solutions (described in 
the chapter 5.3.1.1) are used. Ca. 2,5-3.0 mg T-gel resin are weighed. 1ml 20% HNO3 is 
added, sonicated for 2 min, then the total amount of solution is removed and filled up to 5ml 
with nanopure water. The 5ml solution is filtered, in order to remove the beads, and 1ml of 
the filtrate is diluted to 10ml with water. The silver concentration of the prepared solution is 
determined and the loading respectively calculated. 
     
5.4 
5.4.1 General method descriptions  
Molecular mechanism of Ag+ 
 
General description of the light reduction method:  
Around 30mg T-gel beads are weighed into a 3ml plastic vessel. Then, 2 ml 0.05M AgNO3 
solution (made with nanopure water) is measured and the closed vessel is sonicated for 15min 
in the dark. For some experiments, only 10mg T-gel beads are used. This quantity of beads is 
treated with 0.66ml 0.05M AgNO3 solution, to keep the Ag+/peptide ratio fixed around ten. 
The incubated T-gel beads are washed 5 times with 2.5ml nanopure water to remove all free 
Ag+. The last washing solution is almost completely removed and the wet beads are placed 
under the 15W electrical lamp from a 10cm distance. After 8h, the beads are removed, a photo 
is taken with the optical microscope, and the sample is dried under vacuum for further 
experiments.  
General description of the chemical reduction method: 
Around 30mg T-gel beads are weighed into a 3ml plastic vessel. Then, 2 ml 0.05M AgNO3 
solution (made with nanopure water) is measured and the closed vessel is sonicated for 15min 
in the dark. For some experiments, only 10mg T-gel beads are used. This quantity of beads is 
treated with 0.66ml 0.05M AgNO3 solution, to keep the Ag+/peptide ratio fixed around ten. 
The incubated T-gel beads are washed 5 times with 2.5ml nanopure water to remove all free 
Ag+. The last washing solution is almost completely removed and 3ml 0.05M sodium 
ascorbate solution (in nanopure water) is added to the wet beads. After 5-10min, the sodium 
ascorbate solution is removed and the reduced beads are washed 5 times with nanopure water. 
The wet beads are than photographed with the optical microscope and dried under vacuum for 
further experiments.  
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General description of the uptake measurements: 
The AAS method is developed to determine the silver uptake of the tripeptide coupled T-gel 
beads.  
a) Standards
 
: The standard solutions are different than during the previous experiments were 
used. Since concentration of the samples solutions are much higher the standard 
concentrations should be adjusted. The following standard solutions are prepared (Table 5-
16) from the AgNO3 stock solution: 100 ppm. 5ml Standard certified solution AgNO3 from 
FLUKA/ACROS 1000 ppm to 50 ml Nanopure water. 
Table 5-16: Standard solutions for silver uptake measurements 
Standard 
No. 
ml of the stock 
AgNO3 sol. 
ml HNO3 
10% 
Theoretical 
conc. ppm 
Blank 0 1 0 
Stand1 1 1 1 
Stand2 2 1 2 
Stand3 4 1 4 
Stand4 6 1 6 
Stand5 8 1 8 
All the standard solutions are filled up with Nanopure water to 100 ml. 
 
b., Samples
 
 Sample solutions are prepared from the remaining AgNO3 solution after the 
incubation of the T-gel beads. For the incubation, the same procedure is used as for the 
tripeptide treated for the light and chemical reduction methods. Exactly weighed ~ 10 mg 
tripeptide loaded T-Gel are measured into a plastic vessel and 0.66ml of the prepared ~0.05 M 
AgNO3 solution is added. After 15 min of sonication (keep the samples away from the direct 
light and shake it from time to time to avoid that the T-Gels stick together), the beads are 
decanted and 0.50 ml of the AgNO3 solution is removed above the beads and filled up to 50 
ml with Nanopure water (1st dilution). Then, 5 ml of this solution is removed, added to 1.0 ml 
of HNO3 10% in nanopure water solution and filled up to 100 ml with Nanopure water. The 
sample solutions are then measured and the silver concentration is determined and the uptake 
is calculated. In order to control the processes reference solutions are prepared. These 
solutions represent the 0 % uptake. The 0.05M AgNO3 solution, used for the incubation, is 
diluted in the same way as the sample solutions. The treating 0.05M AgNO3 solution is 
prepared from 0.423 g AgNO3 salt measured into 50 ml Nanopure water. It is important to 
prepare the silver nitrate solution freshly and use the same solution for the sample preparation 
and for the reference solutions. 
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AAS measurements parameters: 
Ag(328.1nm) Comment: Flame 
 
Instrument Information 
Device Name: AA-6300 
Type Model Name ROM Version S/N 
AA AA-6300 1.03 A30524300690 
ASC    
GFA    
 
Optics Parameters 
Element: Ag Slit Width(nm): 0.7 
Socket #: 6 Lamp Mode: NON-BGC 
Lamp Current Low(mA): 10 Peak(nm) : 327.94 
Wavelength(nm): 328.1   
  
Atomizer/Gas Flow Rate Setup 
Fuel Gas Flow Rate(L/min): 2.2 Burner Height(mm): 12 
Support Gas Flow Rate (L/min): 15.0 Burner Angle(degree): 0 
Flame Type: Air-C2H2   
 
Measurement Parameters 
Order: 1st Pre-Spray Time (sec): 3 
Zero Intercept: Non-Pass Integration Time (sec): 5 
Conc. Unit: ppm Response Time: 1 
Repetition Sequence: SM-M-M-...   
 
 Num 
Reps. 
Max 
Reps. 
RSD 
Limit 
SD Limit 
Blank 2 3 0.00 0.1000 
Standard 2 3 3.00 0.0000 
Sample 2 4 3.00 0.0000 
Reslope 2 3 3.00 0.0000 
 
Example 
BLK Average 
Abs. %RSD 
0.0001 282.84 
 
Calibration Curve (C# : 02) 
Abs=0.086310Conc+0.064320 
r=0.9970 
 
Conc(ppm) Abs 
2.0000 0.2158 
4.0000 0.4166 
6.0000 0.6097 
8.0000 0.7632 
10.0000 0.9056 
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5.4.2 Preliminary experiments with isonicotinate T-Gel beads  
 
The 1:1 mixture of the iso-TG – acet-TG and NH2-TG‒acet-TG is treated in the same way as 
described in the general procedure for the light reduction method.  
For the XPS measurements, iso-TG beads are prepared: light reduced, chemical reduced, 
silver nitrate treated and no treated iso-TG beads. The first two samples are prepared via 
general procedure. The AgNO3 treated samples are prepared in a following way: 30mg iso-
TG were incubated in 2ml 0.05M AgNO3 aq. solution for 15min. The silver excess was 
removed from the beads by washing 5x with nanopure water. Then the beads were dried 
under vacuum and kept away from light until further utilisation. For the XPS measurements, 
silicium wafers were used as substrate. The prepared T-gel beads were watered with nanopure 
water and placed onto the silicium wafer. The samples were then dried under vacuum and 
kept in the dark. During the XPS measurements, the samples were protected against the light. 
The samples were measured, at room temperature, in high vacuum and on different spots.    
 
5.4.3 Peptide Ag+ interactions 
5.4.3.1 Combinatorial assay  
 
Library synthesis [176] 
Splitting and encoding: Amino-functionalized Tentagel resin (2.1 g, 0.92 mmol, loading 0.44 
mmol/g) was split into seven equal portions of 300 mg (0.13 mmol) each and placed into 
fifteen 25 mL Merrifield shaking vessels. Each portion was then suspended in dry CH2Cl2 (5 
mL). 2 mol% of each tag were dissolved in 1 mL DMF and added into the fifteen reaction 
vessels together with HOBt (20 mg, 0.13 mmol, 1 eq. per tag) dissolved in DMF (0.5 mL). 
The mixtures were shaken for at least 5 min to ensure an equal distribution of the tags. After 
the addition of DIC (20 μL, 0.20 mmol, 1.5 eq. per tag) to each reaction vessel, the mixture 
was shaken immediately and the reaction allowed to proceed overnight. The fifteen portions 
of resin were then washed with DMF (3x) and with CH2Cl2 (3x). 
Decoding of tags: In order to check the success of the tag coupling, three beads from each of 
the fifteen vessels were isolated and placed into 25 μL micropipettes. The beads were washed 
with DMF (2x), then DMF (2.5 μL) was added and the micropipettes were sealed. The tag 
alcohols were released by photolysis using a UV lamp (366 nm, 15W) for 2 h and analyzed by 
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EC-GC. If EC-GC detection of the tags was successful, the resin was carried on to the amino 
acid coupling, if not, the tag coupling process was repeated. 
Coupling of the Amino Acids: The amino acid couplings and the Fmoc-deprotections were 
performed as described in the general protocol of peptide synthesis (chapter 5.2.4.1.). After 
drying the resin for at least 2 hours; the processes of splitting, encoding of the resin and 
coupling of each amino acid cycles were repeated using the protocols described above until 
the tripeptides were assembled. Finally, the N-termini were acetylated following the general 
protocol for acetylation. [2,194] 
 
Figure 5-2:  Tag molecules formula and amount used for each encoding step 
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Figure 5-3: Scheme of the encoding 
 
 
Combinatorial screening results: 
Approximately 10 mg of the library were suspended in a solution of AgNO3 (0.05 M, 660 μL, 
~6 equiv.), sonicated for 5 min and allowed to incubate for another 10 min. After washing 5x 
with deionized water (1 mL each), the beads were either irradiated with an electric lamp for 8 
h (light reduction assay) or incubated with a solution of sodium ascorbate (0.05 M, 660 μL, 
~6 eq.) for 5 min (chemical reduction assay) before washing with deionized water (5x). The 
combinatorial screening assays were evaluated using a light microscope, single beads were 
isolated and the peptide sequences analyzed. 
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Table 5-17: Consensus sequences of library 1 after light reduction 
Colour AA2 Linker AA1 No. of analyzed beads 
bearing this sequence 
Red 
D-His Achc L-Tyr 7 
L-His Achc L-Tyr 3 
D-His Pro-Aib L-Tyr 4 
D-His Pro-Gly L-Tyr 1 
L-Ser Achc L-Tyr 3 
D-Ser Achc L-Tyr 4 
L-Tyr Achc L-Tyr 2 
D-Ser Pro-Aib L-Tyr 1 
L-Ser Pro-Aib L-Tyr 2 
D-Ser Pro-Gly L-Tyr 1 
L-Tyr Achc D-Ser 5 
D-Ser Pro-Aib L-Ser 1 
L-Ser Pro-Aib L-Ser 1 
D-Ser Pro-Gly D-Ser 2 
L-Tyr Pro-Gly D-Ser 1 
L-His Pro-Gly D-Ser 1 
D-His Achc L-Ser 1 
D-His Achc L-Ser 1 
L-His Gly D-Ser 1 
D-His Ahx L-Ser 1 
L-His Gly L-Ser 1 
D-His Pro-Aib L-Ser 1 
D-Ser Pro-Aib L-His 2 
D-Ser Pro-Gly L-His 1 
D-Ser Pro-Gly D-His 1 
L-Ser β-Ala D-His 1 
L-Ser Gly L-His 1 
L-Tyr Achc L-His 1 
L-Tyr Pro-Aib D-His 2 
L-Tyr Pro-Gly D-His 1 
L-Tyr Ahx D-His 1 
L-His Gly L-His 1 
D-His β-Ala L-His 1 
L-His Gly D-His 1 
L-Ser Pro-Aib D-Asp 1 
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Table 5-18: Consensus sequences of library 1 after chemical reduction 
 
Colour AA2 Linker AA1 No. of analyzed beads bearing 
this sequence 
Dark 
orange 
Red 
D His Pro-Aib D Asp 1 
D His Pro-Aib L Asp 2 
L His - L Asp 1 
L His Achc D Asp 1 
D Asp Ahx D His 1 
D Asp Achc D His 1 
D Asp - L His 1 
D Asp Pro-Gly L His 1 
L Asp Pro-Aib L His 1 
L Asp Achc L His 1 
L Asp Ahx D His 1 
D His - D Ser 1 
L His Achc L Ser 1 
L Ser Gly L His 1 
L Ser Ahx D His 1 
L Ser Achc L His 1 
D Ser Ahx D His 1 
L His Ahx L Tyr 1 
L His Achc L Tyr 1 
L Tyr Achc D His 1 
L Tyr Gly D His 1 
L Tyr Ahx L His 1 
L Tyr Achc L Tyr 1 
D His Pro-Gly D His 1 
L His - D His 1 
D His β-Ala L His 1 
D His Gly L His 1 
D His Pro-Aib L His 1 
L His Gly D His 1 
L His Gly D His 1 
L His Achc D His 1 
Light 
orange 
Yellow 
L-Tyr Achc D-Ser 1 
L-Tyr Ahx D-Ser 1 
D Asp Pro-Aib D Asp 1 
D Asp Pro-Gly L Asp 1 
L Asp β-Ala D Asp 1 
L Asp Pro-Gly L Asp 1 
L Asp β-Ala L Asp 1 
L Asp Gly L Asp 1 
D Asp Pro-Gly L Ser 1 
L Asp Ahx D Ser 1 
D Ser Pro-Aib D Asp 1 
D Asp Pro-Gly D His 1 
D Asp - D His 1 
D His Ahx D Asp 1 
D Ser - D His 1 
D Ser - L His 1 
D His - L His 1 
L Tyr - D His 1 
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5.4.3.2 Silver nanoparticle generation on a surface  
 
The synthesised tripeptide sequences (the detailed parameters are presented in the Chapter 
5.2.4) are reduced by the previously described two methods. The reduced beads are 
photographed via the optical microscope and SEM measurements are carried out. The 
characterisation of the last group of the tripeptides is presented in the supplementary 
information of the [2]. In Table 5-19, the results of other synthesized tripeptide sequences are 
listed. 
 
Table 5-19: The results of the complementary tripetide sequences (not shown in the Chapter 
3) 
Peptides-NHTG 
Light reduction Chemical reduction Uptake 
mMAg/
mM pept Colour NP size (nm) Colour NP size (nm) 
AcDHis-SSturn-LTyr Red ~500nm aggr. D.red 1-300nm aggr. 0.63 
AcDHis-RRturn-LTyr Red 3-500 cryst. D.red 1-300nm aggr.. 0.44 
AcDSer-SSturn-LTyr L.orange 500 cryst.few Yellow 100nm few 0.30 
AcDSer-RRturn-LTyr L.orange 500 cryst.few Yellow 100nm few 0.57 
AcLTyr-SSturn-DSer Orange >1 µm isol.cryst. L.Yellow <100nm aggr. 0.33 
AcLTyr-RRturn-DSer Orange >1 µm isol.cryst. L.Yellow <100nm aggr. 0.15 
AcCys-Gly-Ala Colourless - D.yellow <30nm 0.36 
AcLAsp-turn-LTyr Colourless - Grey ~400nm aggr. 0.37 
AcDHis-turn-LPhe Violet 2-300nm D.violet 200nm agg 0.43 
AcLHis-ProGly-DAsp Colourless 2-300nm isol Orange 1-400nm aggr 0.64 
AcLAsp-βAla-DHis Colourless 2-300nm isol. D.yellow 1-200nm cov 0.59 
AcLSer-βAla-LHis Violet 1-200nm Braun 1-200nm cov 0.70 
 
 
Powder X-ray measurements were carried out on different chemically reduced beads. The 
light reduced beads did not contain enough crystalline particles to be detected with this 
method. The Fig.5-4,5 present all the performed powder X-ray spectra. 
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Figure 5-4: Powder X-ray spectra of the chemically reduced silver incubated beads with 
tripeptides: LAsp-ProGly-LAsp-NHTG, LAsp-βAla-LAsp-NHTG, DHis-Gly-LHis-NHTG, 
DHis-LTyr-NHTG, LHis-Gly-LHis-NHTG, DHis-LHis-NHTG    
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Powder X-ray spectra of the CR Ag+ treated tripeptides I.
 Cryst. Ag bulk
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In
t.
2θ
   
 
Figure 5-5: Powder X-ray spectra of the chemically reduced silver incubated beads with 
tripeptides: DHis-proAib-LTyr-NHTG, DHis-racAchc-LTyr-NHTG, DHis-RRAchc-LTyr-
NHTG, DHis-SSAchc-LTyr-NHTG  
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5.4.3.3 Complementary experiments of the solution phase tripeptides 
NMR titration of the AcDHis-Achc-LTyrNH2 TFA salt:  
The chemical shifts of the tripeptide signals with 700eq Ag+ excess: 
 Hε-His (180 ppb), NH-Tyr (67.4 ppb), NH-His (63.5 ppb), NH-Achc (97.2 ppb), NH2-
Terminus (-21.2/35.2 ppb), Hδ-His (-22.8 ppb), Hε-Tyr (-110 ppb), Hα-His (-64.1), 
Hα-Tyr (-9.7), H1-Achc (-41.4), H2-Aachc (-50.8), Acetyl (-30.7), Hδ-Tyr (-131 ppb), 
Hβ-Tyr (-24.0/ -77.1 ppb), Hβ-His (-28.1/ -81.7 ppb). 
 
Figure 5-6a,b: The NMR spectra of the AcDHis-Achc-LTyrNH2 tripeptide with different 
AgNO3 concentrations: 
a, 
b, 
The binding constant of the TFA salt of the tripeptide was calculated from the chemical shifts 
represented as a function of the silver concentration. (Fig.5-7).   
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Figure 5-7: Chemical shift- silver concentration curve 
for the binding constant calculation 
 
 
 
 
 
 
5.5 
5.5.1 Isothermal microcalorimetry experiments 
Biological assays 
For the IMC measurements, the following samples were used: 
Free compounds: Adl7, prepared in the previously described way (Chapter 5.2.3.) AgCl is 
filtered from the equimolar mixture of AgNO3 and NaCl aq. solution. 
Adl7 compound on polymer surface: the compounds are presented in the Chapter 5.3.4. All of 
the three compounds were tested. 
The peptide generated AgNPs tested by IMC are the LR,CR AcHis-Achc-Tyr-NHTG, LR iso-
TG, Ag+ incubated AcHis-Achc-Tyr-NHTG, LR iso-TG, no treated iso-TG, acetylated-TG. 
The preparation of these samples is presented in Chapters 5.2.4.and 5.4.1. The Ag+ incubated 
samples are prepared as the reduced beads, just the last redaction step is skipped.  
General sample preparation for the IMC measurements. The dried materials are weighed 
very exact because the weight of the sample is important to normalize the heat flow values or 
to compare the heat flow of the different weighed samples. The samples are weighed directly 
into the 3ml volume glass vessels, then the bacterial suspension (S.epidermidis) in BHI is 
added. The vessels are sealed and placed into the calorimeter. The vessels are shaken before 
the experiment in order to avoid the aggregation of the substrate. The measurements begin 
after 40 min equilibration time. During this time, the vessel takes on the surrounding 
temperature assured by the thermostat. Except for the free compound measurements, 1ml 
bacterial suspension is added to the sample. The free compounds are measured with 3ml 
suspension. Heat flow is measured as a function of the time. The experiment time was varied 
between 36h-72h. In some cases, the normalized heat flow value is presented, during the 
calculations, because it facilitates the interpretation. The normalized heat flow means that the 
heat flow value is corrected by the weight of the sample.  
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5.5.2 Flow chamber experiments 
 
The following samples were prepared to optimize the surface treatment method for the flow 
chamber experiments. 
  
Table 5-20: Gold alloy plates surface treatment methods to optimize the coating 
Treatment method Observations 
2,5 mM AgNO3:Ladl complex sol. EtOH/THF; there was a 
precipitation, but I heated it to 60°C and cooled it down 
slowly after putting the sample in the glass, for 2 weeks   
Nice crystals on the surface 
Complex crystals (adl7) were deposited on the cleaned Au 
surface and heated in the oven at 200°C for 1 h. 
Small black particles, can be 
removed easily. 
Disulfide (5mM in CH2Cl2/EtOH for 5 days) +[(AgL1)NO3] 1 
mM in EtOH/THF for 2 weeks 
Spotted small crystals and 
inhomogeneous surface 
[(AgL1)NO3] 2 mM in EtOH/THF for two weeks Big crystals 
2 mM [(AgL1)NO3] complex sol. EtOH/THF for 2 weeks, 
solution mixed normally without heating; nice crystals on the 
surface; plates are removed from the solution, washed and 
dried, put into the oven for 50 min in 200ºC 
Big and small dark crystals. 
 
Table 5-21: Titanium plates surface treatment methods to optimize the coating  
Treatment method Observations 
1,5 mM disulfid solution in EtOH/CH2Cl2 treated for 1.5 days Nothing can be observed 
1,5 mM AgNO3:Ladl complex sol. EtOH/THF for 1.5 days Crystals on the surface 
2,5 mM AgNO3:Ladl complex sol. EtOH/THF for 2 weeks, 
solution mixed normally without heating 
Nice crystals on the surface 
5 mM disulfide solution in EtOH/CH2Cl2 treated for 5 days 
08.-13.06.06 and put into a 1,5 mM AgNO3 and leave it in for 
7 days 
Crystals on the surface 
2,5 mM AgNO3:Ladl complex sol. EtOH/THF for 2 weeks, 
solution mixed normally without heating, nice crystals on the 
surface, plates are removed from the solution, washed and 
dried, put in the oven for 40 min in 200ºC 
Small metallic crystals on 
the surface 
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Table 5-21 continued: 
 
Treatment method Observations 
5 mM disulfide solution in EtOH/CH2Cl2 treated for 7 days 
02.-8.06.06 and 2,5 mM AgNO3:Ladl complex sol. EtOH/THF 
for 10 days, solution mixed normally without any  heating 
Nice crystals on the surface 
[(AgL1)NO3] 1 mM in EtOH/THF for two weeks Inhomogeneous surface  
Isonicotinic acid solution (5mM in CH2Cl2/EtOH for 5 days) 
+[(AgL1)NO3] 1 mM in EtOH/THF for 2 weeks 
Small spots, probably cryst, 
homogeneous surface 
Isonicotinic acid solution (5mM in CH2Cl2/EtOH for 5 days) 
+[(AgL1)NO3] 2 mM in EtOH/THF for 2 weeks 
Big crystals+small crystals 
  
All of these samples were tested in the flow chamber and after discussion of the results, the 
best sample preparation method was chosen. The further experiments were done on gold 
plates treated by 2 mM [(AgL1)NO3] in EtOH/THF for two weeks. The titanium plates were 
treated with isonicotinic acid solution (5mM in CH2Cl2/EtOH) for 5 days, then the plates are 
removed, washed with EtOH and treated with 2 mM (AgL1)NO3] in EtOH/THF for 2 weeks. 
 The prepared samples were placed in the flow chamber and the result evaluations were done 
in a previously described way (Chapter 3.3.1.3). For the SEM measurements, the removed 
gold and titanium plates were prepared as follows: the plates are treated with 2-4 % 
Glutaraldehyd for 2h in 20°C. Then these are washed twice with PBS for 1 min, then washed 
twice with H2O for 2-5 s and dried with different concentrations ethanol: 30%   50%   70%   
90%   2x100%   per 10 min, to remove all of the water. Then the plates are dried and 
sputtered with gold, or platinum. 
5.5.3 In vitro biological assays 
5.5.3.1 In vitro bacterial growth inhibition tests  
Au(111) plates 
General sample preparation is described in the previous chapter concerning the coatings. The 
following Au(111) plates were prepared, shown in Table 5-22. 
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Table 5-22: Different surface treatment methods to optimize the coating on Au(111) surface 
Samples Ag(L1)NO3 Treat.time Method Method description 
Adl7+AgNO3 
and  L1 control 
2mM 1h, 3h, 5h, 1d, 
3d, 7d, 14d 
1 The plate is placed into the 
mixture of the Ag(L1)NO3 for 
the determined time interval. 
Then removed, rinsed with 
EtOH and dried under 
vacuum. 
Adl7+AgNO3 
and  L1 control 
1mM 1h, 3h, 5h, 1d, 
3d, 7d, 14d 
1 
Adl7+AgNO3 
and  L1 control 
0.5mM 1h, 3h, 5h, 1d, 
3d, 7d, 14d 
1 
Adl7+AgNO3 
and  L1 control 
2mM 1h, 3h, 5h, 1d, 
3d, 7d, 14d 
2 5mM disulfide solution in 
CH2Cl2/EtOH for 10 days, the 
plate is removed, rinsed and 
placed into the mixture of the 
Ag(L1)NO3 for the 
determined time interval. 
Then removed, rinsed with 
EtOH and dried under 
vacuum. 
Adl7+AgNO3 
and  L1 control 
1mM 1h, 3h, 5h, 1d, 
3d, 7d, 14d 
2 
Adl7+AgNO3 
and  L1 control 
0.5mM 1h, 3h, 5h, 1d, 
3d, 7d, 14d 
2 
 
Silver determination in the inhibition zone
The inhibition zone is removed diluted with 1ml 10%HNO3 and 1ml nanopure water, and the 
suspension is heated until the complete dissolution. From the cooled solution, 1,0 ml is 
removed and diluted to 10ml with nanopure water. The remained solution is filtered through 
0,22 µm sterile single use filter (Millipore, Millex-GV, PVDF 0,22 µm) and 0,5ml filtered 
solution is diluted to 5ml with nanopure water. Parallel with the samples solution, control 
solutions were prepared in the same way than the samples using the agar, outside from the 
inhibition zone.  These samples, all, without any exception, showed zero silver concentration. 
(It means that the silver never diffused further than the inhibition zone.) The prepared 
solutions, samples and controls, were then measured by AAS (described previously). The 
standard solutions are:  
:  
 
stock solution: 40 ppm (2ml 1000ppm standard is 
diluted to 50ml)  
 
 
 
 
 
 
 conc.real 
x ml stock to      
100ml 
Blank 0 0 
stand1 0.2 0.5 
stand2 0.40 1.0 
stand3 0.80 2.0 
stand4 1.60 4.0 
stand5 4.00 10.0 
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The silver concentration in the inhibition zone is then calculated.  
 
Titanium and stainless steel substrates 
The general treatment method is described previously in Chapter 5.3.3  
 
Table 5-23: 1st General method development for titanium and steel restorative implant 
materials 
No. Method description 1a 1b 2a 2b 3a 4a 4b 5 
0 Cleaning x x x x x x x x 
1 Isonic. acid 5mM, 3 days+ Ladl/AgNO3 cryst, 
 2 mM, 10 days 
x x x x x x x  
2 Isonic. acid 5mM, ~8 days+ Ladl/AgNO3 
cryst, 1 mM, 20 days 
x x x x x x x  
3 Bisulfide 5mM, ~8 days+ Ladl/AgNO3 cryst, 1 
mM, 20 days 
       x 
4 Ladl/AgNO3 cryst, 2 mM, 14 days x x x x x x x x 
5 Pyridine-4-boronic acid, ~8 days+ 
Ladl/AgNO3 cryst, 1 mM, 20 days 
x x x x x x x  
1a : Steel rough cylinder; 1b : Steel smooth cylinder; 2a : Steel rough disks; 2b : Steel smooth 
disks; 3a : Ti rough cylinder; 4a : Ti rough disks; 4b : Ti smooth disks; 5 : Gold plate 
 
Table 5-24: Method development to optimize the crystallisation time for titanium and steel 
restorative implant materials 
Samples Ag(L1)NO3 Treat.time Substrate Material 
Adl7+AgNO3 
and  L1 control 
2mM 3h, 7h, 1d, 5d, 10d Ti rough disks Titanium 
Adl7+AgNO3 
and  L1 control 
2mM 3h, 7h, 1d, 5d, 10d Ti rough cylinder 
Adl7+AgNO3 
and  L1 control 
2mM 3h, 7h, 1d, 5d, 10d Ti smooth cylinder 
Adl7+AgNO3 
and  L1 control 
2mM 3h, 7h, 1d, 5d, 10d Steel polished disk Stainless 
steel Adl7+AgNO3 
and  L1 control 
2mM 3h, 7h, 1d, 5d, 10d Steel rough disk 
Adl7+AgNO3 
and  L1 control 
2mM 3h, 7h, 1d, 5d, 10d Steel polished cylinder 
Adl7+AgNO3 
and  L1 control 
2mM 3h, 7h, 1d, 5d, 10d Steel rough cylinder 
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5.5.3.2 In vivo assays 
Coating of the Ti cages for in vivo experiments  
(Regine Landmann’s group)  
 
d: 10mm; l:30mm surface: 2041 mm2  
The cages (13pcs) are cleaned: 1x15min sonication with EtOH, 3x15min sonication with 
nanopure water, then dried in desiccator over P2O5 under vacuum. Half of the cages are used 
as control sample: these are used without any coating. The other cages (7pcs) are placed into a 
24 ml solution (in a 25ml glass container) of a 1 to 1 mixture of 2mM AgNO3 in THF/EtOH 
and 2mM Ladl in THF/EtOH for 3 days in the dark. The cages are removed and washed with 
EtOH and  dried over P2O5 under vacuum and delivered on the next day. (On the surface of 
the cages, there are only some small crystals.) 
 
Silver loading determination by AAS
a, Silver concentration of the tissue cage fluid measured by AAS 
  
b, On the surface of the cages before and after in vivo experiment 
a, For the silver determination, the whole quantity of the removed tissue cage fluid has been 
diluted to 5ml using 100µl 10% HNO3. The acid is given to the almost completely diluted 
solution to avoid the precipitation of the peptides. The solution is then measured by AAS 
using standard solutions between 0,1-3,2 ppm (described previously). The silver 
concentration is then calculated. The results are shown on Fig.5-7a,b. 
 
Figure 5-7a,b: Silver concentration of the tissue cage fluid, after 2,5,9 and 14 days the 
implantation. 
a,
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b, To determine the silver concentration of the treated cages, after and before the in vivo 
experiments, the cages are placed in a thin glass tube and 4ml 20%HNO3 is added. The glass 
tube is then sonicated for 15min to remove all the coating from the surface, and the whole 
5 Experimental part   
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amount of acidic solution is transferred and diluted to 20ml. Further dilutions were made 
when needed. The silver concentration of the solutions was then measured and the loading 
calculated.   
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